Cadherins, Catenins and Associated Proteins in Normal Epidermis, Basal Cell Carcinoma and Other Cutaneous Tumours: An Immunohistochemical Study by Al-Myouf, Abdullah Abdulaziz
Cadherins, Catenins And Associated Proteins In Normal Epidermis, 
Basal Cell Carcinoma And Other Cutaneous Tumours: An 
Immunohistochemical Study
by
Abdullah Abdulaziz Al-Myouf MBBS, MSc.
Thesis submitted for the degree of Ph.D. 
University of Glasgow,
Faculty of Medicine, 
Department of Dermatology. 
January, 2000.
ProQuest Number: 11007855
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 11007855
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
GLA SGCV V 
UNi YE Riiii'Y  
LIBRARY
m
Dedicated to my parents, my wife 
and our three lovely children.
Summary
Background 1: In carcinoma, the detachment of cancer cells from a primary tumour site 
as a result of disorganised cell-cell association is a critical step leading to tumour 
invasion and metastasis. Adherens junctions (AJ) are multiprotein complexes localised 
at intercellular and cell-matrix contacts, mediating the adhesion of cells to each other or 
to matrix structures. The association of actin filaments with the actin-binding proteins 
enables them to serve a variety of functions including the stability of cell shape, 
mechanical support, cell-cell adhesion and cell motility. The latter is thought to be 
driven largely by the polymerisation of actin monomers into filaments near the plasma 
membrane. The maintenance of epithelial differentiation requires proper formation of 
cell-cell junctions where destabilisation of such junctions allows the initiation of the 
invasive process and the progression of carcinoma. Because there is evidence that down- 
regulation or complete loss of the major AJ component, E-cadherin, occurs in 
association with human epithelial cancers, it has been suggested that E-cadherin could 
play a role as an invasion-suppressor molecule.
Aim 1:
• To investigate the cellular distribution of AJ components (E- and P-cadherin, a - and 
P-catenin and associated proteins) in the normal human epidermis and in a variety of 
skin tumours including basal cell carcinoma (BCC), pilomatrixoma (PMX), 
squamous cell carcinoma (SCC) and precursor lesions and melanocytic lesions. Also 
to assess whether the decrease in membranous distribution of the AJ major 
components, particularly cadherins and p-catenin, in human skin cancer progressed 
further in de-differentiation tumours.
• To investigate the possible co-localisation of E- and P-cadherin in the basal and the 
first layer of suprabasal cells of the human normal epidermis and BCC with respect 
to the hypothetical stepwise loss of cadherins by tumour cells.
• To characterise the overall structure of AJ in BCC versus the normal epidermis and 
to investigate the association of AJ components with the actin-based cytoskeleton. 
Also to examine the patterns of distribution of filamentous actin in the normal
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epidermis and BCC and how actin bundles are arranged in the tumour cells with 
respect to their shape, migratory behaviour and thus invasiveness.
• To compare the changes in the abundance and distribution of actin and the expression 
of E-, P-cadherin and p-catenin in nodular and infiltrative BCC with those in 
migrating keratinocytes in vitro.
Methods 1: Immunoperoxidase and double immunofluorescent staining. Cell culture.
Findings 1:
1. In routinely processed paraffin-embedded BCC, E-cadherin staining was reduced in 
tumour cell membranes in 30/32 cases, p-catenin in 29/32 cases and P-cadherin in 
11/32 cases in comparison with the normal epidermis.
2. E-Cadherin, a- and p-catenin were reduced in tumour cell membrane in all the frozen 
samples of BCC (12/12). P-Cadherin was reduced in 10/12.
3. In some cases of BCC, tumour lobules expressed reduced E-cadherin membrane 
staining centrally, while the palisading cells on the peripheries showed positive 
membrane staining similar to that of normal epidermis
4. In well differentiated SCC, E-cadherin and p-catenin staining was reduced in tumour 
cell membranes in 8/10 cases and P-cadherin in 6/10 cases. All were reduced in 
moderately differentiated SCC and keratoacanthoma.
5. In benign hyperplasia, Bowen’s disease and actinic keratosis, P-cadherin was 
expressed in the full thickness of the lesions.
6. E-, P-cadherin and p-catenin membrane staining was reduced in all cases of primary 
and metastatic melanomas and was variable in benign melanocytic lesions.
7. Double immunolabelling of E- and P-cadherin revealed co-localisation of both 
cadherins in the basal and first suprabasal layer of the normal epidermis and in a 
substantial number of BCC tumour cells. However, the majority of tumour cells 
demonstrated preservation of membranous P-cadherin only.
8. There was a dramatic increase in actin filaments polymerisation (stress fibers) in 
infiltrative BCC when compared with the nodular subtype and normal epidermis.
9. The double immunolabelling results of normal skin and most tumour cells in nodular 
and infiltrative BCC have shown separate localisation of E- and P-cadherin, a- and
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p-catenin from actin filaments. However, a portion of E- and P-cadherin, a-catenin 
and a-actinin was co-localised with actin filaments at the plane of the plasma 
membrane.
lO.Keratinocytes cultured in low calcium grew individually in a loose clustered 
morphology, but they closed the wound partially. They also showed weak E-, P- 
cadherin and p-catenin membrane immunofluorescent staining and diffuse 
polymerisation of actin filaments. Keratinocytes, in high calcium conditions, showed 
stronger staining of the cell adhesion molecules, increased actin filaments 
polymerisation (fine stress fibers) and associated more closely to close the wound 
completely.
11 .Double immunolabelling of E-, P-cadherin and p-catenin with actin in both low and 
high calcium keratinocyte cultures revealed no co-localisation.
Main conclusions 1:
1. The reduction in tumour cell membrane E-cadherin, a- and p-catenin in comparison 
with the normal epidermis is a characteristic in BCC and SCC.
2. The decrease in membranous distribution of E- and P-cadherin, a - and p-catenin in 
superficial, nodular BCC, well-differentiated SCC and malignant melanoma 
progressed further in dedifferentiated and metastatic tumours in a direct proportion 
relationship.
3. The downregulation or loss of E-cadherin but not of P-cadherin, particularly in BCC 
and SCC tumours with less aggressive behaviour in addition to the double 
immunolabelling results in BCC may point to a stepwise loss of cadherins during 
tumour progression.
4. The preserved E-cadherin membrane staining in the palisading cells of the BCC 
tumour lobules may indicate that E-cadherin is one of multiple biological factors 
involved in the prevention of free stromal invasion and metastasis.
5. Suprabasal P-cadherin expression in benign hyperplasia and pre-malignant lesions 
may indicate that this molecule is proliferation-associated.
6. Co-localisation of E- and P-cadherin in normal epidermis suggests that E- and P- 
cadherin could be in the same junction plaque.
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7. The dramatic increase in actin filaments polymerisation (stress fibers) in infiltrative 
BCC when compared with the nodular subtype and normal epidermis indicates a 
relation to the infiltrative growth pattern of BCC rather than rapid growth. This was 
accompanied by decreased membrane staining of the cell adhesion molecules E- 
cadherin, a- and p-catenin and a-actinin emphasising enhanced tumour cell motility 
and thus invasion.
8. Co-localisation of a-catenin and a-actinin with the actin filaments could be 
explained by the interactive role of a-catenin where it connects the membrane 
associated complex to the actin-based cytoskeleton.
9. Results of keratinocyte culture indicate that the cells grown in low calcium were less 
motile (similar to nodular BCC) as they showed weak actin staining and migrated 
into the wound but failed to close it completely, while the cells grown in high 
calcium were more motile as they showed increased actin filament polymerisation 
(similar to infiltrative BCC) and migrated in a sheet-like colony and closed the 
wound completely.
Background 2: During development there is interaction between the Sonic hedgehog 
(Shh)/Patched (Ptc) and the Wnt/Wingless (Wg) signalling pathways. It has been 
reported that the Shh/Ptc signalling pathway is dysregulated in BCC. Recently, 
mutations in p-catenin were found in the hair follicle tumour PMX. In addition to P- 
catenin’s role in supporting cell adhesion at the cell-cell junctions by association with E- 
cadherin, another role for p-catenin in signal transduction has been proposed where it 
acts as a key component of the Wnt signalling pathway possessing a nuclear function as 
it binds transcription factors, Lymphoid Enhancer Factor (LEF-1) and T Cell Factor 
(TCF). The activation of the Hedgehog/patched signalling pathway in drosophila is 
associated with transcriptional activation of specific target genes including Wg which 
may lead to the secondary activation of the Wnt/p-catenin signalling pathway 
contributing to the development of BCC. The transcription factor Gli-1 is required 
during the activation of the Shh/Ptc signalling pathway which is associated with 
transcriptional activation of specific target genes including Wg and Ptc.
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Aim 2:
• To investigate whether any decrease in membrane p-catenin expression in epidermal 
tumours is accompanied by redistribution to the cell nucleus secondary to the 
activation of the Wnt pathway.
• To investigate the expression of the transcription factor Gli-1 in normal skin and 
BCC as there is evidence that the activation of the Shh/Ptc-Smo signalling pathway 
plays a key role in BCC development.
Methods 2: Immunoperoxidase staining.
Findings 2:
1. Routinely processed, paraffin-embedded BCC showed nuclear localisation of P- 
catenin in 13/32 cases (N-terminus) and 8/32 cases (C-terminus), while frozen BCC 
showed nuclear staining of both termini in 1/12 cases. This was accompanied by 
reduced P-catenin membrane staining.
2. Tumour cell membrane staining of N and C termini of p-catenin was evenly reduced 
in 4/10 PMX but there was strong nuclear staining with both the N and C terminal 
antibodies in 7/10 tumours.
3. Bowen’s disease showed nuclear localisation of C-terminus p-catenin in 2/10 cases 
accompanied by reduced membrane staining.
4. In routinely processed, paraffin-embedded BCC, tumour cell nuclear staining of Gli- 
1 was seen in 16/32 cases (N-terminus) and 21/32 cases (C-terminus). Normal 
epidermis showed variable and weak nuclear staining in the basal cells in a minority 
(5/32 N-terminus, 6/32 C-terminus).
Main conclusions 2:
1. The detection of nuclear p-catenin staining in Bowen’s disease and BCC in addition 
to PMX is novel as it suggests that dysregulation of P-catenin cellular distribution 
may be common to several pathways leading to epidermal carcinogenesis.
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2. While activation of p-catenin by mutation may be a primary event in PMX, it seems 
more likely that in BCC and Bowen’s disease nuclear localisation of P-catenin would 
be secondary to activation of the Wnt pathway or possibly due to redistribution of p- 
catenin as a result of disruption in AJ.
3. Gli-1 nuclear localisation in BCC strongly supports the evidence which indicates that 
Gli-1 may be a transcriptional activator in which it provides evidence for the 
activation of the Shh/Ptc signalling pathways in this tumour.
Background 3: BCC is the commonest cutaneous tumour in humans. It is locally 
invasive but rarely metastasises. Biochemical and molecular studies of BCC were 
limited by the lack of a suitable and reproducible tissue-culture model system. Unlike 
other cutaneous tumours, attempts to grow BCC in primary cultures have not been 
found to be successful.
Aim 3: To grow different subtypes of BCC tumours in vitro.
Methods 3: Cell culture by seeding fresh single cell suspension of BCC derived by 
collagenase/dispase treatment onto fibroblast-embedded collagen gel model.
Findings 3:
1. Dermal equivalents seeded with tumour single cell suspensions derived from an 
infiltrative BCC showed massive degradation after 48 hours of incubation at 37°C in 
a humidified atmosphere of 5% CO2 in air. Results were confirmed by using cells 
from a second infiltrative BCC.
2. BCC-derived cells from nodular and superficial BCC did not degrade the dermal 
equivalents following incubation at 37°C in a humidified atmosphere of 5% CO2 in 
air for 5 days as submerged cultures.
3. Dermal equivalent seeded with 1 x 105 tumour-derived cells from nodular BCC 
showed viable basaloid cells reminiscent of BCC cells after 11 days of culture.
4. BCC-derived cell cultures using tissue culture flasks coated with foetal calf serum 
and/or with Type I collagen failed to yield cell growth. In addition, culture of tumour
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cells mixed with or without normal keratinocytes onto fibroblast-free and standard 
dermal equivalents gave similar negative results.
Main conclusions 3:
1. The massive degradation of dermal equivalents could be due to several reasons: 
firstly, due to the production of collagenase by infiltrative BCC cells, secondly due to 
a fibroblast-derived collagenase activity released either from BCC stromal cells or 
dermal equivalent fibroblasts upon interaction with BCC cells.
2. The absence of dermal equivalent degradation using superficial and nodular BCC in 
contrast to the massive degradation using infiltrative BCC strongly suggest that the 
various subtypes of BCC differ in their degrading properties in vitro and may explain 
the more aggressive behaviour of infiltrating BCC clinically.
3. In general, the results of BCC culture were not satisfactory, however, modification of 
the technique used in my work may allow future studies using dermal equivalents as 
a potential model for BCC culture.
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Chapter 1: Introduction
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1.1. Basal cell carcinoma (BCC)
BCC is the commonest cutaneous tumour in humans, particularly in the white 
population (MacKie, 1996a). Although accurate data are not available, about 1.2 
million BCC cases were managed in the USA in 1995 alone and the incidence of this 
tumour in the western countries is increasing by 3-6% each year (Bastiaens et al., 1998). 
Overexposure of fair-skinned individuals to ultraviolet radiation is generally accepted as 
the main causal factor of BCC; however, this correlation is not complete, since about 
20% of tumours still occur in unexposed body areas (MacKie, 1996a; McKee, 1996a). 
Sun exposure during childhood and adolescence may be the critical factor for 
establishing adult risk for BCC (Gallagher et al., 1995). Other causes of this tumour 
include ionising radiation (Lever and Schaumburg-Lever, 1990a) and, less commonly, 
chronic forms of physical injury e.g. bum scars, tattoos and smallpox vaccination sites 
(MacKie, 1996a; McKee 1996a; Preston and Stem, 1992). Prolonged intake of 
inorganic arsenic and exposure to coal tar derivatives may also lead to the development 
of BCC (McKee, 1996a).
Although there is no formal grading system for BCC, they could be classified into five 
main clinical subtypes (McKee, 1996a):
1. Nodulocystic/ulcerative BCC (45-60%) starts as a small translucent papule which 
subsequently becomes nodular with few telangiectatic vessels and ulcerates centrally. 
The margin of the ulcer is well-defined, slightly raised and rolled (du Vivier and 
McKee, 1993a). Histologically the tumour is composed of large basaloid lobules 
varying in size and shape with a loose surrounding stroma usually rich in mucin. 
This tumour is characterised by separation of the lobules from their associated stroma 
and retraction which could be related to basement membrane abnormalities of 
adhesion and fixation resulting in mucin shrinkage (McKee, 1996a).
2. Diffuse (infiltrating and morphoeic) BCC (4-17%) is most likely to be misdiagnosed 
as a scar. It may present as a slightly elevated, smooth, firm plaque (du Vivier and 
McKee, 1993a). The morphoeic pattern of this tumour is due to excessive connective 
tissue proliferation with narrow tongues of epithelium that extend deeply into the 
adjacent fibrous stroma (MacKie, 1996a; du Vivier and McKee, 1993a).
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3. Superficial (multifocal) BCC (15-35%). The lesions are usually multiple and appear 
as erythematous, slightly scaly plaques often with a fine, rolled margin (Fitzpatrick et 
al., 1992). This tumour is typified by many discrete downgrowths of small and dark 
basaloid cells from the dermoepidermal junction (MacKie, 1996a).
4. Pigmented BCC (1-7%) differs from the nodulocystic/ulcerative subtype only by the 
heavily pigmented margins of the tumour (Lever and Schaumburg-Lever, 1990a). 
The pigmentation may be evident in both dendritic melanocytes and stromal 
macrophages. Dense deposits of haemosiderin may also sometimes be present 
(McKee, 1996a).
5. The fibroepithelioma of Pinkus is frequently found adjacent to a basal cell carcinoma 
(MacKie, 1996a). It consists of usually only single but occasionally multiple papules 
or nodules, covered by smooth, slightly reddened skin (du Vivier and McKee, 1993a; 
Fitzpatrick et al., 1992). The characteristic feature of this tumour is multiple strands 
of basaloid epithelial cells arising from the epidermis that have anastomosed to create 
a complicated net-like pattern (McKee, 1996a).
Other variants of BCC include the basisquamous or metatypical type, where squamous 
differentiation is a feature (MacKie, 1996a). Occasionally some tumours may show 
focal clear cell change due to glycogen accumulation, hence the clear cell variant, others 
may be called keratotic where horn cysts are evident or granular due to membrane- 
bound lysosomal-like granules (McKee, 1996a).
In addition, there are clinical syndromes in which BCC play an important part. They are 
Gorlin’s syndrome (basal cell naevus syndrome) (Howell and Caro, 1959; Gorlin, 1987), 
linear unilateral basal cell naevus (Anderson and Best, 1962) and Bazex syndrome 
(Plosila et al., 1981; Goeteyn et al., 1994).
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1.1.1. Pathogenesis and biology of BCC
In BCC there is a dual population of a fibrous stroma surrounding lobules of dependent 
cells which have a large, oval or elongated nucleus and relatively poorly defined 
cytoplasm that resemble those of basal cells of the epidermis and outer root sheath 
(ORS) of hair follicle (Lever and Schaumburg-Lever, 1990a). A peripheral palisade is 
usually present around the edge of the lobule (McKee, 1996a). BCC cells differ from 
basal cells and ORS cells by having a larger ratio of nucleus to cytoplasm and by the 
absence of intercellular bridges (Lever and Schaumburg-Lever, 1990a). Recently, 
(Kore-eda et al., 1998) have reported evidence that BCC cells are more closely related to 
follicular matrix cells than they are to ORS cells. However, the analysis of the 
immunophenotype of BCC in comparison with the human vellus hair follicular 
keratinocytes revealed a close relationship between BCC and ORS cells and the bulge 
region of the vellus hair follicle (Kruger et al., 1999).
The mechanism of pathogenesis in BCC could be due to flawed rehearsal of 
embryological differentiation because of stromal dependence and the capacity of the 
tumour for limited differentiation towards any skin appendage (McKee, 1996a).
Probably, due to the difficulty in ascertaining that BCC excision is complete, 
basisquamous and infiltrating tumours are more likely to recur (MacKie, 1996a; Sloane,
1977). However, the form of therapy chosen, as well as size, location, and histology 
play an important role in defining the risk of recurrence. Although BCC is typically a 
slowly growing tumour that may recur, metastatic cases are a rare entity (Miller, 1991).
Treatment of BCC is with excision with primary closure, skin flaps, or grafts. The use of 
cryosurgery, curettage and electrosurgery are other options. For lesions in the nasolabial 
area or around the eyes and in morphoeic BCC, Mohs surgery is the best approach 
(Telfer et al., 1999).
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1.2. Squamous cell carcinoma (SCC) and precursor lesions
Squamous cell carcinoma (SCC) of the skin is a malignant lesion which may occur 
anywhere on skin and on mucous membranes with squamous epithelium (Lever and 
Schaumburg-Lever, 1990b). SCC of the skin is the second commonest malignancy 
following BCC in fair-skinned people (Preston and Stem, 1992; Marks et al., 1988a). 
SCC is derived from epidermal keratinocytes in sun-damaged skin commonly from solar 
keratosis or Bowen’s disease, and composed of cytologically malignant cells with the 
capacity for metastatic spread (MacKie 1996b). Bowen’s disease and solar keratoses are 
in situ dysplastic lesions of particular importance. They indicate previous exposure to 
ultraviolet radiation and most importantly predict the strong possibility of developing 
SCC of the skin (Marks et al., 1988b).
Keratoacanthoma is histologically similar to SCC and regarded as a squamous cell 
carcinoma variant rather than as a benign or pseudomalignant tumour (McKee, 1996b).
The tme incidence of SCC is variable and difficult to determine with accuracy, but is 
progressively rising in developed countries (Ko et al., 1994). The most common cause 
of SCC in Caucasians is ultraviolet irradiation, but exposure to polycyclic hydrocarbons 
and ingestion of arsenic may induce the tumour. SCC may be a late consequence of the 
scarring process and skin disease affecting the mucosae, for example, lichen planus and 
lichen sclerosus et atrophicus, or can be a consequence of certain genetic diseases such 
as albinism and xeroderma pigmentosum. The tumour may arise as a complication of 
treatment with photochemotherapy (PUVA), extensive application of topical nitrogen 
mustard and prolonged use of immunosuppressive agents in renal transplant patients (du 
Vivier and McKee, 1993a). Human papilloma virus has been implicated in the 
development of SCC. Typically, the lesion will start as a thickening of the skin and 
becomes an indurated plaque which grows laterally and vertically. Eventually, the 
lesion becomes nodular and may ulcerate (du Vivier and McKee, 1993a; MacKie, 
1996b).
Histologically, SCC are subdivided into 3 major variants depending upon the degree of 
differentiation. Well-differentiated tumours are characterised by invading islands of
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squamous epithelium that shows obvious and abundant keratinisation with well-formed 
intercellular bridges readily apparent. Moderately differentiated tumours are typified by 
more mitotic activity and nuclear pleomorphism with architectural disorganisation. In 
poorly differentiated variants, there is marked nuclear and cytoplasmic pleomorphism 
with hyperchromatic and sometimes bizarre nuclei and conspicuous mitotic figures. 
Rarely, poorly differentiated variants will show intercellular bridges and foci of 
keratinisation (du Vivier and McKee, 1993a; McKee 1996b). In comparison with BCC, 
cutaneous and mucosal SCC have a higher metastatic potential. High recurrence and 
metastasis rates are associated more with poorly differentiated than well-differentiated 
variants particularly with the presence of perineural, lymphatic and vascular 
involvement. The frequency of metastasis in SCC is variable and the rate is higher 
particularly with recurrent SCC (25-45%) (Rowe et al., 1992). SCC metastatic 
frequency seems to be dependent upon many factors. These include the site of the 
primary tumour in the skin, histologic subtypes, tumour diameter, aetiology, host 
immunosupression and prior treatment (Kwa et al., 1992).
1.3. Benign melanocytic lesions and malignant melanoma
In the earliest stage of development, the melanocyte migrates from the neural crest to the 
dermoepidermal junction (MacKie, 1996c). Melanocytes at the basal layer of the 
epidermis may be polygonal and epithelioid with eosinophilic cytoplasm and contain 
uniform round-oval small nuclei with prominent nucleoli (McKee, 1996c).
Benign melanocytic tumours composed of naevus cells derived from the melanocytes in 
the basal layer are hamartomatous conditions that usually present in childhood and 
adolescence (McKee, 1996c). They can be divided into 3 main categories. Junctional 
naevi which are solely intraepidermal, form well-circumscribed nests of many naevus 
cells with no involvement of the upper epidermis (MacKie, 1996c). Intradermal naevi 
show no junctional activity and are entirely dermal lesions (du Vivier and McKee, 
1993b). In these, naevus cells are small and compact with a relatively epithelioid 
appearance particularly in the more superficial aspects of the lesion (MacKie, 1996c). 
With the increasing depth of the lesion, the naevus cells become progressively smaller 
with minimal cytoplasm and hyperchromatic nuclei and occasionally may adopt a
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spindle cell morphology (du Vivier and McKee, 1993b). Compound naevi possess 
features of both junctional and intraepidermal naevi (Lever and Schaumburg-Lever, 
1990c). Other totally benign melanocytic lesions are Spitz and blue naevi. The Spitz 
naevus in most instances has the basic architecture common to all melanocytic naevi 
(Hoss and Grant-Kels, 1986). It is composed of large melanocytes nests with spindle 
and epithelioid features at the junctional and/or dermal regions (Paniago-Pereira et al.,
1978). Although it may be histologically misdiagnosed as a malignant melanoma 
(Okun, 1979), it shows marked retraction artefacts in its junctional components, and 
striking lateral symmetry in contrast to the disorganised morphology and irregular lateral 
border of melanoma (McKee, 1996c). In blue naevus, the overlying epidermis is usually 
normal and the lesion is typically confined to the deeper aspect of the dermis and may 
extend to the hypodermal region (Lever and Schaumburg-Lever, 1990c). Its pathology 
is that of a spindle cell population of naevus cells which tend to be large and bipolar 
interwoven between collagen bundles (MacKie, 1996c).
Atypical naevi whether familial or sporadic show melanocytic architectural and 
cytologic dysplasia and are associated with an increased incidence of malignant 
melanoma particularly in the familial variants (Cook and Robertson, 1985; Barnhill,
1991). They may be junctional or compound, displaying the characteristic lentiginous 
melanocytic hyperplasia along the sides as well as the tips of the epidermal ridges. The 
dysplastic cells which may be present singly or in clusters usually show increased 
nuclear size, cytoplasmic pleomorphism and variable hyperchromatism (McKee, 
1996c). These features in addition to the occasional mitotic figures seen in atypical 
melanocytes must be differentiated from the in situ superficial spreading melanoma with 
radial growth phase.
Malignant melanoma is a very important neoplasm because of the current increase in its 
incidence rate leading to a rise in morbidity and mortality (MacKie et al., 1991). In 
Australia, for instance, about 30 males and 24 females/100,000 of the population are 
affected each year (Jelfs et al., 1994).
The aetiology of malignant melanoma is multifactorial including genetic and racial 
factors, however, in the majority of tumours, excessive exposure to ultraviolet light is 
the most important predisposing factor (McKee, 1996c).
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Malignant melanoma could be divided on clinical pathological grounds into 4 subsets,
these are:
1. Lentigo maligna melanoma is an intraepidermal proliferation of usually spindle- 
shaped malignant melanocytes replacing the epidermal basal layer particularly in the 
lateral growth phase. The epidermis is usually atrophic and the dermis shows solar 
elastosis (MacKie, 1996d)
2. Superficial spreading malignant melanoma is not usually associated with features of 
severe actinic damage. Malignant cells characteristically spread from one epidermal 
ridge to the adjacent one and are irregularly distributed, singly or in nests, throughout 
the epidermis involving the upper layers. These cells are large with abundant 
cytoplasm and pleomorphic vesicular nuclei. Invasive tumours are usually of 
epithelioid cell type (du Vivier and McKee, 1993a).
3. Nodular malignant melanoma is characterised by a very sharp transition from normal 
epidermis to an area of invasive tumour with downgrowths of malignant cells into the 
dermis (MacKie, 1996d). Melanoma cells in this subset are typically divided into 
two type. Epithelioid cell type in which melanoma cells are large and rounded with 
abundant cytoplasm and prominent pleomorphic vesicular nuclei showing abnormal 
mitotic figures occasionally. The spindle cell type is characterised by elongated cells 
reminiscent of mesenchymal cells (McKee, 1996c)
4. Acral lentiginous melanoma and its variant subungual malignant melanoma (MacKie, 
1996d) have a similar pathology to that of lentigo maligna melanoma except that the 
epidermis is hyperplastic (du Vivier and McKee, 1993a).
The survival of patients with malignant melanoma can be related to depth of the 
infiltration of the dermis by using the Clark subclassification.
Level I: where tumour confined to the epidermis.
Level II: infiltration of the papillary dermis by single cells.
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Level III: infiltration to the junction of the papillary with the reticular dermis.
Level IV: infiltration of the reticular dermis.
Level V : infiltration of the subcutaneous fat.
Prognosis is good for levels I and II but increasingly poor for III to V (du Vivier and 
McKee, 1993a).
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Overview
One of the prominent phenotypic alterations exhibited by tumour cells is the change in 
cellular morphology and histological differentiation compared to normal cells. 
Development of malignant tumours, including malignant cutaneous tumours, is 
characterised by the ability of tumour cells to overcome the cell-cell adhesion, served by 
desmosomes and AJ, and to invade surrounding tissue. Many different cell adhesion 
molecules, including major AJ components, are implicated in human carcinogenesis in 
which changes in these molecules accompany the tumour de-differentiation.
In the following sections I will give an introduction to the structures, properties and 
functions of the major AJ components (cadherins, catenins and other associated 
proteins). Additionally, the cellular distribution of these proteins in normal human 
tissues and tumours will be reviewed.
1.4. Adherens junctions ( AJ)
AJ are multiprotein complexes localised at intercellular and cell-matrix contacts, 
mediating adhesion of cells to each other or to matrix structures (Knust and Leptin, 
1996; Alberts et al., 1998). The initiation of AJ formation is maintained by focal 
accumulation and homophilic binding between the cell-cell adhesion molecules,
I
cadherins, which require Ca ions be present in the extracellular medium (Lodish et al., 
1995; Alberts et al., 1998; Hitt and Luna, 1994).
There are 3 different types of AJ localised at cell-cell and cell-matrix contacts which 
have been demonstrated in tissues and cultured cells: In vitro focal contact, which is 
formed at sites of attachment of cells to the culture surface; the classical zonula 
adherens which form a continuous adhesion belt (belt desmosome) around polarised 
epithelial cells in the apical region of the cell, just below the tight junctions; and a third 
type, localised at cell-cell contacts which appear structurally similar to desmosomes by 
conventional electron microscopy (Kaiser et al., 1993). It has been shown that AJ are 
present in human normal epidermis and oral mucosa (Kaiser et al., 1993).
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E-Cadherin is considered to be a key element of the AJ where its cytoplasmic portion is 
associated with a variety of cytoplasmic proteins, some of which, such as (3-catenin, 
bind directly to E-cadherin, while others, like a-catenin, vinculin, a-actinin or radixin, 
link the cadherin/p-catenin complex to actin filaments, thereby coupling cell adhesion to 
the modulation of cell shape (reviewed by Hitt and Luna, 1994; Kemler, 1993; Ranscht, 
1994). The regulatory role of E-cadherin in Ca -induced adherens junction 
organisation in cultured keratinocytes may be mediated through activation of protein 
kinase C (Lewis et al., 1995).
1.5. Cadherin superfamily classification
There are 6 gene families comprising the cadherin superfamily depending on the number 
of repeats and on sequence homologies (reviewed by Aberle et al., 1996). These gene 
families are as follows:
1. Classical cadherins (type I) which are mainly localised in AJ and include epithelial 
(E-); neural (N-); placental (P-); retinal (R-); xenopus blastomere (XB-); ubiquitously 
expressed during early development (U); related to E- and P-cadherin (EP); brain (B- 
); chicken liver cadherin (L-CAM); kidney (K-) and osteoblast (OB) cadherin (Xiang 
et al., 1994; Okazaki et al., 1994), (reviewed by Kemler, 1993; Ranscht, 1994).
2. Classical cadherins (type II) which include cadherin-6 to -12. Apart from cadherin- 
11 which was localised in the human placenta (Getsios et al., 1998), their localisation 
and function have not been identified fully. Other classical cadherins which were 
not classified under the above 2 types include muscle (M-) cadherin and cadherin-5 
(Alattia et al., 1999).
3. Desmosomal cadherins which include desmocollins 1-3, desmogleins 1-2 and the 
pemphigus vulgaris antigen (desmoglein 3) (Amagai et al., 1991; Buxton et al.,
1993). These are localised in the intercellular adhesion junction structures, termed 
desmosomes, which mediate strong adhesion between cells in many epithelial (e.g. 
between keratinocytes) and non-epithelial tissues (Garrod, 1993). They may 
participate in the actual binding of the keratinocytes and are thought to be involved in
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maintaining the mechanical strength of the epidermis under physiological conditions 
(Horiguchi et al., 1994).
4. Cadherins with a very short cytoplasmic domain or none e.g. truncated (T-) cadherin 
and liver/intestine (LI-) cadherin (Bemdorff et al., 1994; Ranscht, 1994).
5. Protocadherins PC42 and PC43 which are cadherin-related molecules shown to 
mediate calcium-dependent, homophilic cell adhesion (Sano et al., 1993).
6. Related gene products including the drosophila fat tumour suppressor gene (Mahoney 
et al., 1991), the dachsous gene, and the ret-protooncogene (Hashizume et al., 1996; 
Aberle et al., 1996).
1.6. Classical cadherins
The intercellular adhesion molecule, cadherin, was first reported in 1977 (Takeichi, 
1977). Numerous members of the classical cadherin family have been identified and E- 
and N-cadherin are the best characterised molecules in the family (Barth et al., 1997). 
Classical cadherins mediate Ca2+-dependent cell-cell adhesion which are expressed on 
the cell surface and which function as intercellular adhesion molecules (Rasbridge et al.,
1993). They play important roles in membrane integration, cytoskeletal interactions, 
and posttranslational modifications such as glycosylation, phosphorylation and 
proteolysis. Furthermore, they possess functional sites for adhesive recognition and 
calcium binding (Alattia et al., 1999). Cadherins play a role in the regulation of 
keratinocyte growth and differentiation and may be involved in controlling integrin 
expression (Moles and Watt, 1997). They are transmembrane proteins which are 
characterised by a highly conserved carboxy-terminal cytoplasmic domain (Kemler, 
1992). Many studies on classical cadherins have shown that the cytoplasmic domain 
regulates the function of these proteins through its direct interactions with a number of 
cytoplasmic components called catenins or plakoglobin that link them to the actin-based 
cytoskeleton (Mathur et al., 1994; Cowin and Burke, 1996). Their extracellular 
domains, located in the N-terminal part of the molecule, consist of repeated Ca - 
binding subdomains (Vleminckx and Kemler, 1999). This part is structurally 
determined by the binding of calcium ions which are central to the homophilic adhesion 
with cadherin molecules on adjacent cells (Ringwald et al., 1987; Nagafuchi et al.,
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1987) (Fig. 1). Intracellularly they are attached, via linker proteins, to cytoskeletal 
filaments (Barth et al., 1997; Alberts et al., 1998).
Each of the classical cadherins is an integral membrane glycoprotein of 720-750 amino 
acids. On average, 50-60% of the sequence is identical among different cadherins. 
Importantly, each cadherin has a characteristic tissue distribution (Lodish et al., 1995). 
Suppression of cadherin expression has been found to correlate with tumour-cell 
invasion and metastasis (reviewed by Takeichi, 1993). However, expression of 
cadherins is developmentally regulated in which it facilitates several morphogenetic 
processes such as cell-sorting mechanisms (Nose et al., 1988), migration of cells, cell 
polarity, formation of boundaries between cell layers, maintenance of proliferation of 
cells within a cell layer and ultimately, differentiation of each cell layer into functionally 
distinct structures (Takeichi, 1988; 1991).
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Figure 1. Classical cadherin structure (Ranscht, 1994; W heelock et al., 1996). Mature 
cadherins are transm em brane proteins derived from a precursor by cleavage o f  the Pre-region. 
The m em brane-spanning domain is labelled TM  and the extracellular portion is labelled EC1- 
EC5 o f  approxim ately  110 am ino acids each. Calcium  ion-binding sites between adjacent EC 
dom ains are indicated. EC1 is enlarged to show  the s trand-dimer tryptophan, the H A V  
(Histidine, Alanine, Valine) domain, and the domain in which H A V  interacts with its 
homotypic partner cadherin. The strand-dimer tryptophan near the N -term inus o f  EC1 plays a 
role in the formation o f  the strand dimer. The cytoplasmic region interacts with p-catenin and 
is highly conserved between different cadherin species.
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1.7. E-Cadherin
The mechanisms of cell adhesion play a key role in many major cellular processes such 
as embryogenesis, tissue and organ patterning, maintenance of specific tissue 
architectures and tumour formation (Navarro et al., 1991).
In carcinoma, detachment of cancer cells from a primary tumour site as a result of 
disorganised cell-cell association is a critical step leading to tumour invasion and 
metastasis (Liotta, 1986; Nicolson, 1988). This phenomenon is attributable largely to 
the disruption of intercellular adhesion mediated by epithelial (E-) cadherin which acts 
as an invasion suppressor molecule (Schipper et al., 1991; Vleminckx et al., 1991; 
Fuller et a l, 1996) (reviewed by Takeichi, 1993; Behrens, 1999).
E-Cadherin as all the members of the classical cadherins is composed structurally of a 
highly conserved cytoplasmic region and an ectodomain with four structural repeats 
containing calcium-binding motifs and a cysteine-containing region (Fig. 1) (Ranscht, 
1994).
The carboxy-terminal cytoplasmic domain of E-cadherin interacts directly with p- 
catenin (Fig. 2) and can also associate with other proteins in the complex like 
plakoglobin and pl20cas. E-Cadherin competes with adenomatous polyposis coli (APC), 
tumour suppressor gene product, for the direct binding with p-catenin; however, there 
are differences between E-cadherin/catenin and APC/catenin complexes and both 
molecules cannot be bound to p-catenin at the same time (Hulsken et al., 1994; Ilyas and 
Tomlinson, 1997). The binding of E-cadherin to p-catenin is positively regulated by 
serine phosphorylation (Cowin and Burke, 1996). P-Catenin is central to the 
architecture of E-cadherin/p-catenin complex, linking E-cadherin indirectly to a-catenin 
(Aberle et al., 1996). E-Cadherin has a regulatory role in the organisation of Ca2+- 
induced AJ in cultured keratinocytes and in other epithelial tissues (O’Keefe et al., 
1987; Lewis et al., 1995). This role may be mediated through activation of protein 
kinase C (PKC) (Lewis et al., 1995).
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Figure 2. Connections at adherens junctions (Cowin and Burke, 1996). E-Cadherin dimers 
connect directly to repeats 5-8 of p-catenin (p-cat). Binding of p-catenin to E-cadherin is posi­
tively regulated by serine phosphorylation indicated with (*). The amino terminus (N) and the 
first repeat of p-catenin bind to the amino-terminal half of a-catenin (a-cat). Tyrosine phospho­
rylation (**) of the amino terminus of p-catenin negatively regulates the association between the 
cadherin-catenin complex and filamentous actin (F-actin); serine phosphorylation (*) of the head 
domain targets cytosolic form of p-catenin for degradation. a-Catenin (a-cat) associates with 
filamentous actin through its amino and carboxyl termini and it also binds to a-actinin (a-act). 
The latter binds both filamentous actin and vinculin (V).
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1.7.1. Expression and gene mutations of E-cadherin in various tumours
The maintenance of epithelial differentiation requires proper formation of cell-cell 
junctions where destabilisation of such junctions allows initiation of the invasive 
process and the progression of carcinoma (Behrens et al., 1989; Frixen et al., 1991; 
Vleminckx et al., 1991; for review see Nicolson, 1988; Takeichi, 1993).
E-Cadherin is considered to be the major adhesion molecule found in AJ where it is 
expressed on most cell types that form solid tissues (Takeichi, 1988; Tang et al., 1994).
Down-regulation or complete loss of E-cadherin occurs in association with human 
epithelial cancers and it may convey additional signals to induce tumour-cell invasion 
(Fuller et al., 1996; Perl et al., 1998; Cano et al., 1996). This inverse correlation 
between the expression of E-cadherin and tumourigenicity has led to the proposition that 
E-cadherin acts as an invasive suppressor and may be a useful prognostic marker in 
cancer (Navarro et al., 1991; Cheng et al., 1996).
Recently, there is an accumulating experimental evidence suggesting that down- 
regulation or change in structure of one or more of the major components of AJ could 
lead to junctional disassembly and consequently to a reversion from a benign to an 
invasive epithelial phenotype (Perl et al., 1998; Vleminckx et al., 1991; Schipper et al., 
1991; Shiozaki et al., 1994; Takayama et al., 1996).
During the past several years, various laboratories and institutions have realised the 
importance of characterising the structure and function of cellular adhesion molecules in 
human epithelium. This led to the awareness of the central role of E-cadherin in the 
formation of epithelial cell-cell junctions (AJ) and of the potential function of this 
protein as a biochemical marker for tumour progression. Because E-cadherin may 
function as an invasive suppressor of malignant tumours, studies have concentrated on 
the examination of E-cadherin expression and cellular localisation in various human and 
animal malignancies suggesting a correlation between reduced expression of E-cadherin 
and loss of differentiation and increased invasive potential of malignant tumours. These 
studies were carried out in a variety of tumours, including skin (Schipper et al., 1991; 
Pizarro et al., 1994; Fuller et al., 1996; Cowley and Smith, 1996; Cano et al., 1996), 
breast (Rasbridge et al., 1993; Oka et al., 1993; Glukhova et al., 1995), colorectal 
(Kinsella et al., 1993) and prostate cancers (Cheng et al., 1996). However, in skin,
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studies on E-cadherin expression were limited, for instance, to a particular tumour such 
as SCC of the head and neck (Schipper et al., 1991), where it was found to be inversely 
correlated with the loss of differentiation. In addition, although the reduction of E- 
cadherin expression was related to the growth pattern and the local aggressive behaviour 
of BCC, it was reported to be strongly preserved in both superficial and nodular 
subtypes of BCC (Pizarro et al., 1991). Fuller and colleagues (1994) demonstrated that, 
in BCC and SCC, expression of E-cadherin was reduced, however, no correlation with 
tumour de-differentiation in BCC was mentioned and insufficient material was present 
to correlate SCC behaviour with level of E-cadherin expression.
Transformation from a normal epithelial cell to a malignant cell is a complicated 
process involving many steps and results from accumulation of multiple gene 
abnormalities. Mutations of the E-cadherin gene have recently been discovered in a 
variety of carcinomas including human gastric carcinoma and cell lines (Becker et al., 
1994; Oda et al., 1994), carcinomas of the endometrium and ovary (Risinger et al.,
1994). The truncated E-cadherin protein which is unable to associate with P-catenin is 
predicted to act as a dominant negative by preventing wild type E-cadherin forming 
normal AJ.
Since I started my work, other studies of E-cadherin expression in tumours took place 
such as in skin (Silye et al., 1998; Montonen et al., 1998), gastric (Guilford et al., 1998; 
Jawhari et al., 1999), pancreatic (Perl et al., 1998), bladder (Giroldi et al., 1999), 
nasopharyngeal (Zheng et al., 1999). The findings of these studies will be discussed in 
relation to my work in the discussion section.
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1.7.2. E-Cadherin expression in normal skin and in skin tumours
In the normal epidermis, E-cadherin is expressed on the cytoplasmic membranes of 
human epidermal keratinocytes (Fujita et al., 1992; Horiguchi et al., 1994) where it 
maintains adhesion between these cells by homophilic binding (Lewis et al., 1994; 
Horiguchi et al., 1994). In addition, E-cadherin is expressed on the membranes of 
normal epidermal melanocytes, and more recently Langerhans cells, although they lack 
both desmosomes and AJ (Tang et al., 1994; Blauvelt et al., 1995; Seline et al., 1996). 
Through homophilic binding, E-cadherin may function to organise and maintain the 
epidermal-melanin unit (Seline et al., 1996).
E-Cadherin is distributed in the full thickness of the epidermis excluding stratum 
comeum (Shimoyama et al., 1989; Horiguchi et al., 1994), with an increased expression 
in the suprabasal layers as compared with the basal cells (Cano et al., 1996). In the hair 
follicle, E-cadherin is strongly expressed in the outer root sheath cells at the region of 
the infundibulum and weaker in the lower segment while sebaceous and sweat glands 
express E-cadherin in their outermost cells (Fuller et al., 1996).
Loss of E-cadherin expression in BCC and SCC, but not in premalignant lesions, was 
found to be consistent with the observation that the loss of E-cadherin is associated with 
tumour invasion (Fuller et al., 1996). In the previous study, although there was a 
reduction in E-cadherin expression in almost all cases of BCC, E- cadherin expression 
was decreased more extensively in SCC than in BCC. The reduction of E-cadherin 
expression was related only to infiltrating growth of BCC (Pizarro et al., 1994), whereas 
solid tumours such as superficial and nodular, showed preserved E-cadherin expression. 
Downregulation or loss of E-cadherin in BCC, SCC and malignant melanoma indicated 
a close association with de-differentiation and invasion potential of these tumours 
(Schipper et al., 1991; Montonen et al., 1998). In malignant melanoma, a differential 
loss of E-cadherin expression was noted (Silye et al., 1998). This was particularly 
observed in dermal nests of melanomas in their radial growth phase and in Clark level II 
and III lesions, whereas it was present in a considerable proportion of melanomas in 
their vertical growth phase, in Clark level IV and V lesion and in metastasising 
melanomas. In the previous study, membranous E-cadherin expression was detected in
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all benign naevi, although heterogeneous in junctional naevus cell nests. However, 
Cowley and Smith (1996) reported that cadherin expression, and particularly E-cadherin 
expression, tended to be much greater in malignant melanomas than in benign 
melanocytic naevi.
E-Cadherin expression may be focally downregulated or even lost in premalignant 
lesions (Cano et al., 1996). This kind of observation seems to represent an earlier 
indication of the more pronounced changes seen at the invasive stage of the tumours and 
it could provide an advantage to the premalignant cells by detaching from the adjacent 
cells, in agreement with the proposed anti-invasive role for E-cadherin (Cano et al., 
1996).
1.8. P-Cadherin
Placental (P-) cadherin, a 120 KDa glycoprotein, belongs to the subfamily of classical 
cadherins, glycoproteins with single transmembrane domain (Kemler, 1993). P- 
Cadherin has been localised in the AJ mediating intercellular adhesion through a 
homophilic mechanism (Jensen et al., 1997). It shares overall structural and functional 
similarities with E-cadherin (see above) as well as with the other members of the 
classical cadherin subfamily (Fig. 1) (Kemler, 1993).
Normal keratinocytes and melanocytes express both P-cadherin and E-cadherin 
(Horiguchi et al., 1994; Lewis et al., 1994). Furthermore, adhesion between 
keratinocytes and melanocytes is mediated by homophilic E- and P-cadherin binding 
(Tang et al., 1994). In normal murine epidermis, as in normal human skin, expression 
of P-cadherin follows a well defined pattern where it is restricted to the basal 
proliferative compartment (Hirai et al., 1989; Cano et al., 1996). It is also expressed in 
the keratogenous region of the precortical hair matrix and in the outer root sheath cells 
of the hair follicle during murine hair follicle morphogenesis and cycling (Cano et al., 
1996; Muller-Rover et al., 1999). In addition to P-cadherin expression in the skin, it is 
found to be present in several other tissues and cell lines including the sertoli cells of
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mouse testis (Lin and DePhilip, 1996), the membranes of the epithelial and lateral 
borders of the myoepithelial cells of the breast (Rasbridge et al., 1993; Glukhova et al.,
1995) and more recently in bladder carcinoma cell lines (Giroldi et al., 1999).
The exact role of P-cadherin is less well defined than that of E-cadherin (Tang et al., 
1994). Since both E- and P-cadherin are expressed in the basal layer of normal 
epidermis, they probably share the capability of regulating intercellular junction 
organisation (Jensen et al., 1997). When E-cadherin function is blocked in primary 
keratinocyte cultures, the calcium-induced formation of both AJ and desmosomes is 
delayed leading to an abnormally stratified culture (Lewis et al., 1994). Blocking P- 
cadherin function alone has no effect on the calcium-induced redistribution of adhesion 
molecules and the keratinocytes stratify normally. However, when both E- and P- 
cadherin are blocked, stratification does not occur and adhesion molecule concentration 
along the cell-cell borders is not detected (Lewis et al., 1994). Inhibition of either of the 
cadherins alone does not affect the initiation of stratification (Jensen et al., 1997). 
These findings imply that E-cadherin plays the primary role in regulating intercellular 
junction organisation and stratification. In addition, P- and E-cadherin may have 
redundant roles in the basal layer of epidermal keratinocytes with regard to the process 
of stratification (Jensen et al., 1997).
In cancer, E- and P-cadherin play an important role in tumour formation, progression 
and metastasis. Previous studies have demonstrated different expressions of E- and P- 
cadherins in human cancers and cell lines that vary inversely with the stage of clinical 
disease or even is preserved in these tumour cells (Seline et al., 1996; Shimoyama et al., 
1989; Shimoyama and Hirohashi 1991; Cano et al., 1996; in abstract form, Abbasi et al.,
1992). The findings of these studies along with the more recent ones will be discussed 
in more details in the discussion section in comparison to my work.
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1.9. Catenins
The cell adhesion molecules, cadherins, form protein complexes with cytoplasmic 
polypeptides called catenins (reviewed by Gumbiner, 1995). Three proteins were 
initially identified by co-immunoprecipitation with the cytoplasmic domain of E- 
cadherin (Aberle et al., 1996). They also form complexes to bind other proteins of the 
cadherin family (Butz et al., 1992). The catenins have molecular weights of 102, 94 and 
86 KDa and were termed a , p, and y  catenin, respectively and cloning of catenin genes 
revealed that a-catenin is homologous to vinculin, P-catenin is similar to the drosophila 
armadillo gene product, while y-catenin is identical to plakoglobin (Kemler, 1993; 
Hashizume et al.,1996). Experimental analysis revealed the critical role of the catenins 
in regulating cadherin function, where deletion of the catenin-binding domain generates 
cadherin mutants that cannot mediate cell-cell adhesion (Hinck et al., 1994c). Catenins 
are implicated in many major cellular events: they mediate the connection of the E- 
cadherin with the actin filament network, and they link E-cadherin with other 
transmembrane proteins such as Na+ /K+ ATPase, and with peripheral cytoplasmic 
proteins such as fordin (Ozawa et al., 1990; McNeil et al., 1990). In addition to its 
adhesive role, p-catenin functions as a nuclear effector participating in many cellular 
processes including signal transduction and transcription regulation (Korinek et al., 
1997; reviewed by Gumbiner, 1995; Willert and Nusse, 1998). These functions and 
properties will be discussed in more detail in the following sections.
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1.9.1. P-Catenin
1.9.1.1 Structure of P-catenin and its role in cell adhesion
p-Catenin is a multifunctional 94-KDa protein that shares about 65% sequence identity 
with plakoglobin, an 82-KDa protein which is apparently the same as y-catenin (Peifer 
and Wieschaus, 1990; McCrea et al., 1991; Fouquet et al., 1992; Knudsen and 
Wheelock, 1992; reviewed by Cowin and Burke, 1996). Both p-catenin and 
plakoglobin are members of the armadillo family of proteins in which their central 
region contains a 42 amino acid motif repeated 12-13 times known as the arm repeats 
(Piefer et al., 1992; Butz et al., 1992; reviewed by Willert and Nusse, 1998). The 
amino-terminal domain of p-catenin contains 130 amino acids and also contains 
multiple phosphorylation sites which are correlated with the downregulation of P- 
catenin. Its carboxy-terminus contains a transcriptional activation domain of 100 amino 
acids. The arm repeats (central region) interact in an overlapping and mutually 
exclusive manner with E-cadherin (Fig. 2), adenomatous polyposis coli (APC) tumour 
suppressor gene, T-cell factor (TCF) and lymphoid enhancer factor 1 (LEF1) 
transcription factors (Aberle et al., 1994; Hulsken et al., 1994; Huber et al., 1997; for 
review see Willert and Nusse, 1998). p-Catenin is also similar to the drosophila 
armadillo gene product which was originally identified as one of a group of proteins that 
regulate segment polarity (Riggleman et al., 1989).
The exact role for p-catenin in cell adhesion as a structural component of the AJ is less 
clear. It associates directly with a-catenin which then mediates the interaction between 
the cadherin-catenin complex and the actin based cytoskeleton (Ozawa et al., 1990; 
Gumbiner, 1995). p-Catenin binds to both the cytoplasmic domain of the cadherin 
molecule and the amino-terminal domain of a-catenin, whereas there is no direct 
interaction of a-catenin with the cadherins. However, the association of the cadherins 
with a-catenin through p-catenin is a crucial requirement for the adhesive function of 
the cadherins. Cells that express cadherin molecules but lack a-catenin are non­
adherent, but become adhesive when a-catenin is expressed (Hinck et al., 1994c; 
Nathke et al., 1994). Experimentally, a direct mechanical fusion between E-cadherin
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and a-catenin could bypass the need for P-catenin where it acts as a kind of negative 
regulator for the cell adhesion activity (Nagafuchi et al., 1994). It has been proposed 
that P-catenin plays a role in regulating adhesion, at least in part because it is a substrate 
for several tyrosine kinases that suppress cell adhesion (Behrens et al., 1993). P-Catenin 
has also been reported to form complexes with epidermal growth factor receptor in in 
vitro kinase assays, but the function of this intriguing interaction, mediated by the 
conserved central region of p-catenin, is not yet known (Hoschuetzky et al., 1994).
1.9.1.2. Expression of P-catenin in normal tissue and tumours
P-Catenin plays a major role in the cadherin-mediated cell-cell adhesion system 
(reviewed by Cowin and Burke, 1996; Miller and Moon, 1996). In normal epithelial 
cells, P-catenin is mainly localised at the membranes of the cell-cell borders (Takayama 
et al., 1996) where it binds to cell surface cadherins (E- and P-) and also to a-catenin to 
be connected to the actin cytoskeleton (Ozawa et al., 1989). Non-cutaneous normal 
epithelia express strong P-catenin especially on cell-cell boundaries. These include 
human oesophagus and stomach (Takayama et al., 1996), human colon (Takayama et al., 
1996; Inomata et al., 1996) and normal breast mammary duct tissue (Hashizume et al.,
1996). More recently, strong p-catenin membrane staining has been observed in rat 
colon (Takahashi et al., 1998), nasopharyngeal epithelium (Zheng et al., 1999), capillary 
endothelial cells of the thyroid gland (Garcia-Rostan et al., 1999) and human 
oesophagus (Kimura et al., 1999).
There is evidence of a close association between abnormal expression and/or structural 
abnormalities of P-catenin as well as E-cadherin (see above) and tumour development 
(Nakanishi et al., 1997; Jawhari et al., 1997; Valizadeh et al., 1997). This is to say that 
downregulation of membranous p-catenin is associated with malignant transformation 
as demonstrated in carcinomas of breast (Hashizume et al., 1996), oesophagus and 
stomach (Takayama et al., 1996) and colon (Takayama et al., 1996; Inomata et al.,
1996). This may affect the E-cadherin-mediated adhesion system, as p-catenin forms a
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complex with E-cadherin in normal human epithelium and cancerous tissues (Ozawa et 
al., 1989; Takayama et al., 1996).
Recently, it has been reported that in normal skin, P-catenin is localised in a linear 
pattern along the lateral and upper surfaces of basal keratinocytes at the sites of cell-cell 
junctions (Tada and Hashimoto, 1998; Silye et al., 1998). The normal keratinocytes in 
suprabasal layers express P-catenin around their peripheries. Membranous p-catenin is 
also present in the outer root sheath cells of the hair follicles, acinar germinative cells of 
the sebaceous glands and in sweat glands cells (Silye et al., 1998). However, p-catenin 
is absent at the basal cell surface, in stratum comeum, inner sheath cells of the hair 
follicle and the hair shaft (Silye et al., 1998; Tada and Hashimoto, 1998).
Since I started my work, reports on p-catenin immunolocalisation in human tumours and 
cell lines have been published. Abnormalities of p-catenin cellular expression have 
been observed in desmoid tumours (Alman et al., 1997), colon tumours (Takahashi 
1998; Back et al., 1999), oesophageal cancers (Kimura et al., 1999), gastric carcinoma 
cell lines (Jawhari et al., 1999) and anaplastic thyroid carcinoma (Garcia-Rostan et al., 
1999). However, apart from 2 recent reports in benign and malignant melanocytic 
lesions (Silye et al., 1998; Rimm et al., 1999), immunohistochemical studies of p- 
catenin expression in epidermal tumours are lacking. The findings of the published 
studies will be discussed in relation to my work in the discussion section.
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1.9.1.3. P-Catenin’s mutation and its role in signal transduction
In addition to P-catenin’s role in supporting cell adhesion, another role for P-catenin in 
signal transduction has been proposed; however, these are separable (reviewed by 
Gumbiner, 1995; Cowin and Burke, 1996). p-Catenin is a key downstream component 
of the Wnt signalling pathway participating in signal transduction, developmental 
patterning and cell fate determination in both drosophila and vertebrates (Gumbiner, 
1995; Brown and Moon, 1998). This role was suggested by the finding that P-catenin, as 
well as y-catenin/plakoglobin, are highly homologous to the product of drosophila 
segment polarity gene armadillo (McCrea et al., 1991; reviewed by Miller and Moon,
1996). There are many associated and binding partners of P-catenin controlling its 
activity and affecting its stability and cellular localisation (reviewed by Willert and 
Nusse, 1998).
I.9.I.4. Role of p-catenin in the Wnt/Wingless signalling pathway
Wnt/Wingless (Wg) proteins, a large family of cysteine-rich secreted molecules 
associated with the extracellular matrix and cell surface, control embryonic patterning 
and cell fate decisions in development (van den Heuvel et al., 1989; Bradley and Brown, 
1990; Papkoff and Schryver, 1990; reviewed by Morata and Lawrence, 1977; Nusse and 
Varmus, 1992; Klingensmith and Nusse, 1994; Moon et al., 1997; Cadigan and Nusse,
1997). Wnt family members may also modulate cell-cell interactions during 
morphogenetic movements by regulating the stability and accumulation of P-catenin and 
cadherin indirectly leading to the increased strength of cell-cell adhesion (Hinck et al., 
1994b). During development there is interaction between the Wnt/Wingless and the 
Sonic hedgehog/Patched signalling pathways (see below) (Von Ohlen and Hooper,
1997). The Wnt signalling pathway has not been ordered fully and less is known about 
this pathway in vertebrates than the Wg pathway in drosophila (Peters et al., 1999). 
However, there are many similarities between the two signalling systems such as Wg 
and armadillo in drosophila are homologous to Wnt-1 and to p-catenin/plakoglobin in 
vertebrates respectively (reviewed by Gumbiner, 1995). Regulation of catenin function
48
by Wnt-1 was derived primarily from early studies on homologous proteins in 
drosophila (reviewed by Hinck et al., 1994a). Wnt/Wg signalling pathway regulates P- 
catenin negatively and is highly conserved throughout evolution from insects to 
vertebrates (Ben-Ze’ev and Geiger, 1998). There are different molecular interactions of 
p-catenin in Wnt/Wg signalling as well as in cell adhesion.
When Wnt/Wg signalling is activated (Fig. 3), a Wnt molecule binds to the extracellular 
cysteine-rich domain of the Frizzled (Frz) family of transmembrane receptors (Wang et 
al., 1996). This binding likely will lead to phosphorylation and activation of 
Dishevelled (Dsh) protein (Noordermeer et al., 1994; Peters et al., 1999) which is the 
most proximal intracellular component known in the pathway (Klingensmith et al.,
1994). The way that Dsh is activated is less clear and its phosphorylation by casein 
kinase II does not necessarily lead to its activation (Willert et al., 1997) and it seems 
likely that other events are also required (Cook et al., 1996; for review see Brown and 
Moon, 1998). When Dsh is activated it will be recruited to the cell membrane area 
leading to inhibition of the serine kinase glycogen synthase kinase 3P (GSK-3P) action, 
possibly involving protein kinase C (PKC) (Cook et al., 1996). In the absence of 
Wnt/Wg signalling, P-catenin is found in a cytoplasmic multiprotein complex 
(Rubinfeld et al., 1996) in addition to its presence in the cell adhesion complex with 
cadherins at the plasma membrane. P-Catenin in the cytoplasm associates with APC, 
GSK-3p, Axin (reviewed by Eastman and Grossched, 1999) and the Axin homologue 
conductin (Behrens et al., 1998) where GSK-3p normally phosphorylates p-catenin and 
directs it together with APC and Axin to degradation by the ubiquitin-proteosome 
system (Aberle et al., 1997; Orford et al., 1997; Peifer, 1997; Polakis, 1999). Inhibition 
of GSK-3p by activated Dsh leads to decreased degradation of p-catenin (stabilisation) 
and as a result p-catenin cytoplasmic levels rise (Yost et al., 1996; reviewed by Brown 
and Moon, 1998). Accumulated and stabilised p-catenin appears to be translocated 
independently to the nucleus by less clear mechanisms (Tlsty, 1998) where it is 
associated with the T-cell-specific factor (TCF)/lymphoid enhancer binding factor (LEF) 
transcription factors (Huber et al., 1996; Molenaar et al., 1996; Fearon and Dang, 1999; 
Yokoya et al., 1999). This association results in increased transcriptional activation of 
mostly unknown target genes (Behrens et al., 1996; Korinek et al., 1997; reviewed by
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Eastman and Grossched, 1999). One of these target genes recently discovered is the 
cyclin D1 gene which when accumulated and triggered by increased p-catenin levels 
may promote neoplastic conversion (Shtutman et al., 1999; Tetsu and McCormick, 
1999).
In the absence of Wnt/Wg signalling (Fig. 4), Wnts are bound and inhibited by members 
of the Frizzed b (Frzb) family which seem to act by binding to secreted Wnt proteins 
and preventing productive interaction between Wnt proteins and Frz proteins (reviewed 
by Brown and Moon, 1998). In these circumstances, Dsh is inactive which, in turn, 
leads to the activation of GSK-3p (Ben-Ze’ev and Geiger, 1998). As a result, the 
cytoplasmic complex of GSK-3p, APC and Axin targets P-catenin for degradation by 
the ubiquitin-proteosome pathway. The low levels of degraded cytoplasmic p-catenin 
are insufficient to be translocated to the nucleus and associate with TCF/LEF 
transcription factors which are likely to bind to promoters in the absence of p-catenin 
and repress basal transcription proteins (Brown and Moon, 1998; Willert and Nusse,
1998).
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Figure 3. The Wnt signalling pathway. In the presence of a Wnt signal (Ben-Ze’ev and 
Geiger, 1998; Brown and Moon, 1998; Willert and Nusse, 1998; Eastman and Grossched, 
1999). Binding of Wnt to the Frizzled (Frz) family of receptors leads to activation of Wnt 
signalling. Dishevelled (Dsh) becomes hyperphosphorylated (P) by casein kinase II (CKH), 
activated and recruited to the membrane area. This leads to the inactivation of glycogen 
synthase kinase-3 p (GSK-3P) by a poorly understood mechanism that may involve protein 
kinase C (PKC). GSK-3P normally phosphorylates (P) p-catenin (P-cat) and targets it together 
with adenomatous polyposis coli (APC) and Axin for degradation. p-Catenin fails to be 
phosphorylated and thus is no longer targeted into the ubiquitin-proteosome pathway. Instead, 
P-catenin accumulates in the cytoplasm as a result of decreased rates of degradation mediated 
by GSK-3p and appears to be translocated to the nucleus where it interacts with T-cell-specific 
factor (TCF)/lymphoid enhancer binding factor (LEF) transcription factors which results in 
transcriptional activation.
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Figure 4. The Wnt signalling pathway. In the absence of a Wnt signal (Ben-Ze’ev and Geiger, 
1998; Brown and Moon, 1998; Willert and Nusse, 1998; Eastman and Grossched, 1999).
Wnt is bound and inhibited by members of Frizzled b family (Frzb). Dsh is inactive and GSK-3p 
is active. GSK-3P phosphorylates (P) P-catenin (P-cat) and targets it together with adenomatous 
polyposis coli (APC) and Axin for degradation through the ubiquitin-proteosome pathway. Low 
levels of cytoplasmic p-catenin are insufficient to be translocated to the nucleus and associate 
with T-cell-specific factor (TCF)/lymphoid enhancer binding factor (LEF) transcription factors.
I.9.I.5. Interaction of P-catenin with the APC tumour suppressor protein
An inherited defect in the APC gene results in the development of colorectal polyps and 
colon cancer in afflicted patients, and similar APC mutations have been implicated in 
the majority of spontaneous non-familial colorectal tumours (Miyoshi et al., 1992).
The direct association of p-catenin with APC tumour suppressor protein (Su et al., 1993; 
Hulsken et al., 1994; Rubinfeld et al., 1993; 1995) suggests that it may be involved in 
regulating and/or mediating P-catenin signalling activity leading to regulating tumour 
growth (Gumbiner, 1995; Ilyas and Tomlinson, 1997). This was demonstrated by recent 
biochemical studies where APC, in addition to cadherin, may regulate the intracellular 
levels of p-catenin, thus implicating APC as a modulator of p-catenin signalling 
(Munemitsu et al., 1995; reviewed by Miller and Moon, 1996). In addition to GSK-3p, 
APC may act to antagonise Wnt signalling by targeting p-catenin for degradation 
through the ubiquitin-proteosome pathway and eliminating its free cytoplasmic pool 
(Orford et al., 1997; Miller and Moon, 1996). Mutations in the p-catenin-binding site of 
APC may result in cytoplasmic accumulation of p-catenin and blockade of its 
degradation (Munemitsu et al., 1995). Furthermore, levels of free cytoplasmic p-catenin 
rise in colon cancer cells with mutant APC suggesting that APC suppresses P-catenin 
signalling activity by maintaining low cytoplasmic levels (reviewed by Miller and 
Moon, 1996; Ben-Ze’ev and Geiger, 1998). Thus APC may possibly function primarily 
to regulate cadherin-mediated cell adhesion via P-catenin (Barth et al., 1997). However, 
P-catenin’s signalling activities are separable from its function in cadherin-mediated cell 
adhesion and APC-catenin complex is distinct from the cadherin-catenin complex 
(Hulsken et al., 1994; Inomata et al., 1996). Recently it is known that the association of 
p-catenin with TCF/LEF transcription factors in the nucleus activates gene expression 
(Behrens et al., 1996; Korinek et al., 1997; Eastman and Grossched, 1999). APC may 
regulate the formation of transcriptionally competent p-catenin-TCF complexes where 
loss of APC function may result in uncontrolled transcriptional activation of TCF target 
genes contributing to colon carcinogenesis (Korinek et al., 1997). These findings 
strengthened the early suggestions by Gumbiner (1995) that APC has a distinct role in
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the p-catenin signalling pathway initiated by Wnt growth factors controlling cell growth 
and tumourigenesis by transducing signals leading to changes in gene expression.
1.9.1.6. P-Catenin redistribution to the nucleus
p-Catenin translocation to the nucleus seems to be a highly specific process although its 
mechanism is not completely understood (Willert and Nusse, 1998). Stabilisation of p- 
catenin is associated with its nuclear localisation in the presence of Wnt/Wingless 
signals, where it binds to TCF/LEF transcription factors (reviewed by Brown and Moon, 
1998; Eastman and Grossched, 1999). In the nucleus, P-catenin acts as a transcriptional 
co-activator leading to increased expression of TCF/LEF-regulated target genes (Fearon 
and Dang, 1999). Traffic of macromolecules occurs in both directions through the 
nuclear pores which span the nuclear envelope (Alberts et al., 1998). Large molecules 
(proteins) and macromolecular complexes are generally passed through the nuclear 
pores via an active, receptor-mediated mechanism (Yokoya et al., 1999). At elevated 
expression levels, p-catenin may be detected in the nucleus although it may not contain 
any obvious nuclear localisation signal (Funayama et al., 1995). In addition, P-catenin 
is very large to passively enter the nuclear envelop through nuclear pore complexes 
(Cowin and Burke, 1996; Yokoya et al., 1999). Recently it was found that p-catenin can 
be translocated to the nucleus using a permeabilised cell system (Fagotto et al., 1998). 
P-Catenin nuclear translocation in this particular system was independent of nuclear 
localisation signal sequences and probably without associating in the cytoplasm with 
TCF/LEF transcription factors or other cytoplasmic factors. P-Catenin, like importin-p 
and p-karyopherin, appears to use a domain with common nuclear pore components that 
are nuclear localisation signal-independent (Fagotto et al., 1998; Ben-Ze’ev and Geiger,
1998). Furthermore, Yokoya and colleagues (1999) have recently shown that p-catenin 
possesses the ability to migrate into the nucleus through nuclear pore complex by a 
facilitated mechanism without requiring importin-p-related transport factors and Ran, a 
small GTPase, suggesting that the nuclear levels of P-catenin could be regulated by 
several alternative mechanisms.
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1.9.2. a-Catenin
a-Catenin, a 102 KDa cytoplasmic polypeptide, is homologous to vinculin 
(Herrenknecht et al., 1991; Nagafuchi et al., 1991), a peripheral cytoplasmic protein 
which connects membrane bound proteins to the cortical actin cytoskeleton (reviewed 
by Kemler, 1993; Ranscht, 1994). At AJ, the amino-terminal half of a-catenin binds to 
the amino terminus and the first repeat of P-catenin (Knudsen et al., 1995; Rimm et al., 
1995; reviewed by Cowin and Burke, 1996). It is not known whether a-catenin can 
interact directly with the cadherins in the AJ or only through P-catenin (Ozawa and 
Kemler, 1992), however, it has been found to be associated with all classical cadherins 
(Kemler, 1993). In addition to associating with actin through its amino and carboxyl 
termini (Ozawa et al., 1990), a-catenin also connects the cadherin-catenin complex to 
a-actinin which binds both filamentous actin and vinculin (Knudsen et al., 1995; Rimm 
et al., 1995; reviewed by Aberle et al.,1996; Cowin and Burke, 1996). Apart from 
possible free pool of a-catenin, it can also associate with APC (Su et al., 1993) and with 
other, as yet unidentified, proteins (Hinck et al., 1994a; 1994c). a-Catenin is found in 
cells that do not express any cadherin where it is localised in the cytoplasm possibly 
having, as yet undetermined, biological functions (Hinck et al., 1994c; Kemler, 1993). 
Adhesive functions of the cadherins require the association with a-catenin in which a- 
catenin-deficient cells that express cadherins are non-adherent, but become adhesive 
when a-catenin is expressed (Ranscht, 1994). This possible modulation of cadherin 
adhesive functions by a-catenin was also noted in some human cancer cells which have 
impaired E-cadherin-mediated cell adhesiveness through the downregulation of a- 
catenin expression (Shiozaki et al., 1994).
Normal epithelial cells of human breast, oesophagus, stomach and colon express a- 
catenin in an almost identical distribution pattern to those for E-cadherin and p-catenin 
(Shiozaki et al., 1994; Hashizume et al., 1996). In these normal epithelial cells, a- 
catenin is located mainly on the cell membrane, particularly at the area of cell-cell 
contact. While normal epithelial cells express strong a-catenin, the reduction of a- 
catenin expression in cancer cells may be a characteristic feature acquired through
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malignant transformation (Shiozaki et al., 1994). a-Catenin membranous expression 
was found to be frequently reduced in tumours of the breast, oesophagus, stomach, 
colon, and recently in malignant melanoma (Shiozaki et al., 1994; Hashizume et al., 
1996; Silye et al., 1998). Thus functional or structural abnormalities of a-catenin might 
take place in tumours with reduced a-catenin expression interfering with cadherin- 
mediated cell-cell adhesion since the functions of E-cadherin are modulated by a- 
catenin (Shiozaki et al., 1994).
Since I commenced my work, studies on the distribution of a-catenin in normal and 
cancerous tissues have been published (Silye et al., 1998; Glukhova et al., 1995). These 
were done using immunostaining in normal breast and in invasive breast carcinoma, 
benign and malignant melanocytic lesions. The distribution of a-catenin in the normal 
epidermis follows the same pattern as E-cadherin and p-catenin (Silye et al., 1998). It is 
localised along the lateral and upper surfaces of normal basal keratinocytes at the cell­
cell junctions and uniformly around the periphery of the cells in suprabasal layers, a- 
Catenin is also expressed in the membranes of adnexal structures. Membranous a- 
catenin is present in the outer root sheath cells, cell membrane of acinar germinative 
cells of sebaceous glands and in sweat gland cells. There is no expression of a-catenin 
in stratum comeum, hair follicle inner root sheath cells and hair shaft.
The findings of these studies will be discussed in relation to my own results.
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1.10. Sonic hedgehog (Shh)/Patched (Ptc)-Smoothened (Smo) signalling pathway
Studies of embryonic development in drosophila, have led to the identification of many 
genes which are important in postnatal control of cell growth and differentiation 
(reviewed by Gailani and Bale, 1997). Mutations in some of the vertebrate and human 
homologues of these genes such as the patched gene have been implicated to cause 
disease and cancer (reviewed by Ingham, 1998).
Mutations in human Ptc were identified as the underlying genetic event in the autosomal 
dominant naevoid BCC syndrome (NBCC), some sporadic BCC (Gailani et al., 1996; 
Johnson et al., 1996; Hahn et al., 1996a; Aszterbaum et al., 1998; Smyth et al., 1999) 
and NBCC-associated medulloblastoma (Smyth et al., 1999; Vortmeyer et al., 1999). 
Furthermore, deletion of the Ptc gene has been shown in sebaceous naevus (Xin et al., 
1999). In these studies, particularly in hereditary BCC, both alleles of Ptc are lost or 
mutated suggesting that Ptc is a tumour suppressor gene acting probably as the 
gatekeeper of basal cell carcinoma (Sidransky, 1996).
The Ptc gene is the vertebrate homologue of the drosophila segment polarity gene ptc 
(Goodrich et al., 1996; Hahn et al., 1996b), identified originally as a regulator of 
embryonic pattern formation (Nusslein-Volhard and Wieschaus, 1980). Ptc gene 
encodes a 12 transmembrane domain protein (Hooper and Scott, 1989; Nakano et al.,
1989) that specifically and physically binds with high affinity to the vertebrate 
homologue of the drosophila hedgehog (Hh), sonic hedgehog (Shh) (Stone et al., 1996; 
Marigo et al., 1996). This provides evidence that Ptc is the Shh receptor (Stone et al., 
1996; Murone, et al., 1999). The product of another drosophila segment polarity gene, 
Smoothened (Smo), complexes with Ptc but not directly with Shh (Stone et al., 1996; 
reviewed by Ingham, 1998). Smo encodes a seven-transmembrane protein which is 
most homologous to the Frizzled (Frz) family of serpentine proteins (van den Heuvel & 
Ingham, 1996; Alcedo et al., 1996).
In drosophila, it is suggested that ptc protein inhibits the Hh signalling pathway through 
its interaction with the Smo protein forming an inactive complex (Fig. 5) (Murone et al.,
1999). Smo is downstream of ptc suggesting that its activity is regulated by Ptc (Chen 
and Struhl, 1996; Alcedo et al., 1996; Ingham, 1998). Based on this model, Shh might
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activate the signalling pathway by relieving Ptc inhibition of Smo on binding to Ptc or 
following mutational inactivation of Ptc (Stone et al., 1996; Marigo et al., 1996). This 
alteration of the complex will free Smo to transduce the signal, which in drosophila, is 
associated with transcriptional activation of specific target genes including Wg, ptc, 
decapentaplegic, and repression of others such as Hh (Ingham et al., 1991; Ingham and 
Hidalgo, 1993; Capdevila et al., 1994; Basler and Struhl, 1994; Sekelsky et al., 1995). 
Cubitus interruptus (ci) is a drosophila transcription factor (Ohlmeyer and Kalderon, 
1998) related to the human Gli family of zinc-finger transcription factors by showing 
significant homology (Kinzler et al., 1987; 1988). Ci is needed for the transcriptional 
activation of the signalling pathway target genes by mediating Hh signalling. In the 
presence of Hh, ci is functionally activated by loss of ptc (Aza-Blanc et al., 1997; 
Akimaru et al., 1997; Ingham, 1998). Thus, Ptc gene inactivation by mutation and 
chromosome loss may lead to the inability of Ptc to repress Smo activity, resulting in 
the activity of the Shh signalling pathway and causing cancer e.g. BCC (Hahn et al., 
1996b; Lam et al., 1999). In accord with this, transgenic mice that overexpress Shh 
specifically in the skin develop BCC-like tumours suggesting that Shh may have a role 
in human tumourigenesis (Oro et al., 1997).
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Figure 5. Interactions between patched, smoothened and hedgehog proteins (Gailani and 
Bale, 1997). Complementary DNA sequence predicts that patched (Ptc) is a trans membrane 
protein with 12-membrane spanning domains and two large extracellular loops which are 
required to bind hedgehog (Hh). Patched represses transcription of hedgehog target genes by 
inactivating smoothened (Smo). Hedgehog binds to patched, which activates smoothened and 
results in the increase of many genes including wingless (Wg), decapentaplegic (Dpp) and 
patched. In the absence of patched, smoothened may be constitutively activated which results 
in the overexpression of these genes. Cubitus interruptus (Ci) is a transcription factor that is 
activated in the presence of hedgehog.
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1.11. Gli-1 role in BCC development
Up to date 3 Gli genes have been identified (Kinzler et al., 1987; Ruppert et al., 1988;
1990). Gli-1, a member of the Gli family of zinc-finger transcription factors (Kinzler et 
al., 1988), was originally isolated as an amplified gene in human malignant glioma 
(Kinzler et al., 1987). It has been identified as a candidate downstream mediator of the 
Shh signalling and acting as a transcriptional regulator in development (Dominguez et 
al., 1996; Alexandre et al., 1996; Lee et al., 1997; Hynes et al., 1997).
Since I commenced my work, two reports have investigated the expression of Gli-1 and 
Gli-3 in normal skin and BCC by reverse transcription-polymerase chain reaction and in 
situ hybridisation (Dahmane et al., 1997; Green et al., 1998). The results of these 
studies suggested that Gli-1 transcription factor plays a key role in BCC development. 
Recently, by using immunohistochemistry, Ghali and colleagues (1999) reported that 
Gli-1 protein is expressed in the cytoplasm of the outer root sheath keratinocytes and 
BCC cells. The findings of these studies will be discussed in more details in relation to 
my own results in the discussion section.
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1.12. Vinculin and a-actinin
The focal adhesion is a complicated complex formed at sites where cells attach to the 
extracellular matrix, connecting actin to the plasma membrane (reviewed by Goldmann 
et al., 1996). Vinculin, a 130 KDa protein, is a major protein component of focal 
adhesion and AJ probably performing a similar function in both structures (Kaiser et al., 
1993; Hazan et al., 1997). It shares 25-30% sequence homology with a-catenin 
(Herrenknecht et al., 1991; Nagafuchi et al., 1991; Ranscht, 1994). Both a-catenin and 
vinculin are capable of binding to a-actinin and actin (Ozawa et al., 1990; Knudsen et 
al., 1995). In addition to its adhesive functions, vinculin controls cytoskeletal 
remodelling and cell spreading by mechanically stabilising the molecular bridge 
between actin and integrins that form the core of focal adhesion (Ezzell et al., 1997).
At AJ, a-catenin connects the cadherin-catenin complex to a-actinin and filamentous 
actin in addition to associating with actin through both termini. a-Actinin in the 
complex binds both filamentous actin and vinculin (Fig. 2) (reviewed by Cowin and 
Burke, 1996). The self-associating properties of vinculin and the presence of actin- 
binding domain in its structure may contribute to the lateral clustering of the entire 
complex in the plane of the plasma membrane (Goldmann et al., 1996; Cowin and 
Burke, 1996).
a-Actinin is a major component of the AJ (Arikawa and Williams 1991; Knudsen et al., 
1995; reviewed by Cowin and Burke, 1996). In normal epithelia, a-actinin is 
distributed largely in the cytoplasm with enrichment at the normal cell peripheries 
(Graig and Pardo, 1979; Geiger et al., 1979; Sanger et al., 1983; Drenckhahn and Franz, 
1986).
In breast cancer cell lines, vinculin was found to play a role in the establishment or 
regulation of the cadherin-based cell adhesion complex substituting for a-catenin by 
direct interaction with p-catenin (Hazan et al., 1997).
In human skin and oral mucosa, vinculin was reported to be present in all epidermal 
layers except the stratum comeum (Kaiser et al., 1993). In the basal layer, vinculin is 
expressed in the area of the plasma membrane at sites of cell-cell contacts and the 
dermal-epidermal junction. Suprabasally, its plasma membrane expression is less
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marked than the basal cells but strong in the granular layer with minimal or absent 
cytoplasmic distribution. Lifschitz-Mercer and colleagues (1997) reported that vinculin 
is also expressed strongly in a large variety of normal human tissues including 
squamous epithelia, smooth muscle, hair follicle epithelia and myoepithelial cells. 
However, the vinculin labelling in stratified epithelia was particularly prominent in the 
suprabasal cells of the epidermis which was largely cytoplasmic and was often enriched 
at cell borders and intercellular bridges. Furthermore, they have examined the 
expression of vinculin in different carcinomas including BCC, keratoacanthoma, 
Bowen’s disease and invasive cutaneous and non-cutaneous SCC of different grades of 
tumour differentiation. Their results indicate that the level of expression of vinculin is 
inversely related to the degree of tumour-metastasising potential where most BCC, 
keratoacanthomas and Bowen’s disease were uniformly positive whereas most invasive 
and metastatic SCC were either negative or highly non-uniform with extensive negative 
regions. These findings support the general indication that malignant transformation is 
commonly associated with reduced adhesiveness pointing to the role of vinculin in the 
formation of cell-matrix and cell-cell adhesion.
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1.13. Actin filaments
Actin is a widely distributed protein found in all eukaryotic cells. The actin-based 
cytoskeleton is a dynamic structure, consisting of actin filaments and associated actin- 
binding proteins, localised in the cortical cytoplasm lying beneath the plasma membrane 
of cells (Cantiello and Prat, 1996). Actin filaments appear in electron micrographs as 
thin threads about 7 nm in diameter, and are formed from a chain of globular actin 
molecules (Alberts et al., 1998). The association of actin filaments with the actin- 
binding proteins enables them to serve a variety of functions including stability of cell 
shape, mechanical support, cell-cell adhesion and cell motility (Carlier, 1998; Alberts et 
al., 1998). Cell movement is thought to be driven largely by the polymerisation of actin 
monomers into filaments near the plasma membrane (Machesky and Way, 1998).
In polarised epithelial cells, AJ form a continuous belt around the apical portion of the 
cell and are connected to a circumferential band of actin filaments which may allow 
morphogenetic movements of the cells through actin filaments contraction (Kaiser et al., 
1993). At AJ, the cadherin-catenin complex associates with actin filaments via the 
amino and carboxyl termini of a-catenin which also binds to a-actinin (Knudsen et al., 
1995). The latter binds both vinculin and actin filaments (Rimm et al., 1995).
Keratinocytes in human normal epidermis have been shown to express weak staining of 
actin filaments which were arranged in parallel bundles beneath the cell membrane 
(Metze et al., 1996). Recently, it was reported that the pattern of distribution and degree 
of development of actin bundles vary in different parts of human hair follicles reflecting 
local demands of cytoskeletal activities for the growth and integrity of hair follicles 
(Furumura and Ishikawa, 1996).
During terminal differentiation of human epidermal keratinocytes, changes in the 
abundance and distribution of actin filaments and several actin-associated proteins 
including vinculin, a-actinin were examined by Kubler and colleagues (1991) using 
indirect immunofluorescent staining and confocal microscopy. The ventral cytoplasm 
of basal keratinocytes, located towards the centre of colonies, contained prominent 
bundles of actin filaments, often concentrated in the centre of the cells. In basal cells at 
the edges of the colonies, the actin filaments were concentrated at the leading edge of
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the cells. In suprabasal cells, actin staining was concentrated at lateral cell margins, but 
was less pronounced and more diffuse than in the basal layer. Vinculin and a-actinin 
staining revealed typical focal contact structures, although a-actinin was most 
pronounced at the free margins of cells at the edges of colonies. The findings of Kubler 
and colleagues (1991) reflected differences in actin filaments distribution and cell shape 
between rapidly dividing keratinocytes at the basal layer and those with low probability 
of division at the centre of colonies as they grow by lateral migration.
Morphological changes of tumour cells due to quantitative and/or qualitative changes in 
actin proteins can contribute to malignant tumour progression by affecting their invasive 
and metastatic potential (Tsukamoto et al., 1994). Using immunoelectron microscopy 
and immunofluorescence staining, previous reports have suggested increased numbers 
of actin microfilaments in BCC and different tumour cell lines (Gabbiani et al., 1976; 
McNutt, 1976; Kumakiri and Hashimoto, 1978; Low et al., 1981; Jones et al., 1989). 
Similar microfilaments were also found in epidermal cells during wound healing 
(Martin and Lewis, 1992). The findings of these studies in BCC will be discussed in 
relation to my own results in the discussion section.
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1.14. Culture of basal cell carcinoma
BCC is locally invasive (Leffell et al., 1991; Ko et al., 1992; McKee, 1996a) but rarely 
metastasises (Domarus and Stevens, 1984; Lo et al., 1991). In comparison with other 
tumours, BCC is a slow-growing tumour (Brysk et al., 1992). The cell origin of BCC 
remains unknown or highly controversial (Kore-eda et al., 1998; Kruger, et al., 1999). 
BCC is composed of two essential components, namely epidermal downgrowths of 
small, dark, epithelioid cells cytologically similar to the cells of the basal layer and the 
abnormal connective tissue matrix or stroma surrounding these downgrowths (MacKie, 
1996a). The stroma proliferates with the tumour in a symbiotic fashion (Brysk et al., 
1992) and is arranged in parallel bundles around the tumour lobules (Lever and 
Schaumburg-Lever, 1990a). It may appear mucinous and often shows numerous 
fibroblasts, a mild inflammatory infiltrate and deposits of amyloid (Lever and 
Schaumburg-Lever, 1990a).
Biochemical and molecular studies of BCC were limited by the lack of a suitable and 
reproducible tissue-culture model system. Establishment of BCC cultures in the 
absence of the connective tissue stroma was not successful (Van Scott et al., 1961; 
Cooper et al., 1977). However, there are studies reporting growth of BCC cells in 
culture (Flaxman, 1972; Hernandez et al., 1985; Bradbeer et al., 1988; Brysk et al., 
1992; Asada et al., 1992). Unfortunately, all these attempts to establish pure BCC cell 
lines were complicated by the presence of normal keratinocytes and they failed because 
the cells keratinised or differentiated and eventually died or they yielded cell cultures 
that are substantially unlike in vivo tumours (Brysk et al., 1992). Moreover, Grando and 
colleagues (1996) reported that the contamination of BCC cultures with normal human 
epidermal keratinocytes can suppress the growth of BCC cells.
In general there is interaction between the tumour and its adjacent connective tissue 
matrix in which tumours may directly alter the stroma by producing proteolytic enzymes 
that may degrade stromal glycoproteins and proteoglycans (Liotta et al., 1979; Kramer et 
al., 1982). In addition, tumours may regulate the function of the stromal cells by 
producing incompletely characterised soluble factors that stimulate proteolytic enzyme 
synthesis such as collagenase by the surrounding fibroblasts leading to indirect 
alteration of the stroma (Biswas, 1982; Barsky et al., 1987). These connective tissue
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changes have been associated with BCC in which the tissue surrounding the tumour 
lobules characteristically has an increased number of fibroblasts (Lever and 
Schaumburg-Lever, 1990a) and increased amounts of hyaluronic acid and extractable 
collagenase (Liotta et al., 1979; Barsky et al., 1987). These interactions between the 
tumour and its stroma may play a critical role in the establishment, growth and invasive 
properties of the tumour (Lozzo, 1984).
The inconsistent outcomes of BCC culture attempts have cast a doubt on how genuine 
these results are in producing a suitable and reproducible tissue-culture model system of 
BCC.
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1.15. Aims of the study
Aim la :
There is accumulating experimental evidence suggesting that down-regulation, complete 
loss or change in structure of one or more of the major components of AJ could lead to 
junctional disassembly and consequently to a reversion from a benign to an invasive 
epithelial phenotype. In biopsy specimens of human non-cutaneous carcinomas, the 
major components of AJ are frequently reduced or absent in association with malignant 
transformation particularly in the most differentiated tumours (Shimoyama and 
Hirohashi, 1991; Oka et al., 1992; Kinsella et al., 1993; Shiozaki et al., 1994). In 
human cutaneous tumours, studies of cell-cell adhesion have concentrated mainly on the 
expression of E-cadherin. E-Cadherin was found to be inversely correlated with the loss 
of differentiation of SCC of the head and neck (Schipper et al., 1991), but this 
observation was only limited to the expression of E-cadherin in this tumour. Although 
the reduction of E-cadherin expression was related to the growth pattern and the local 
aggressive behaviour of BCC, Pizarro and co-workers (1991) reported strongly 
preserved expression of E-cadherin in both superficial and nodular subtypes. Fuller and 
colleagues (1994) demonstrated that, in BCC and SCC, expression of E-cadherin was 
reduced, however, no correlation with tumour de-differentiation in BCC was mentioned 
and insufficient material was present to correlate SCC behaviour with level of E- 
cadherin expression. In addition, apart from melanocytic lesions, studies of P-cadherin 
and p-catenin expression in human cutaneous tumour tissues are lacking. Therefore, 
one of my aims was to investigate and define in detail the cellular distribution of AJ 
components in the normal human epidermis and in a variety of skin tumours including 
BCC, pilomatrixoma, SCC and precursor lesions and melanocytic lesions using 
immunohistochemical techniques. In order to do this, it was necessary to develop 
techniques for cadherin and catenin immunostaining of routinely processed, paraffin- 
embedded specimens. As there is evidence that down-regulation or complete loss of E- 
cadherin occurs in association with human epithelial cancers, this work aimed to assess 
whether the decrease in membranous distribution of the AJ major components, 
particularly cadherins and P-catenin, in human skin cancer progressed further in 
dedifferentiated or cancers with a poorer outlook.
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Aim lb :
By using immunofluorescence staining and laser scanning confocal microscopy, this 
part of the work was intended to characterise and define the overall structure of AJ in 
BCC versus the normal epidermis. Primarily, the immunofluorescence staining of the 
major AJ components was used to investigate the various types of adhesion deficiencies 
in BCC and compare it with the normal epidermis. Accordingly, double 
immunolabelling of the major components of AJ with filamentous actin was done to 
investigate the expression and the association of these components with the actin-based 
cytoskeleton. In my study, the distribution of filamentous actin in BCC was identified 
by Rhodamine-Phalloidin in contrast to a previous study which used anti-actin antibody 
(Low et al., 1981). Furthermore, this present work has attempted to examine the 
patterns of distribution of filamentous actin in the normal epidermis and BCC and how 
actin bundles are arranged or rearranged in the tumour cells with respect to their shape, 
migratory behaviour and thus invasiveness.
Aim lc:
Although E- and P-cadherins share an overall structural similarity, they mediate the cell­
cell adhesion of distinct cell types by homophilic binding. However, in the normal 
epidermis, both E- and P-cadherins are expressed on the cytoplasmic membranes of 
normal human keratinocytes following a specific distribution. E-Cadherin is distributed 
in the full thickness of the epidermis excluding the stratum comeum with an increased 
expression in the suprabasal layers as compared with the basal cells. In the hair follicle, 
E-cadherin is strongly expressed in the outer root sheath cells at the region of the 
infundibulum and weaker in the lower segment. P-Cadherin is restricted to the basal 
proliferative compartment and is also expressed in the keratogenous region of the 
precortical hair matrix and in outer root sheath cells of the hair follicle. Although E- 
cadherin is thought to be the major adhesion molecule found in AJ, basal cells of the 
normal epidermis have two cadherins regulating intercellular junction organisation. 
Therefore, it was decided to investigate the possible co-localisation of these cadherins in 
the basal and the first layer of suprabasal cells of the human normal epidermis.
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Likewise, double immunolabelling of E- and P-cadherin in BCC was carried out to 
determine their expression, co-localisation and to test the hypothetical stepwise loss of 
cadherin by tumour cells.
Aim Id:
Cultures of human keratinocytes provide a useful experimental model with which to 
study the factors that regulate cell proliferation, terminal differentiation and the 
assembly of cell-cell and cell-substrate junctions. Therefore, to extend the analysis of 
actin filaments, this present work attempted to compare the changes in the abundance 
and distribution of actin in nodular and infiltrative BCC with those in migrating 
keratinocytes in vitro. To achieve this aim, the surfaces of the cultured keratinocytes 
wells were wounded vertically and horizontally in straight lines. In addition, as the 
cultured keratinocytes differentiate by elevation of calcium concentration, it was of 
interest to compare the expression of E-, P-cadherin and P-catenin, in relation to actin, 
in both low and high calcium conditions with regard to the cell-cell adhesion. Thus, 
three days prior to the staining of cultured keratinocytes, the calcium concentration in 
the culture medium was shifted in half of the cultures from low (0.1 mM) to high (1.5 
mM) CaCL.
Aim 2:
During development there is interaction between the Shh/Ptc-Smo and the Wnt/Wg 
signalling pathways (Von Ohlen and Hooper, 1997). Recently, it has been reported that 
the Shh/Ptc-Smo signalling pathway is dysregulated in BCC (Hahn et al., 1996a; 
Johnson et al., 1996). In addition to P-catenin’s role in supporting cell adhesion at the 
cell-cell junctions by association with E-cadherin, another role for p-catenin in signal 
transduction has been proposed. P-Catenin is a key component of the Wnt signalling 
pathway possessing a nuclear function as it binds the transcription factors T-cell-specific 
factor and lymphoid enhancer binding factor (Huber et al., 1996; Molenaar et al., 1996). 
There are many striking parallels between the Wnt/p-catenin and the Wg/armadillo
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signalling pathways in which they may operate via a similar biochemical mechanism. 
Because the activation of the Hh/ptc-Smo signalling pathway in drosophila is associated 
with transcriptional activation of specific target genes including Wg, it is possible that 
this may lead to the secondary activation of the Wnt/p-catenin signalling pathway 
contributing to the development of BCC. Nuclear localisation of p-catenin may indicate 
its activation as an oncogene reflecting activation of the Wnt/Wg signalling pathway in 
human cancers. In vivo, cytoplasmic and/or nuclear accumulation of p-catenin has been 
observed in non-cutaneous tumours including colorectal polyps and cancers, 
oesophageal and stomach cancers and desmoid tumours (Inomata, et al., 1996; 
Takayama et al., 1996; Alman et al., 1997). However, apart from a recent report on 
malignant melanoma (Rimm et al., 1999), nuclear localisation of p-catenin has not been 
demonstrated in epidermal tumours. Therefore, another aim was to investigate whether 
any decrease in membrane p-catenin expression in epidermal tumours is accompanied 
by redistribution to the cell nucleus as there is evidence that the activation of the 
Shh/Ptc-Smo signalling pathway plays a key role in BCC development.
Aim 3:
An investigation of the expression of the transcription factor Gli-1 in normal skin and 
BCC was undertaken because Gli-1 is required during the activation of the Shh/Ptc-Smo 
signalling pathway underlying the development of this tumour. This pathway is 
associated with transcriptional activation of specific target genes including Wg and Ptc 
(Ingham et al., 1991; Ingham and Hidalgo, 1993; Basler and Struhl, 1994).
Aim 4:
Because of the lack of a suitable and reproducible tissue-culture model system for BCC, 
this part of my study attempted to grow this tumour by seeding fresh single cell 
suspension of BCC derived by collagenase/dispase treatment onto fibroblast-embedded 
collagen gel model (dermal equivalents). As controls and for comparison, seeding of 
suspension of cells derived by collagenase/dispase from normal foreskin onto dermal 
equivalents was undertaken.
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Immunohistochemical methodology was used in this present work for several reasons. 
Immunohistochemical staining techniques nowadays are well defined and standardised. 
They are considered to be essential in the differential diagnosis of a large variety of skin 
diseases and tumours. In addition, they have given us the potential to localise antigens 
in cells and tissues with strongly improved diversity, selectivity and specificity of 
staining reactions. More importantly, immunohistochemical staining is the best 
methodology for subcellular localisation of antigens which will achieve my aims. 
Provided that a suitable, sensitive and specific antibody can be produced and is 
commercially available and the antigen is preserved, it seems that there is no limit to the 
specific antigen-antibody reaction that may be localised by using 
immunohistochemistry. However, as with all techniques, pitfalls and problems are 
possible if the limitations of the technique were not fully understood.
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Chapter 2: Materials and Methods
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2.1. Introduction to antigen retrieval systems
Immunohistochemical techniques are powerful tools in diagnostic and investigative 
studies, which have provided the potential to localise antigenic constituents in cells and 
tissues with strongly improved selectivity and specificity of staining reactions (De Mey 
and Moeremans, 1986). Although formaldehyde remains the most popular fixative used 
in pathology (Mason and O’Leary, 1991), the molecular mechanism of the fixation 
process remains obscure (Fox et al., 1985). Formaldehyde probably is not always the 
best fixative for the preservation of tissue antigens to be used in immunohistochemistry 
(Shi et al., 1991). Although fixation in formaldehyde preserves tissue structures and 
prevents decomposition, masking of antigenic constituents is the major artifact induced 
by the fixation process (Cattoretti et al., 1993). This has been thought to be due to either 
intermolecular cross-links formed between formaldehyde reactive sites which include 
cyclic aromatic rings, alcoholic hydroxyl and amide groups, primary amines and thiols 
or of adjacent proteins (Fox et al., 1985; Mason and O’Leary, 1991). Thus, Mason and 
O’Leary (1991) showed that significant denaturation of proteins occurred at 
temperatures of 70-90°C in unfixed, purified globular proteins, whereas these 
temperatures have no adverse effect on formaldehyde-fixed protein structure.
Because of the good preservation of tissue morphology, antigen retrieval techniques 
have mainly been applied to formalin-fixed, paraffin-embedded material since cryostat 
sections often showed poor cytological details (Pileri et al., 1997).
The antigen retrieval techniques include enzymatic treatment (Cattoretti et al., 1993; 
Pileri et al., 1997), microwave treatment (Shi et al., 1991; Cattoretti et al., 1992; Kayser 
et al., 1992; Taylor et al., 1994; Shi et al., 1995; in abstract form, Suurmeijer, 1992), 
autoclave pre-treatment (Morgan et al., 1994) and pressure cooking (Norton et al., 1994; 
Pileri et al., 1997).
Shi and colleagues (1991) reported for the first time the heat-based antigen retrieval of 
formalin-fixed paraffin-embedded tissue sections, before immunostaining, using 
microwave oven and heavy metal salt solutions. It was found that strong enhancement 
of immunostaining could be obtained with saturated lead thiocyanate, 1% zinc sulphate 
(Shi et al., 1991), aluminium chloride (Suurmeijer, 1992), calcium chelating agents 
(EDTA, EGTA and citrate buffer solution) (Morgan et al., 1994; Taylor et al., 1994),
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glycine HC1 or urea solution (Taylor et al., 1994). Although the mechanism of the 
microwave-stimulated antigen retrieval is not yet completely defined, Shi et al (1991) 
found this method superior to enzymatic digestion and could substantially improve the 
accessibility to antigens that was achievable with no treatment. In addition, similar 
results were reported by Pileri et al (1997) in which they found that high temperatures 
proved more effective than protease XIV (Sigma chemical Co). It was suggested that 
the heat-based antigen retrieval can affect tissue proteins either by increasing the 
molecular agitation or by raising their temperature (Cattoretti et al., 1993). Thus, it is 
possible that protein denaturation, re-exposing epitopes masked by fixation, is the most 
likely mechanism involved (Cattoretti et al., 1993; Norton et al., 1994). Furthermore, 
Cattoretti and colleagues (1993) found that enzymatic (trypsin or Pronase) and non- 
enzymatic (microwave oven heating) antigen retrieval are not dependent on the epitope 
sequence, although some antigens benefit selectively from one treatment but not from 
the other.
Norton and colleagues (1994) have reported that superheating in citrate buffer using 
pressure cooking is an effective and reliable method of antigen retrieval showing several 
advantages over microwave heating. They suggested that the antigen retrieval 
mechanism of action in this new method could be due to further protein denaturation 
together with rupture of some of the aldehyde cross-links. According to the findings of 
Norton and colleagues (1994), pressure cooking heat-mediated antigen retrieval is very 
easy to use; not time-consuming; the cooker accommodates large batches of slides; and 
it needs only extremely cheap equipment. Furthermore, it improves antigen retrieval 
efficiency by avoiding the occurrence of hot and cold spots especially when heating 
many slides (Pileri et al., 1997).
As high temperature heating of tissues remains one of the most critical factors of antigen 
retrieval, the choice of the retrieval fluid is also crucial (Pileri et al., 1997). Although 
high temperature is believed to be the primary mechanism in antigen retrieval, the type, 
molarity and the pH value of the buffer solutions can be involved in this process as co­
factors (Cattoretti et al., 1993; Shi et al., 1995). Currently, the most widely used 
antigen retrieval solution is sodium citrate buffer (0.01M, pH 6.0) (Cattoretti et al., 
1993; Taylor et al., 1994; Pileri et al., 1997). Shi and colleagues (1995) have shown 
that Tris-HCl or sodium acetate buffer pH 8-9 may be suitable for most antigens. In 
addition, Pileri and colleagues (1997) reported that the use of 1 mM EDTA (pH 8.0)
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achieved the best results in terms of staining intensity and the number of positive cells 
when compared 0.1 M Tris-HCl (pH 8.0) and 0.01M citrate buffer (pH 6.0). Therefore, 
these findings clearly stated the importance of choosing the appropriate antigen retrieval 
solution and method for investigated antibody to guarantee excellent immunostaining 
results. I have tested several conditions for each antibody used in my experiments. The 
conditions chosen for applications of these antibodies in immunohistochemical staining 
of frozen and routinely processed tissues are shown in table 3 and appendices C and D.
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2.2. Patients and tissue specimens
Tissue specimens used in this study were:
1. Paired paraffin-embedded and frozen specimens of basal cell carcinoma (BCC) (n = 
12). The excised fresh specimens were obtained from the biopsy clinic, Department 
of Dermatology, Glasgow Western Infirmary. They were bisected; one-half was 
fixed in 10% formalin and then processed in paraffin for routine diagnostic 
histopathology (see Appendix A) and the other half immediately snap frozen in liquid 
nitrogen and stored in special storage vials in liquid nitrogen tanks. Serial sections of 
frozen BCC specimens were cut at 5-6 pm, attached to Silane-coated glass 
microscope slides (BDH Laboratory supplies, Poole, England) (see Appendix B) and 
stored at - 20°C.
2. Formalin fixed and paraffin-embedded (routinely processed) specimens of 
pilomatrixoma (n = 10), invasive well differentiated squamous cell carcinoma (SCC) 
{n = 10), moderately differentiated SCC (n = 5), keratoacanthoma (n = 3), Bowen’s 
disease (n = 10), actinic keratosis (n = 10), psoriasis (n = 5), lichen simplex chronicus 
(n = 5), benign naevi (n = 6), blue naevi (n = 6), atypical naevi (n = 6), Spitz naevi (n 
= 6), primary malignant melanoma (n -  6), metastatic melanoma (n = 6) and further 
formalin fixed and paraffin-embedded BCC (n = 20) (Table 1) were obtained from 
the departmental archives, Department of Dermatology, University of Glasgow. 
Cases were not age matched. Representative tissue blocks of paraffin- embedded 
specimens were selected and serial sections were cut at 5-6 pm. The sections were 
attached to Silane coated glass microscope slides by heating overnight in an oven at a 
temperature of 60°C.
3. Fresh specimens of BCC (n = 8) for cell culture were obtained from the Glasgow 
Southern General hospital. After excision, the tumours were bisected; one-half was 
processed in paraffin for routine diagnostic histopathology and conformation of BCC 
diagnosis and the other half containing tumour was transported in a sterile universal 
on ice to start the preparation of cell suspension immediately.
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CLINICOPATHOLOGICAL SUBTYPE NUMBER
Superficial (multifocal) 12
Diffuse (infiltrating) 9
Nodular 8
Metatypical 2
Spindle cell 1
T able 1. Subtypes o f  BCC.
2.3. Antibodies
The antibodies used in this study are listed in Tables 2 and 3.
Antibody Clone Specificity Isotype Host Source
C-fTCatenin 14 Human IgGl Mouse TL
N-(3-Catenin 7D11 Human IgG2a Mouse Affiniti
E-Cadherin 36 Human IgG2a Mouse TL
P-Cadherin 56 Human IgGl Mouse TL
a-Catenin
- ■ ". . 5 Human IgGl Mouse TL
Vinculin hVIN-1 Human IgGl Mouse Sigma
a-Actinin Poly I Iuman Poly Rabbit Sigma
Phalloidin a fluorescent phallotoxin TRITC labelled to 
identify filamentous actin
Sigma
C-Gli 1 Poly Human Poly Goat Santa Cruz
N-Gli 1 Poly Human Poly Goat Santa Cruz
APC CC-1 Human IgG2bK Mouse Calbiochem
T able 2. Properties and sources o f  the an tibodies used in the study.
Staining in tumours was compared to normal epidermis.
C = carboxyl terminus; N = amino terminus; E = epithelial; P = placental; APC = adenomatous polyposis 
coli; Poly = polyclonal; TCS Bio = TCS Biologicals; TL = Transduction Laboratories.
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Antibody Tissue PT Fix Dilution Concentration Incubation Temp Remarks
C-(3-Catenin
P-Cadherin
Frozen
Paraffin
Frozen
Paraffin
Frozen
Paraffin
Frozen
Paraffin
None
PC
None
PC
None
PC
Triton
PC
A
F
A
F
A
F
A
F
1:1000
1:500
1:800
1:400
1:200
1.200
1:500
■
1:500
0.25 |ig/ml 
0.5 pg/ml 
0.25 pg/ml 
0.5 pg/ml
1.25 pg/ml
1.25 |ig/ml 
0.5 pg/ml 
0.5 pg/ml
O/N
1 Hour
1 Hour 
O/N 
1 Hour
4°C
37°C
4°C
37°C
4°C
37°C
4°C
37°C
a-C aten in8 Frozen Triton A 1:100 2.5 [ig/ml 1 hour RT
Paraffin F Negative
Vinculin Frozen Triton F 1:400 0.2 pg/ml 2 Hours RT See
Paraffin PC F 1:400 0.2 |ig/ml 1 hour 37°C Appx. C
a-Actinin Frozen Triton F 1:400 0.2 gg/ml 2 Hours RT for
Paraffin PC F 1:400 0.2 pg/ml 1 hour 37°C results
Phalloidin Frozen Triton F 1:50 2.0 pg/ml 30 min RT
Paraffin Not done
C-Glil Frozen Not done
Paraffin PC F 1:200 1.0 pg/ml 1 hour 37°C
N-Glil Frozen Not done
Paraffin PC F 1:200 1.0 pg/ml 1 hour 37°C
APC Frozen Triton AbFc o o 1.0 pg/ml O/N 4°C Appx. C
Paraffin None F 1:100 1.0 (ig/ml O/N 4°C
Table 3. Final conditions chosen for applications o f  the an tibodies in im m unohistochem ical 
stain ing o f  frozen and form alin Fixed paraffin-em bedded tissues.
C = carboxyl terminus; N = amino terminus; E = epithelial; P = placental; APC = adenomatous polyposis 
coli; PT = pre-treatment; Fix; fixative used; A = acetone; F = 10% formalin; O/N = overnight; PC = 
pressure cooker; RT = room temperature.
aNegative staining in paraffins despite using several dilutions, pre-treatments and incubation times. 
b In immunoperoxidase staining method. 
c In immunofluorescent staining.
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2.4. Pre-treatments
Each of the following pre-treatments was carried out after the paraffin sections were 
dewaxed and dehydrated. The sections were cut on Silane coated slides.
A. High temperature antigen retrieval
I. Microwaving
This was carried out as described previously (Shi et al., 1991) with modifications. The 
slides were placed in a container containing approximately 800 ml of one of the 
following buffers:
10 mM citrate buffer pH 6.0. (Standard).
Tris buffer at pH 9.
The slides were microwaved on full power (950 W) for 10-60 min. The buffer was 
topped up with distilled water every 10 min to maintain the fluid level. Optimum times 
were established for each antibody.
After microwaving, the slides were left to cool at room temperature for 20 min and then 
washed in running water for 2 min and in TBS for 5 min afterwhich they were ready for 
immunohistochemical staining.
II. Microwaving using a pressure cooker
The basic protocol, as described previously (Norton et al., 1994), was used with 
modifications. The special plastic microwave pressure cooker (Nordic Ware, 
Minneapolis, USA) was filled with 1 L CB pH 6 for 1 rack of slides or 1.5 L of buffer 
for 2 racks of slides.
With the lid off, the pressure cooker was placed inside the microwave and brought to 
boil using 80% power, usually 12-15 min. The pressure cooker was then taken out 
carefully, the slides immersed and the lid secured.
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After microwaving for 3-4 min to make sure that the cooker was under pressure, a 
further microwaving time of 5-6 min was allowed. Very carefully, the cooker was taken 
out, left to cool for 15-20 min at room temperature to reduce the pressure.
The slides were then washed in running tap water for 2 min prior to staining 
immunohistochemically.
B. Enzyme digestion
I. Trypsin
The sections were incubated in 0.1% Trypsin Type II-S (Sigma chemical Co) and 0.1% 
calcium chloride in distilled water for 30 min at 37°C, washed in running tap water to 
stop the enzyme digestion, then washed in TBS for 5 min before immunohistochemical 
staining.
II. Pronase
The sections were incubated in 0.1% Pronase Type XIV (Sigma chemical Co) in TB pH 
7.6 for 15-20 min at room temperature (Pileri et al., 1980), washed in running tap water 
to stop enzyme digestion, then washed in TBS before immunohistochemical staining.
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2.5. Immunohistochemical staining
2.5.1. Monoclonal antibodies
A. Formalin fixed and paraffin-embedded specimens
The Extra Avidin-biotin-peroxidase complex technique was used for 
immunohistochemical staining as described previously (Hsu et al., 1981) with 
modifications.
Sections (5-6 pm) on Silane coated slides were cut, incubated in xylene for 10 min, 
hydrated through graded alcohol, and placed in tap water.
Sections were subjected to high temperature antigen retrieval pre-treatment: sections 
were microwaved for 6 min in a 10 mM TB pH 9 using a special pressure cooker as 
described above. Endogenous peroxidase was blocked by immersing sections in 3% 
hydrogen peroxide (BDH Laboratory supplies, Poole, England) in distilled water for 15 
min then washing in 2 changes of TBS over 5 min, before incubating with normal rabbit 
serum (SAPU, Carluke, Lanarkshire, Scotland) diluted 1/5 in TB pH 7.6 for 10 min. 
Tissue sections were incubated with the appropriate monoclonal antibodies (Table 2 and 
3) diluted in TB pH 7.6. After incubation the sections were washed in 4 changes of 
TBS over 15 min and incubated with biotinylated rabbit anti-mouse secondary antibody 
(DAKO, Denmark) diluted 1/200 in TB pH 7.6 for 30 min. After washing in 2 changes 
of TBS over 5 min, the sections were incubated for 30 min with a 1/100 dilution of 
Extra Avidin-biotin peroxidase complex (Sigma, Poole, Dorset, England) in TB pH 7.6. 
After washing in 2 changes of TBS over 5 min, the peroxidase reaction was developed 
with peroxidase substrate kit (Vector VIP, Vector Laboratories, Burlingame, CA). 
Negative controls were established omitting the primary antibody (Fig. 83). Sections 
were counterstained lightly with hematoxylin ‘Z’ (CellPath, Hemel Hempstead Herts, 
UK), dehydrated and mounted with Pertex mounting media (CellPath, Hemel 
Hempstead Herts, UK) and viewed through a light microscope. These sections were 
viewed by two independent advisors.
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B. Frozen specimens
Specimens were snap frozen in liquid nitrogen and embedded in water frozen by dry ice. 
Cryostat sections (5-6 pm) were cut, fixed in one of the following fixative protocols 
according to the primary antibody used (Table 2 and 3):
• Fresh acetone (BDH Laboratory supplies, Poole, England) for 1 hour at -20°C.
• 10% Neutral buffered formalin for 10 min at room temperature.
• Sequential fixation in 10% neutral buffered formalin for 7 min at room temperature, 
chilled methanol (- 20°C) for 5 min and chilled acetone (- 20°C) for 3 min (Choudhry 
et al., 1992).
For certain antibodies (Table 3), sections were extracted with 0.5% (v/v) Triton x-100 
(Boehringer Mannheim Gmbh, Germany) in DPBS for 5-10 min using gentle agitation. 
Extraction with Triton x-100 was found to increase antibody permeablisation and reduce 
non-specific immuno-reactivity (Lin and DePhilip, 1996).
After washing in 3 changes of TBS over 10 min, endogenous peroxidase was blocked by 
immersing sections in 1% hydrogen peroxide in TB pH 7.6 for 10 min. After blocking 
with normal rabbit serum as described above, tissue sections were incubated with the 
appropriate monoclonal antibodies (Table 2 and 3) diluted in TB pH 7.6. Sections were 
then processed in a similar fashion to that outlined for paraffin sections.
2.5.2. Polyclonal antibodies
When a polyclonal antibody (rabbit or goat) was used as the primary reagent, both 
formalin fixed paraffin-embedded and frozen sections were treated as described above 
apart from the serum block and the biotinylated secondary antibody steps.
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A. Rabbit polyclonal antibodies
After washing in 3 changes of TBS over 10 min, sections were incubated for 10 min at 
room temperature with normal swine serum (DAKO, Denmark) (20% (v/v) dilution in 
TB pH 7.6) to block non-specific antibody-binding sites. Without washing, sections 
were incubated with the appropriate rabbit polyclonal antibody (Tables 1 and 2) diluted 
in TB pH 7.6 and then incubated at room temperature with biotinylated swine-anti rabbit 
secondary antibody (DAKO, Denmark) diluted 1/200 for 30 min.
B. Goat polyclonal antibodies
The sections incubated with normal rabbit serum diluted 1/5 for 10 min at room 
temperature. Without washing, the sections were incubated with the appropriate goat 
polyclonal antibody (Tables 2 and 3) diluted in TB pH 7.6 and then incubated with 
biotinylated rabbit anti-goat secondary antibody (Vector Laboratories, CA) diluted 1/200 
for 30 min at room temperature. Sections were then processed in a similar fashion to 
that outlined for paraffin and frozen sections.
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2.6. Multiple immunofluorescence Microscopy of the Cytoskeletal-Membrane 
Associations
2.6.1. Double immunolabelling of monoclonal antibodies with Actin
The double immunofluorescence staining was carried out according to a standard 
protocol (Mies et al., 1998) with modifications. Tissue sections which were already cut 
and stored at -20°C, were allowed to come to room temperature, then rehydrated in 
diluted phosphate buffer saline DPBS (GIBCO BRL, Life technologies Ltd, Paisley, 
Scotland) for 2 min. The sections were fixed by immersion in neutral buffer formalin 
for 10 min at room temperature, then washed in DPBS changing the buffer 3 times in 10 
min. Tissue sections were extracted with 0.5% (v/v) Triton x-100 in DPBS for 5-10 min 
using gentle agitation. After washing in 3 changes of DPBS over 10 min, the sections 
were incubated with normal horse serum diluted 1/5 in TB pH 7.6 for 10 min at room 
temperature; without washing, the sections were incubated with the appropriate primary 
antibody (Table 4).
The sections were then washed in 4 changes of DPBS over 15 min, and incubated with 
biotinylated horse anti-mouse secondary antibody (Vector Laboratories, Peterborough, 
UK) diluted 1/100 in TB pH 7.6 for 30 min at room temperature. After 3 washes in 
DPBS over 10 min, the sections were incubated with Avidin-FITC labelled (Vector 
Laboratories, Peterborough, UK) diluted 1/50 in TB pH 7.6 for 30 min at room 
temperature, then washed in 3 changes of DPBS over a 10 min period.
For the visualisation of polymerised actin, Tetramethylrhodamine Isothiocynate 
(TRITC)-labelled Phalloidin was used. This poisonous alkaloid from amanita 
phalloides exclusively binds to filamentous actin (Verderame et al., 1980; Heidecker et 
al., 1995). The sections were incubated with TRITC-labelled Phalloidin (Sigma 
chemical CO, Poole, Dorset) diluted 1/50 in TB pH 7.6 for 30 min at room temperature. 
Negative controls were established omitting the primary antibody (Fig. 112). The 
sections were then washed in 3 changes of DPBS over 10 min and mounted in 
Vectashield mounting medium (Vector Laboratories, Peterborough, UK). The cover 
slips were sealed with nail varnish and the slides were visualised using laser scanning 
confocal microscopy.
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2.6.2. Double im m unolabelling of polyclonal antibodies w ith Actin
When a polyclonal antibody (rabbit) was used as the primary reagent for the double 
immunolabelling with actin, the sections were treated as described above apart from the 
serum block and the biotinylated secondary antibody steps.
The sections were incubated with normal swine serum diluted 1/5 in TB pH 7.6 for 10 
min at room temperature; without washing, the sections were incubated with the 
appropriate primary antibody (Table 4). The sections were then washed in 4 changes of 
DPBS over 15 min, and incubated with biotinylated swine anti-rabbit secondary 
antibody diluted 1/200 in TB pH 7.6 for 30 min at room temperature. Sections were 
then processed in a similar fashion to that outlined in double immunolabelling of 
monoclonal antibodies with actin.
Antibody PT Fix Dilution Concentration Incubation Temp
C-(TCatenin Triton F 1:500 0.5 |ig/ml 1 hour 37°C
E-Cadherin Triton F 1:200 1.25 }ig/ml 1 hour 37°C
P-Cadherin Triton F 1:50 l ’and 5 pg/ml 1 hour 37°C
a-Catenin Triton F 1:100 2.5 pg/ml 1 hour 37°C
a-Actin in Triton F 1:400 0.2 pg/ml 1 hour 37°C
Phalloidin Triton F 1:50 2.0 fig/ml 30 min: RT
APC Triton A 1:100 1.0 pg/ml O/N 4°C
T able 4. A pplications o f  the an tibodies used for double im m unolabelling  w ith actin in BCC 
frozen sections and keratinocytes cham ber slides.
C = carboxyl terminus; E = epithelial; P = placental; APC = adenomatous polyposis coli; PT = pre­
treatment; Fix; fixative used; F = formalin; A = acetone; RT = room temperature; O/N = Overnight 
*When used in double immunolabelling with E-cadherin.
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2.6.3. Double immunolabelling of P- and E-cadherins
Tissue sections which were already cut and stored at -20°C, were allowed to come to 
room temperature, then rehydrated in DPBS for 2 min. The sections were fixed by 
immersion in 10% neutral buffer formalin for 10 min at room temperature, then washed 
in 3 changes of DPBS over 10 min. To increase antibody permeablisation and reduce 
non-specific immuno-reactivity, the sections were extracted with 0.5 % Triton x-100 in 
DPBS for 10 min using gentle agitation.
After washing in 3 changes of DPBS over 10 min, the sections were then incubated with 
normal horse serum diluted 1/5 in TB pH 7.6 for 10 min at room temperature (1st block) 
then incubated with the 1st primary antibody at the minimum working dilution (P- 
cadherin, 1.0 jig/ml TB pH 7.6) for 1 hour at 37°C. The sections were washed in 4 
changes of DPBS over 15 min, then incubated with concentrated biotinylated horse anti­
mouse secondary antibody diluted 1/25 in TB pH 7.6 for 30 min at room temperature to 
enhance binding to all molecules of the 1st primary antibody. After washing in 3 
changes of DPBS, the sections were incubated with Avidin-FITC diluted 1/50 in TB pH 
7.6 for 30 min at room temperature, then washed in 3 changes of DPBS over 10 min. 
The sections were incubated with normal horse serum diluted 1/5 in TB pH 7.6 for 10 
min at room temperature (2nd block), then incubated with the 2nd primary antibody at 
the usual working dilution (E-cadherin, 1.25 pg/ml TB pH 7.6) for lhour at 37°C. The 
sections were then washed in 4 changes of DPBS over 15 min and incubated with anti­
mouse Texas Red (Vector Laboratories, Peterborough, UK) diluted 1/50 in TB pH 7.6 
for 30 min at room temperature, then washed in 3 changes of DPBS over 10 min and 
mounted in Vectashield mounting medium. The cover slips were sealed with nail 
varnish and visualised using laser scanning confocal microscopy.
3 controls were included in this experiment, one by omitting the 1st primary antibody, 
i.e. P-cadherin, the second by omitting the 2nd primary antibody, i.e. E-cadherin, and a 
third by omitting both primary antibodies.
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2.7. In vitro skin model
2.7.1. Preparation of dermal equivalents (collagen gels)
Materials
Type I collagen 
0.34 M NaOH
Minimal essential medium (MEM)
Foetal calf serum (FCS)
Fibroblasts 
Trypsin 
PBS EDTA
Method
The preparation of dermal equivalents was carried out as described previously (Bell et 
al., 1979; 1983) with modifications. Type I collagen was extracted from rat tail tendons 
in 0.5M acetic acid, precipitated by the addition of an equal volume of 10% w/v NaCl, 
redissolved in 0.25M acetic acid and dialysed against 1/1000 glacial acetic acid, with the 
final solution being adjusted to 3mg collagen/ml. The actual amount of collagen was 
determined by freeze-drying a known volume of the solution and weighing the dried 
material.
The medium from the dish of fibroblasts was removed and the dish was washed gently 
for 2 min with Ca2+- and Mg2+-free PBS/1 mM EDTA, then 10 ml of 0.25% 
trypsin/Ca2+- and Mg2+-free PBS/lmM EDTA was added to the fibroblasts dish and 
incubated for 90 seconds at room temperature, then the solution was sucked off leaving 
a thin layer, and incubated for 1-2 min. at 37°C.
After detaching the fibroblasts by hitting the sides of the dish, 10 ml of media 
containing 10% FCS MEM (GIBCO BRL, Life technologies ltd, Paisley, Scotland) was 
added to stop the activity of trypsin, then the fibroblasts were taken into a sterile
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universal to be centrifuged and pelleted. Neat FCS (5.5ml) was added with pipetting to 
obtain a predominantly single cell suspension.
Collagen gels were prepared by mixing 7 volumes of collagen solution with 2 volumes 
of a mixture of lOx Eagle MEM/0.34M NaOH 2:1 v/v and the pH finely adjusted to 7.2 
with NaOH. The Eagle MEM was supplied by GIBCO BRL, Life Technologies Ltd, 
Paisley, Scotland.
One volume of FCS containing approximately 7.5x105 human adult forearm 
fibroblasts/10 ml of gel mixture was added, thoroughly mixed, and 4 ml pipetted into 
35mm Petri dishes. The gels were allowed to set at 37°C for 15 min, after which 1 ml of 
MEM supplemented with 10% FCS was added, the gels were detached from the dishes 
and incubated for 9 days at 37°C in a humidified atmosphere of 5% CO2 in air, with a 
medium changed every 3 days.
The gels at this stage were highly contracted, with the fibroblasts adopting a spindle- 
shaped morphology.
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2.7.2. Culturing of BCC cells on dermal equivalents
Materials
Fresh specimen of BCC.
Minimal essential medium (MEM).
Antibiotics (streptomycin, penicillin and Fungizone).
Collagenase type XI.
0.5% w/v dispase in PBS.
Trypsin.
PBS/EDTA
Method
The fresh specimen of BCC was transported in a sterile universal container and 
immediately washed in serum-free MEM. Double the normal concentration of 
antibiotics (streptomycin 100 (ig/ml, Penicillin 100 units/ml and Fungizone 
(Amphotericin B) 2.5 pg/ml) (all from GIBCO BRL, Life Technologies Ltd, Paisley, 
Scotland) was added to the specimen.
Ten mg of crude collagenase type XI (Sigma chemical Co, Poole, Dorset) was added to 
5 ml of dispase (0.5 gm/100 ml sterile PBS with antibiotics) and to this mixture, double 
the normal concentration of antibiotics was added.
The specimen was finely chopped in a sterile dish, then the 
collagenase/dispase/antibiotics mixture was added to the specimen and incubated 
overnight at 4°C.
The mixture was pipetted up and down several times, then centrifuged (4 min, 500g) 
and the supernatant fluid was removed. Five ml of 0.25% trypsin/Ca - and Mg -free 
PBS/lmM EDTA was added to the specimen and incubated for 15 min at 37°C. Then 5 
ml of MEM was added, and the mixture was centrifuged and the supernatant fluid 
removed, then 1 ml of MEM was added to the tumour cells for re-suspension. The cells 
were counted using a hemocytometer.
Dermal equivalents were made ready and placed in a 24 well multidish and to each, 0.5 
ml of MEM was added then finally another 0.5 ml of tumour cells was added and the 
dish incubated at 37°C in a humidified atmosphere of 5% C 02 in air, with a medium 
change every 2 days. The wells were inspected on a daily basis and the observations 
recorded.
2.7.3. Culturing of keratinocytes on dermal equivalents 
Materials
Human neonatal foreskins OR 
Tissue from breast reduction surgery.
0.5% w/v dispase in PBS.
Trypsin.
PBS/EDTA.
Sterile gauze.
MEM containing 10% FCS.
Method
Keratinocyte culture on dermal equivalents was carried out as described previously (Bell 
et al., 1993). Human neonatal foreskins or breast reduction tissue were cut into 3mm 
strips after removal of the subcutaneous fat, suspended in 0.5% w/v dispase in PBS 
(Kitano and Okada, 1983), and the tissue incubated overnight at 4°C.
The epidermis was peeled off, finely chopped, and treated with 0.25% trypsin/Ca2+- and 
Mg -free PBS/1 mM EDTA for 3 min with pipetting to obtain a predominantly single 
cell suspension. The cell suspension was passed through a sterile gauze, centrifuged (4 
min., 400g), resuspended in Dulbecco’s MEM (GIBCO BRL, Life Technologies Ltd, 
Paisley, Scotland) supplemented with 10% FCS, and added to contracted dermal 
equivalents placed in the wells of a 24 well multidish.
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2.7.4. Raising collagen gels to the air/liquid interface
Materials
Contracted collagen gels.
6 cm sterile dish.
10% FCS containing MEM.
2 cm permeable glass plates.
Method
Following incubation for 5 days as submerged cultures, the gels were then raised to the 
air/liquid interface on sintered glass discs and incubated for a further 7 days, at which 
time a highly stratified epidermis had developed.
The contracted collagen gels were placed flat onto 2 cm sintered glass discs in a 6 cm 
sterile dish. 10% FCS containing MEM was added to the dish just to cover the glass 
plates and reaching to the edges of the collagen gels, taking extra care not to cover them. 
The dish then incubated at 37°C in a humidified atmosphere of 5% CO2 in air, with the 
medium changed every 2 days. After 7 days a highly stratified epidermis had 
developed.
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2.7.5. Keratinocyte culture on chamber slides
Materials
2 or 4 well glass chamber slides (Nalge Nunc international, IL, USA).
75 cm2 flask of human foreskin keratinocytes.
PBS/EDTA.
Trypsin.
Foetal calf serum (FCS).
Keratinocytes growth medium (KGM).
2 sterile 75 cm2 flasks.
Sterile universal.
Method
24" 2"FThe flask of human foreskin keratinocytes was washed twice with Ca - and Mg -free 
PBS/1 mM EDTA. Trypsin (0.25%) in Ca2+- and Mg2+-ffee PBS containing ImM EDTA 
(1:1, by volume) was added to the keratinocytes and incubated for 3-4 min at room 
temperature with further incubation for 3-4 min at 37°C with shaking to detach most of 
the cells which were transferred to a sterile universal.
The cells were suspended in 1ml of FCS to stop the activity of trypsin, then a further 2 
ml of trypsin/PBS/EDTA mixture (1:1, by volume) was added to the flask of 
keratinocytes and the procedure repeated again to remove most of the cells. The cells 
were pelleted and resuspended in a specific amount of keratinocyte growth medium 
KGM (Clonetics Bio Whittaker Inc., USA) with low calcium concentration (0.1 mM 
CaCb), which is enough to fill the number of the chamber slides wells required for 
culture. As a rule instructed by the manufacturers, 1-1.3 ml is needed for each well of 
the 4 well glass chamber slides and 2-2.5 ml for the 2 well ones. The surfaces of the 
wells were coated with a layer of neat FCS for 1-2 min and then washed with KGM. 
This was found to enhance the attachment of the cells to the surfaces more quickly.
The chamber slides were then incubated at 37°C in a humidified atmosphere of 5% CO2 
in air, with the KGM changed after 2 days to remove dead cells. After 10-12 days of 
incubation in the same circumstances with the medium changed every 2-3 days, a
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confluent layer of cells had developed. Three days prior to staining of cells, the calcium 
concentration was shifted in half of the wells from low 0.1 mM to high 1.5 mM CaCh 
for comparison. In addition, the surfaces of the cultured wells were scraped in straight 
lines, approximately 0.5mm in width, to comment on the migration of the cells 
attempting to fill the gaps in between.
2.8. Subpassaging of cells
2.8.1. Keratinocytes 
Materials
75 cm flask of human foreskin keratinocytes.
PBS/EDTA.
Trypsin.
Neat foetal calf serum (FCS).
Keratinocytes growth medium (KGM).
2 sterile 75 cm2 flasks.
Sterile universal.
Method
The flask of human foreskin keratinocytes was washed twice with 10 ml of PBS/EDTA. 
Two ml of 0.25% trypsin/Ca2+- and Mg2+-ffee PBS/1 mM EDTA was added to the flask 
of keratinocytes and incubated for 3-4 min at room temperature and further incubation 
for 3-4 min at 37°C with shaking to detach most of the cells which were removed to a 
sterile universal.
The cells were suspended in 1ml of neat FCS to stop the activity of trypsin, then a 
further 2 ml of 1:1 trypsin/PBS/EDTA mixture was added to the flask of keratinocytes 
and the process repeated again to remove most of the cells. Without washing, the cells 
were pelleted and resuspended in 10 ml KGM (0.1 mM CaCh).
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Five ml of the cell suspension was transferred to each of the sterile 75 cm2 flasks, with a 
further 5 ml KGM to each flask. The flasks then incubated at 37°C in a humidified 
atmosphere of 5% C 02 in air, with the KGM changed every 2 days.
2.8.2. Fibroblasts 
Materials
75 cm2 flask of confluent fibroblasts.
PBS/EDTA.
Trypsin.
Minimal essential medium MEM.
2 sterile 75 cm2 flasks.
Sterile universal.
Method
The flask of confluent fibroblasts was washed twice with 10 ml of PBS/EDTA. Two ml 
of 0.25% trypsin/Ca2+- and Mg2+-free PBS/1 mM EDTA was added to the fibroblasts 
and incubated at room temperature for 1-2 min, then the trypsin/PBS/EDTA was 
removed leaving a thin layer. The flask was incubated for further 1-2 min at 37°C, then 
the cells were detached by shaking the flask and hitting the sides to remove all the cells. 
Ten ml of MEM (GIBCO BRL, Life technologies ltd, Paisley, Scotland) was added to 
the flask to stop the activity of trypsin. The cells were transferred to a sterile universal 
and centrifuged and resuspended in 10 ml of MEM.
Five ml of the cell suspension was added to each sterile 75 cm flasks and a further 5 ml 
of the MEM was added. The flasks were incubated for 7 days at 37°C in a humidified 
atmosphere of 5% C 02 in air, with the medium changed every 2-3 days. Following the 
incubation for 7 days, the fibroblasts were confluent.
94
2.9. Confocal laser scanning microscope
The immunofluorescence staining of BCC frozen sections and cultured keratinocytes 
were examined with a BioRad MRC 600 confocal laser scanning microscope (BioRad, 
Hemel Hempstead, UK). The confocal microscope was used to scan 
immunofluorescent slides in both green (excitation 488 nm, emission filter 522 nm for 
fluorescein) and red (excitation 568 nm, emission filter 585 nm) (Choudhry et al., 
1997). Gain controls were set to give maximum sensitivity while preventing spillover 
between green and red channels. A neutral density filter was set to provide illumination 
of specimen with 3% of maximum laser output. Slit width was adjusted to give Z-axis 
resolution of approximately 0.5 pm with an X60 oil immersion lens. Confocal images 
series were collected at intervals of 1.0 pm along Z-axis. A Kallman averaging 
procedure was used to collect each image (5-6 scans). Images were stored in a Zip-disc, 
merged and the contrast and background of each colour was adjusted using the 
programme “Confocal Assistant” version 4.02 (Todd Clark Brelje, USA). Images were 
then imported and arranged with PowerPoint and printed on a colour printer.
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2.10. Evaluation of immunohistochemical staining
Assessment of immunohistochemical staining was performed in normal, 
pseudoepitheliomatous and lesional skin samples. Where possible, the 
immunohistochemical staining in lesional skin was directly compared with that of the 
normal epidermis adjacent to the lesion as an internal positive control. The 
immunohistochemical staining in lesions lacking normal epidermis (3/10 cases of 
pilomatrixoma and 3/5 cases of metastatic melanoma) was evaluated and compared with 
that of normal skin attached to similar sample of the same diagnosis.
The intensity of E-, P-cadherin and (3-catenin staining in melanocytic lesions were 
evaluated and compared with normal keratinocytes because it was difficult to relate 
intensity of staining to normal melanocytes due to the surrounding keratinocytes.
When the immunohistochemical staining throughout the lesion is homogeneous 
(particularly in frozen sections), tumour cells were evaluated as strongly positive (++) if 
their intensity was the same as in normal epidermal cells. In lesions in which the 
intensity of immunohistochemical staining was homogeneously weak in comparison 
with normal epidermal cells, tumour cells were evaluated as weakly positive (+/-). 
Negative (Neg) indicated no detectable immunohistochemical staining.
In some cases (particularly in routinely processed, paraffin-embedded sections), the 
immunohistochemical staining throughout the lesion was heterogeneous i.e. presence of 
positive and negative cells. The number of negative tumour cells < 10% was noted as 
strongly positive (++), > 10% was evaluated as weakly positive (+/-). Negative (Neg) 
indicated no detectable immunohistochemical staining.
Repetition of staining experiments was performed on sections from same blocks or 
specimens. Assessment of the immunohistochemical staining was carried out using 
light microscopy.
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Chapter 3: Results
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Results I
Immunoperoxidase Staining of normal epidermis and non-melanocytic
lesions
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3.1. Immunohistochemical staining of E- and P-cadherin in formalin fixed and 
paraffin-embedded BCC (n=32)
Normal skin adjacent to tumour
In normal epidermis adjacent to the tumour, E- and P-cadherin cell membrane staining 
was specific, variable and strongly preserved in all cases (Table 5). Strongly positive 
P-cadherin membrane staining was confined to the basal and the first suprabasal layers 
of the epidermis and negative in the membranes of the upper epidermal cells (Fig.6) 
Hair follicles showed strongly positive P-cadherin membrane staining involving more 
cells in the infimdibulum region when compared with the basal cell layer extending to 
involve most of the spinous cells, while it was only positive in the outer cells of the 
external root sheath especially at the level of the sebaceous gland (Fig.7). Strongly 
positive P-cadherin membrane staining was noted in the cells of hair matrix, while there 
was complete absence of staining in the inner layers of the outer root sheath, dermal 
papilla and hair shaft. Sebaceous glands stained strongly positive for P-cadherin on the 
flattened germinative cells while the matured foamy cells within the gland were 
negative. Both secretory and excretory components of sweat glands showed strongly 
positive P-cadherin membrane staining similar in intensity to basal cells of the normal 
epidermis with variable cytoplasmic staining.
E-Cadherin was distributed in the full thickness of the epidermis excluding the stratum 
comeum with relatively weaker staining intensity in the membranes of the basal layer 
(Fig.8). In hair follicle, E-cadherin membrane staining was strongly positive on all the 
cells of the infimdibulum and external root sheath, but was less intense in the 
membranes of the internal root sheath cells (Fig. 10). The staining of E-cadherin in the 
dermal papilla and the hair shaft was uniformly negative. In sebaceous glands, E- 
cadherin staining was restricted to the membranes of the flattened germinative cells 
whereas the mature cells within were negative. In a similar staining pattern to the 
normal epidermis, E-cadherin staining was strongly positive in the cells of the secretory 
and ductal units of the sweat glands (Fig.9).
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Figure 6. P-C adherin  sta in ing  in norm al 
epidermis. N ote the restriction to the basal and 
the first suprabasal layers.
Original m agnification x500.
Figure 7. P-C adherin staining in hair follicle. 
Positive m em brane staining in O R S and hair 
m atrix  cells, negative in IRS cells and dermal 
papilla. x l2 5 .
Figure 8. E-Cadherin staining in paraffin- 
embedded nodular BCC. Strong staining and 
full thickness distribution in normal epidermis; 
m arked reduction o f  tum our cell m em brane 
staining com pared with epidermis. x250
Figure 9. E -C adherin  s ta in ing  in norm al 
sw eat glands. Positive m em brane staining in 
cells o f  both  secretory  and excreto ry  units. 
x400.
Figure 10. E-Cadherin staining in hair follicle. 
Strongly positive m em brane staining in ORS 
cells, less intense in IRS cells. x320.
Figure 11. E-C adherin staining in paraffin- 
em bedded nodular BCC. M arked reduction o f  
tum our cell m em brane staining centrally and 
strong m em brane staining in palisading cells. 
x500.
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Basal Cell Carcinom as
E-Cadherin staining was present in tumour cell membranes in 30/32 o f  the cases o f BCC 
but in a reduced staining intensity compared with the normal epidermis as the number of 
negative tumour cells was > 10% (Table 5) (Fig.8). Within tum our lobules, there was 
uneven membrane staining compared with the normal epidermis ranging from reduced 
staining intensity to complete absence. In some cases tumour lobules expressed reduced 
E-cadherin membrane staining centrally, while the palisading cells on the peripheries 
showed positive membrane staining similar to that o f normal epidermis (Fig. 11). This 
observation applied to all the different clinicopathological subtypes o f BCC.
P-Cadherin staining was preserved in cell membranes within tum our lobules and at the 
peripheries in 21/32 o f the cases (Table 5) (Fig. 12) and the reduction o f P-cadherin 
staining in the rest o f the cases 11/32 was found to be mainly within tum our lobules 
(Fig. 13). Reduction o f P-cadherin staining was correlated with BCC subtypes o f poorer 
outlook such as infiltrating and metatypical BCC (Table 6) (Fig. 13). There were 
variable degrees o f diffuse cytoplasmic distribution o f both antibodies in normal and 
tumour cells, but no nuclear staining was seen.
E-CADHERIN P-CADHERIN
++ +/- Neg ++ +/-• Neg
Epidermal cell membrane 32 a 0 0 32 k' : 0 0
Epidermal cell cytoplasm 
Tumour cell membrane
5
0
2
2
0
8
0
30
8
0
19
32
0
22
32
0. '--------
21 
0 
0
14
0
li
10
0
18
32
0
22
32
T able 5*. Distribution of E- and P-cadherin in 32 paraffin-embedded BCC.
♦Represents results o f 3 experiments. Results were reproducible and 
consistent in each specimen.
++: strongly positive. +/-: weakly positive (no. o f negative tumour cells > 10%). Neg: negative. 
a Basal and suprabasal cells. 
b Basal cells only.
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Figure 12. P-C adherin staining in paraffin  
embedded nodular BCC. S trong tum our cell 
m em brane staining. x320.
Figure 13. P-C adherin stain ing in paraffin  
em bedded  in f iltra tiv e  B C C . R ed u c tio n  o f  
tum our cell m em brane s ta in ing  and strong  
m em brane staining in palisading cells. x320.
Figure 14. E -C adherin  sta in ing  in frozen 
su p erfic ia l B C C . In co m p ariso n  w ith  the 
normal epiderm is, tum our cells show reduction 
in m em brane staining intensity. x500.
Figure 15. P -C adherin  sta in in g  in frozen 
infiltrative BCC. Tum our cells show reduction 
in m em brane  s ta in in g  in ten sity  in cen tra l 
a spec t o f  the lobule w hile pa lisad in g  cells 
show strong staining. x250.
• - . * i
A B
Figure 16. p-C atenin staining in paraffin embedded nodular BCC. (A) C-term inus. (B) N -term inus. 
Strong staining and full thickness distribution o f  both antibodies in norm al epiderm is; m arked 
reduction o f  tum our cell m em brane staining com pared with epiderm is. x250.
________
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Subtype
Superficial (multifocal) 12 0
    .  -----------------------------
Diffuse (infiltrating) 1 8
lodular
T able 6 . C orrelation  o f  P-cadherin m em brane stain ing w ith BCC subtypes.
++: strongly positive. +/-: weakly positive (no. o f negative tumour cells > 10%). Neg: negative.
3.2. Immunohistochemical staining of E- and P-cadherin in frozen BCC (n=12) 
Normal skin adjacent to tumour
E- and P-cadherins membrane staining in normal epidermis and appendages was 
strongly positive and specific in all cases (Table 7) (Fig. 14) following the same staining 
pattern in paraffin-embedded specimens.
Basal Cell Carcinomas
Staining o f E-cadherin in tumour cell membranes was found to be decreased in all cases 
(Table 7) (Fig. 14) compared with normal epidermis. The reduction o f E-cadherin 
membrane staining was confined to the inner aspects o f the tumour lobules with the 
cells in the palisade showing staining intensity similar to normal epidermis. P-Cadherin 
staining was reduced in tumour cell membranes in 10/12 o f the cases (Table 7) (Fig. 15), 
while the two examples showing strongly positive staining were non-infiltrating solid 
and superficial subtypes. Diffuse cytoplasmic staining was also observed in normal and 
tumour cells stained with both antibodies, but again no nuclear staining was seen.
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E-CADHERIN P-CADHERIN
++ +/- Neg ++ +/- Neg
Epidermal cell membrane 12 a 0 0 12 b 0 0
Epidermal cell cytoplasm 0 6 6 0 12 0
Epidermal cell nuclei 0 0 12 0 0■ Z/PI w 12
Tumour cell membrane 0 12 0 2 10 0
Tumour cell cytoplasm 
Tumour cell nuclei
0
0
7
0
5
12 0
12
.
0 12
T able 7 * .  D istribu tion  o f  E- and P-cadherin in 12 frozen BCC.
*  Represents results o f 2 experiments. Results were reproducible and 
consistent in each specimen.
++: strongly positive. +/-: weakly positive (homogeneously weak). Neg: negative 
a Basal and suprabasal cells. 
b Basal cells only.
3.3. Immunohistochemical staining of C-terminus P-catenin in formalin fixed and 
paraffin-embedded BCC (n=32)
Normal skin adjacent to tumour
All cases have shown uniform and homogeneous membrane staining o f C-terminus p- 
catenin in normal epidermal layers, except stratum comeum, with almost the same 
distribution as for E-cadherin (Table 8) (Fig.l6A ). There was variable cytoplasmic 
staining intensity within the normal keratinocytes and their nuclei were negative.
Basal Cell Carcinomas
C-Terminus p-catenin staining was present in tumour cell membranes in 29/32 of the 
cases o f BCC but in a reduced staining intensity compared with the normal epidermis as 
the number o f negative tumour cells was > 10% (Table 8) (Fig.l6A ). As for E-cadherin 
there was uneven membrane staining within the tumour lobules compared with the 
normal epidermis ranging from reduced staining intensity to complete absence. Similar 
to E-cadherin, C-terminus p-catenin membrane staining was preserved in the peripheral 
cells o f the tumour lobules showing reduction within. In addition, there was variable
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cytoplasmic staining ranging from weakly positive to complete absence. In thirteen of 
the 32 cases (Table 8), there was positive C-terminus p-catenin nuclear staining in 
tumour cells which showed negative membrane staining. Of these, ten were strongly 
positive (Fig.l7A) while three showed weakly positive nuclear staining. This notable 
feature of tumour cell nuclear staining did not seem to be correlated with the 
clinicopathological subtypes of BCC.
3.4. Immunohistochemical staining of N-terminus p-catenin in formalin fixed and 
paraffin-embedded BCC (n=32)
Normal skin adjacent to tumour
N-Terminus p-catenin membrane staining in the normal epidermis and skin appendages 
was uniform and strongly positive in all cases and followed a staining pattern similar to 
C-terminus P-catenin and E-cadherin (Table 8) (Fig.l6B). Variable degrees of diffuse 
cytoplasmic expression were also observed in normal cells but no nuclear staining.
Basal Cell Carcinomas
N-Terminus p-catenin staining was present in tumour cell membranes in 30/32 cases of 
BCC but in reduced intensity compared with the normal epidermis as the number of 
negative tumour cells was > 10% (Table 8) (Fig.l6B). Similar to C-terminus P-catenin, 
there was uneven membrane staining of N-terminus p-catenin within the lobules of the 
tumour compared with the normal epidermis ranging from reduced staining intensity to 
complete absence. The preservation of N-terminus p-catenin staining in the membranes 
of the palisading cells at the peripheries of tumour lobules was also noted (Fig.20). 
Eight tumours showed positive N-terminus P-catenin nuclear staining and negative 
membrane staining, as for C-terminus antibody (Table 8) (Fig.l7B). Of these, six were 
strongly positive while two showed weakly positive nuclear staining. All examples 
which demonstrated N-terminus p-catenin nuclear staining have also shown C-terminus
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Figure 17. p-C atenin nuclear staining in paraffin-em bedded BCC. (A) C-term inus. (B) N -term inus. 
N ote th e  a c c o m p a n y in g  d e c re a se  in m e m b ra n e  p -ca ten in . x500.
B
Figure 18. p-C aten in  stain ing  in frozen nodular BCC. (A) C -term inus. (B ) N -term inus. In 
com parison with the normal epiderm is, tum our cells show reduction in m em brane staining intensity. 
x500.
Figure 19. p-C atenin nuclear staining in frozen BCC (arrow s). (A) C-term inus. (B) N -term inus.
x625.
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p-catenin nuclear staining. The tumour cells expressed variable degrees o f cytoplasmic 
staining ranging from weak positivity to complete absence.
N -terminus C -terminus
++ +/- Neg ++ +/- Neg
Epidermal cell membrane 32 0 0 32 0 0
Epidermal cell cytoplasm 0 5 27 0
7
25
Epidermal cell nuclei 
Tumour cell membrane 
Tumour cell cytoplasm
0
2
0
0
30
9
32
0
23
0.
3
o
0
29 
12
0
20
Tumour cell nuclei 6 2 24 10 3 19
Table 8 * .  D istribution o f  C and N term ini o f  P-catenin in 32 paraffin-em bedded  BCC.
♦  Represents results o f 3 experiments. Results were reproducible and 
consistent in each specimen.
++: strongly positive. +/-: weakly positive (no. o f negative tumour cells > 10%). Neg: negative.
3.5. Immunohistochemical staining of C-terminus p-catenin in frozen BCC (n=12) 
Normal skin adjacent to tumour
There was good agreement between p-catenin staining o f membranes in paraffin- 
embedded and frozen samples. All the 12 frozen BCC showed strong C-terminus P- 
catenin expression in the membranes o f normal epidermis and skin appendages (Table 
9) (Fig.l8A ) as described above in paraffin-embedded samples. The nuclei o f normal 
cells were universally negative.
Basal Cell Carcinomas
All o f the 12 cases showed some reduction o f tumour cell membranes staining which 
was marked within the tumour lobules (Fig.l8A ). Most o f the tumour lobules have 
shown positive membrane staining in the palisading cells which was almost similar to 
the staining intensity in normal cells. Only one case has shown weakly positive C-
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terminus p-catenin nuclear staining (Table 9) (Fig.l9A). Variable cytoplasmic staining 
in normal and tumour cells was present.
3.6. Immunohistochemical staining of N-terminus P-catenin in frozen BCC (n=12) 
Normal skin adjacent to tumour
The staining of N-terminus p-catenin in normal epidermis and skin appendages was 
identical to the C-terminus p-catenin. It was strongly positive in the membranes and 
negative in the nuclei of normal cells in all the cases examined (Table 9) (Fig.l8B).
Basal Cell Carcinomas
Similar to the staining with the C-terminus antibody, N-Terminus p-catenin staining was 
present in tumour cell membranes in all the cases of frozen BCC but in reduced 
intensity compared with the normal epidermis (Table 9) (Fig.l8B). N-Terminus P- 
catenin staining reduction was mainly confined to the inner aspects of the tumour 
lobules. The cells in the peripheries showed staining intensity similar to normal 
epidermis. Uneven membrane staining of N-terminus p-catenin within the tumour 
lobules was also observed. One tumour has shown weakly positive nuclear staining of 
N-terminus p-catenin (Fig.l9B). Variable cytoplasmic staining in normal and tumour 
cells was present.
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N-terminus C-terminus
++ +/- Neg 4* + +/- Neg
Epidermal cell membrane 12 0 0 12 0 0
Epidermal cell cytoplasm 0 5 7 0 4* 8
Epidermal 
Tumour cel
Tumour cel
:ell nuclei 
membrane 
1 cytoplasm 
1 nuclei
0
0
0
0
0
12
4
1
12
0
8
11
0
0
0
0
3
1
12
0
g
11
Table 9 + . D istribution  o f  C and N term ini o f  P-catenin in 12 frozen BCC.
♦  Represents results o f 2 experiments. Results were reproducible and 
consistent in each specimen.
++: strongly positive. +/-: weakly positive (homogeneously weak). Neg: negative.
3.7. Immunohistocheinieal staining of a-catenin in frozen BCC (n=12)
Ten o f twelve specimens have shown strongly positive, uniform and homogeneous 
membrane staining o f a-catenin in normal epidermal layers (Table 10) (Fig.21). There 
was relatively weaker staining intensity in the membranes o f the basal and granular 
layer. The stratum corneum was negative. The staining was located mainly on the cell 
membrane, especially at the area o f cell-cell contact. Hair follicles showed strongly 
positive membrane staining at all levels especially at the region o f the infundibulum and 
on the external root sheath cells with consistently negative staining in the hair shaft, a -  
Catenin membrane staining in sebaceous glands was similar in intensity to the basal and 
granular layer. It was restricted to the flattened germinative cells at the peripheries of 
the acinus o f sebaceous glands. Sweat glands stained positively for a-catenin in their 
membranes. The normal cells expressed variable degrees o f cytoplasmic staining which 
were mostly negative, normal cell nuclei were universally negative.
Two o f twelve cases demonstrated weakly positive a-catenin staining in cells o f normal 
epidermis and skin appendages.
a-Catenin staining was present but in reduced staining intensity in tumour cell 
membranes in 11/12 o f the cases in comparison with the normal epidermis (Table 10) 
(Fig.21). The reduction o f tumour cell membrane staining o f a-catenin was mainly 
confined to the inner aspects o f the tumour lobules while the cells at the peripheries
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expressed staining intensity almost similar to the normal epidermis. One tumour 
expressed a staining intensity identical to normal epidermis. Some tumour cells 
expressed obscure staining in the cytoplasm diffusely. Staining could not be detected in 
the tumour cell nuclei in any o f the cases.
a-CATENIN
++ +/- Neg
Epidermal cell membrane 10 2 0
Epidermal cell cytoplasm 0 2 10
Epidermal cell nuclei 0 0 12
Tumour cell membrane 1 11 0
Tumour cell cytoplasm 0 3 9
Tumour cell nuclei' 0 0 12
T able  10+ . D istribution  o f  a -ca ten in  in 12 frozen BCC.
♦ Represents results o f 2 experiments. Results were reproducible and 
consistent in each specimen.
++: strongly positive. +/-: weakly positive (homogeneously weak). Neg: negative.
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Figure 20. C-Term inus p-C atenin staining in 
paraffin-em bedded nodular BCC. Reduction o f  
tum our cell m em brane staining centrally and 
strong m em brane staining in palisading cells. 
x250.
Figure 21. (x-C atenin  s ta in in g  in frozen  
nodular BCC. In com parison with the normal 
ep iderm is, tu m o u r cells show  reduc tion  in 
m em brane staining intensity. x250.
A B
Figure 22. Gli-1 staining in norm al epiderm is adjacent to BCC (paraffin). (A) C -term inus. (B) N- 
term inus. N ote the weak m em brane staining in upper cells and the nuclear staining mostly in basal 
cells. x400.
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Figure 23. G li-1  s ta in in g  in e p id e rm is  Figure24. C-Term inus Gli-1 nuclear staining
overlying BCC. N o staining detected. x400. in paraffin-em bedded BCC. N ote the nuclear
staining in alm ost all tum our cells. x320.
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3.8. Immunohistochemical staining of C-terminus Gli-1 in formalin fixed and
paraffin-embedded BCC (n=32)
Normal skin adjacent to tumour
The staining of the C-terminus Gli-1 in the normal epidermis adjacent to tumour and in 
skin appendages was patchy and heterogeneous in all the specimens. All specimens 
examined showed weakly positive staining in stratum comeum. Weakly positive and 
patchy staining of C-terminus Gli-1 was observed along the epidermal cell membranes 
in 24/32 of the cases particularly in spinous cells (Table 11). This pattern of staining 
was mainly observed towards the edges of the normal epidermis (Fig.22A) In some hair 
follicles, staining along the membranes of the outer root sheath cells was seen, but was 
not consistent in all normal specimens. Similarly, the pattern of staining in sebaceous 
and sweat glands was weak and heterogeneous. Furthermore, there was no detection of 
staining in the epidermis immediately above the main BCC mass in any of the 
specimens (Fig. 23). In addition, 8/32 of cases showed completely negative staining in 
the normal epidermis and appendages (Table 11). Almost all epidermal cells showed 
negative cytoplasmic staining. A notable feature was the presence of weakly positive 
nuclear staining in normal epidermal cells in 6/32 of the cases. This was particularly 
observed in the nuclei of basal layer cells at the edges of the normal epidermis (Fig. 
22 A).
Basal Cell Carcinomas
Throughout tumour lobules, the staining of the C-terminus Gli-1 was uneven at different 
cellular levels. In almost all cases (30/32), the C-terminus Gli-1 staining in the 
membranes and cytoplasm of tumour cells was negative (Table 11), although, in one, 
the pattern of staining along membranes of tumour cells was similar to the positive 
staining observed in some normal epidermal cells. In addition, there was uneven 
nuclear staining, in some cases, throughout the tumour lobules ranging from strongly 
positive staining intensity to complete absence. This was observed in both central and 
peripheral aspects of the tumour lobules. In 21/32 cases (Table 11), there was positive 
C-terminus Gli-1 nuclear staining in tumour cells which showed negative membrane
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staining (Fig.24). O f these, nine were strongly positive while twelve showed weakly 
positive nuclear staining (Fig.26). Minimal background staining was apparent in some 
specimens. There was no correlation between the different clinicopathological subtypes 
o f BCC and their pattern o f C-terminus Gli-1 nuclear staining.
N-terminus C-terminus
++ +/- Neg | | +/- Neg
Epidermal cell membrane 0 21 11 0 24 8
Epidermal cell cytoplasm 
Epidermal cell nuclei 
Tumour cell membrane
0
0
0
2
5
1
30 
27
31 1
2
6
*
30
26
30
Tumour cell cytoplasm 0 1 31 0 ry 30
Tumour cell nuclei 8 8 16 9 12 11
T able 1 1 * . D istribution  o f  stain ing for C and N term ini o f  Gli-1 in 32 paraffin-em bedded
BCC.
♦ Represents results o f 2 experiments. Results were reproducible and 
consistent in each specimen, however, different background staining 
intensities were seen with each antibody.
++: strongly positive. +/-: weakly positive (no. o f negative tumour cells > 10%). Neg: negative.
3.9. Immunohistochemical staining of N-terminus Gli-1 in formalin fixed and 
paraffin-embedded BCC (n=32)
Normal skin adjacent to tumour
The pattern o f N-terminus Gli-1 staining in the normal epidermis adjacent to tumour 
was similar to that o f C- terminus Gli-1 in which it was patchy and heterogeneous in all 
the specimens. Towards the edges o f the normal epidermis, there was weakly positive 
staining o f N-terminus Gli-1 along the cell membranes in 21/32 o f the cases particularly 
in spinous cells (Table 11) (Fig. 22B). The normal epidermis immediately above the 
main BCC mass was negative in all the specimens. Eleven o f 32 examples showed 
completely negative staining in the normal epidermis and appendages. Similar to C- 
terminus Gli-1, weakly positive nuclear staining in normal epidermal cells was observed 
in 5/32 o f the cases (Fig. 22B).
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Basal Cell Carcinomas
The staining pattern of N-terminus Gli-1 in the tumour cells was similar to that of C- 
terminus Gli-1 (Table 11). Almost all cases (31/32) showed negative staining in the 
membranes and cytoplasms of tumour cells. Uneven nuclear staining was observed in 
16/32 cases. Of these, eight were strongly positive (Fig. 25) while eight showed weakly 
positive nuclear staining. All these cases also showed nuclear staining using the C- 
terminus antibody. Similar to C-terminus Gli-1, there was no correlation between the 
different clinicopathological subtypes of BCC and their pattern of N-terminus Gli-1 
nuclear staining.
NB: The conditions used by Ghali and colleagues (1999) for Gli-1 staining (N and C 
termini) were tried to compare our results. Apart from using VIP developing peroxidase 
substrate kit, instead of Diaminobenzidine, I have carried out 2 staining experiments on 
32 routinely processed, paraffin-embedded cases of BCC using exactly the same 
methods published by Ghali and colleagues (1999). Unfortunately, the results were not 
satisfactory. The staining of both N and C terminal antibodies was very patchy and 
seemed to be non-specific in most of the sections because of the presence of massive 
background staining in collagen bundles, smooth muscles and adipose tissue.
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3.10. Immunohistochemical staining of E- and P-cadherin in formalin fixed and
paraffin-embedded pilomatrixoma (n=10)
The distribution of E- and P-cadherin staining in normal epidermis covering 
pilomatrixoma was identical to the staining in normal epidermis described above apart 
from two examples which showed weakly positive P-cadherin staining in the basal 
layer. There was no normal epidermis found in 3/10 of the cases examined.
E-Cadherin cell membrane staining in the tumour cells was strongly positive in 5/10 
cases (Table 12) (Fig. 27). The staining was pronounced mainly in the membranes of 
the small basaloid cells at the peripheral aspects of the tumour which show some mitotic 
activity. The large cells towards the inner aspects of the tumour were also staining 
strongly positive. However, E-cadherin membrane staining was negative in the 
transformed ghost cells which are showing nuclear pyknosis. E-Cadherin membrane 
staining was present but in reduced staining intensity in two cases in comparison with 
the normal epidermis (Table 12) (Fig. 28). There was no E-cadherin staining observed in 
three cases examined which were composed mainly of sheets of keratinous debris in 
which the ghost outlines of tumour cells were faintly visible and the nuclei were lost. 
There were variable degrees of E-cadherin cytoplasmic staining in tumour cells ranging 
from weakly positive to complete absence. No E-cadherin staining could be detected in 
the tumour cell nuclei of all the cases.
Five of ten cases showed strongly positive P-cadherin cell membrane staining confined 
mainly to the small basaloid germinative cells (Table 12) (Fig. 29). However, in a few 
areas, P-cadherin membrane staining extended to involve some of the viable matured 
cells towards the inner parts of the tumour lobules (Fig. 30). P-Cadherin tumour cell 
membrane staining was present but in reduced staining intensity in 2/10 cases in 
comparison with the basal layer of the normal epidermis. As for E-cadherin, there was 
no P-cadherin staining observed at any cellular level in 3/10 of the cases which were 
composed of anuclear fully matured cells dispersed in sheets of keratinous debris. The 
tumour cell cytoplasms and nuclei were negative.
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Figure 25. N-Terminus Gli-1 nuclear staining 
in paraffin-embedded BCC. Note the nuclear 
staining in almost all tumour cells. x320.
Figure 26. C-Terminus Gli-1 nuclear staining 
in paraffin-embedded BCC. Higher power 
showing weak nuclear staining in some 
tum our cells. x500.
Figure 27. E -C a d h e r in  s ta in in g  in 
pilom atrixom a. Strong tum our cell m em brane 
staining. x625.
Figure 28. E -C a d h e r in  s ta in in g  in 
p ilom atrixom a. N ote the gradual decrease in 
m em brane staining tow ards the central aspect 
o f  the tumour. x320.
Figure 29. P -C a d h e r in  s ta in in g  in 
pilomatrixoma. N ote the restriction to the basal 
cells. x500.
Figure 30. P -C a d h e r in  s ta in in g  
pilom atrixom a. Staining accentuation tow ards 
inner aspect o f  tumour. x320.
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E-CADHERIN P-CADHERIN
++ +/- Neg I j +/- Neg
Epidemiai cell membrane* 7 a 0 0 5 b 2
Epidermal cell cytoplasm 0 7 0 0 0 7
Epidermal cell nuclei 0 0 7 0 0 7
Tumour cell membrane 5 2 3 5 2 -J
Tumour cell cytoplasm 0 7 3 A 10
Tumour cell nuclei 0 0 10 0 0 10
T able 1 2 * . D istribution o f  E- and P-cadherin in 10 paraffin-em bedded  p ilom atrixom a.
♦Represents results o f 2 experiments. Results were reproducible and 
consistent in each specimen.
++: strongly positive. +/-: weakly positive (no. o f negative tumour cells > 10%). Neg: negative 
Three cases have no epidermis. 
a Basal and suprabasal cells. 
b Basal cells only.
3.11. Immunohistochemical staining of C-terminus P-catenin in formalin fixed and 
paraffin-embedded pilomatrixoma (n=10)
The distribution o f C-terminus p-catenin staining in normal epidermis covering 
pilomatrixoma was identical to the staining in normal epidermis described above (Table 
13) (Fig. 31 A). There was no normal epidermis found in 3/10 o f the cases examined. 
C-Terminus p-catenin staining was strongly positive in tumour cell membranes in 3/10 
o f the cases (Table 13) (Fig. 32A) following almost the same pattern o f E-cadherin 
staining in pilomatrixoma. Four o f  ten cases showed positive staining o f C-terminus P- 
catenin in tumour cell membranes but in reduced intensity in comparison with the 
normal epidermis (Fig. 33A). There was negative staining o f  C-terminus p-catenin 
throughout the tumour in 3/10 cases. All the examples o f pilomatrixoma showed highly 
variable degrees o f cytoplasmic C-terminus P-catenin staining ranging from strongly 
positive staining to universally negative. Seven tumours showed positive C-terminus P- 
catenin nuclear staining (Table 13) (Figs. 32A and 33A). O f these, four were strongly 
positive while three showed weakly positive nuclear staining. Although that some of 
the viable large and matured cells showed nuclear staining, the majority o f cells were 
from the small germinative basaloid population. The nuclei o f the fully matured, 
nonviable cells were negative.
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A  B
Figure 31. p-catenin staining in epidermis overlying pilomatrixoma. (A) C-terminus. (B) N- 
terminus. Strong staining and full thickness distribution. x250.
A  B
Figure 32. p-catenin staining in pilomatrixoma. (A) C-terminus. (B) N-terminus. Several tumour 
cells show strong membrane and nuclear staining. (A) x625, (B) x500.
Figure 33. p-catenin nuclear staining in pilomatrixoma. (A) C-terminus. (B) N-terminus. Strong 
nuclear staining in almost all tumour cells. Note the accompanying decrease in membrane 
p-catenin. (A) x250, (B) x500.
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3.12. Immunohistochemical staining of N-terminus P-catenin in formalin fixed and
paraffin-embedded pilomatrixoma (n=10)
The distribution of N-terminus p-catenin staining in normal epidermis covering 
pilomatrixoma was identical to the C-terminus P-catenin staining in normal epidermis 
described above (Table 13) (Fig. 3IB). There was no normal epidermis found in 3/10 of 
the cases examined.
N-Terminus P-catenin tumour cell membrane staining was strongly positive in 3/10 of 
the cases following the same staining pattern observed with C-terminus p-catenin in the 
tumours which showed preservation (Table 13) (Fig. 32B). Four tumours expressed 
reduced membrane staining of N-terminus p-catenin when compared with the normal 
epidermis (Fig. 33B). Three tumours gave negative staining with N-terminus P-catenin. 
Highly variable degrees of cytoplasmic N-terminus p-catenin staining ranging from 
strongly positive staining to universally negative were seen in all the tumours. Seven 
tumours showed positive N-terminus p-catenin nuclear staining (Table 13) (Figs. 32B 
and 33B). Of these, four were strongly positive while three showed weakly positive 
nuclear staining. The seven pilomatrixoma tumours expressed N-terminus p-catenin 
nuclear staining were the same examples which expressed C-terminus P-catenin nuclear 
staining.
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N-terminus C-terminus
++ +/- Neg ++‘ +/- Neg
Epidermal cell membrane* 7 0 0 7 0 0
Epidermal cell cytoplasm 0 7 0 0 7 0
Epidermal cell nuclei 0 0 7 0 0 7
Tumour cell membrane 3 4 3 3 4 3
Tumour cell cytoplasm 4 3 3 4 3 3
Tumour cell nuclei 4 3 3 4 3 3
T able 13+ . D istribution  o f  C and N  term ini o f  p -catenin  in 10 paraffin-em bedded 
pilom atrixom a.
♦  Represents results o f 3 experiments. Results were reproducible and 
consistent in each specimen.
++: strongly positive. +/-: weakly positive (no. o f negative tumour cells > 10%). Neg: negative.
* Three cases have no epidermis.
3.13. Immunohistochemical staining of E- and P-cadherin in formalin fixed and 
paraffin-embedded well differentiated SCC (n=10)
Nine cases showed strongly preserved epidermal cell membrane staining o f  E-cadherin 
either in normal or in pseudoepitheliomatous epidermis (Table 14) (Fig. 34A), although 
the intensity o f staining tended to decrease in upper prickle and granular cell layers and 
was negative in stratum corneum.
P-Cadherin membrane staining was strongly positive in basal and suprabasal cells in 
normal and acanthotic skin in 9/10 examples (Table 14). A notable feature was the 
presence o f strongly positive membrane staining o f P-cadherin involving the basal cells 
and most o f the spinous layer o f the pseudoepitheliomatous skin over the tumour (Fig. 
38).
E-Cadherin tumour cell membrane staining was present in 7/10 cases, but in reduced 
staining intensity (Figs. 34A and B) (particularly in parts o f tum our showing poorer 
differentiation) when compared with normal epidermis. E-Cadherin was strongly 
positive in 2/10 and completely negative in one case (Table 14) (Fig. 35).
Tumour membrane staining o f P-cadherin was present in 5/10 cases, but in reduced 
staining intensity when compared with the basal layer, strongly positive in 4/10 (Fig. 37) 
and negative in one case (Table 14) (Fig. 38). The adjacent normal epidermis was used 
as a positive control. In areas o f tumour with conspicuous keratinisation, both
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antibodies showed decreasing staining intensity towards the centre of whorls (Fig. 36). 
In contrast with both paraffin and frozen BCC, no positive staining was observed on the 
peripheries of the tumours. Variable cytoplasmic staining of both antibodies was noted 
in normal epidermal cells, but was negative in tumour cells in almost all cases with no 
nuclear staining observed.
3.14. Immunohistochemical staining of C-terminus p-catenin in formalin fixed and 
paraffin-embedded well differentiated SCC (n=10)
The staining pattern of C-terminus P-catenin was almost similar to that of E-cadherin 
either in normal epidermis or in tumour cells (Table 14). Nine cases showed strongly 
positive epidermal cell membrane staining with decreasing intensity in granular cell 
layer (Table 14). In tumour cell membranes, C-terminus P-catenin staining was present 
in 7/10 cases, but in reduced staining intensity when compared with the normal 
epidermis (Table 14) (Fig. 39). Membrane staining was strongly positive in 2/10 and 
negative in one case. The reduction of C-terminus p-catenin in tumour downgrowths 
was uneven, which showed different staining intensities ranging from strong positivity 
to complete absence. In contrast to BCC, no positive staining was seen on the 
peripheral aspects of the tumour lobules. In the cytoplasm of normal epidermal cells, C- 
terminus P-catenin staining was variable again, but was negative in tumour cells in 9/10 
cases. There was no observation of C-terminus p-catenin staining in tumour cell nuclei.
1 2 1
A  B
figure 34. E-Cadherin staining in well-differentiated SCC. (A) and (B) In com parison with the 
normal epiderm is, tum our cells show reduction in m em brane staining intensity (arrow s). (A) 
x320, (B) x250.
Figure 35. E -C ad h erin  s ta in in g  in w ell- 
d iffe re n tia ted  S C C . C o m p le te  ab se n c e  o f  
m em brane staining. x500.
Figure 36. E-Cadherin staining in keratinising 
c y s ts  o f  w e ll-d if fe re n tia te d  S C C . W eak 
s ta in in g  in c y s t p e rip h e rie s  and  neg a tiv e  
tow ards the central aspect o f  the whorl. x20 0 .
Figure 37. P -C ad h e rin  s ta in in g  in w ell- 
d if f e re n t ia te d  S C C . S tro n g  tu m o u r  ce ll 
m em brane staining. x500.
Figure 38. P -C ad h e rin  s ta in in g  in w ell- 
differentiated SCC. Tum our cells show marked 
reduction in m em brane staining intensity in 
com parison with acanthotic epiderm is. x320.
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E-CADHERIN P-CADHERIN (3-CATENIN
++ +/- Neg ++ +/- Neg 1 ++ +/- Neg
Epidermal cell membrane* 9 a 1 0 1 0 b n n 9 a 1 0
Epidermal cell cytoplasm 0 8 2 0 6 4 0 7 3
Epidermal cell nuclei 0 0 10 0 0 0 10
Tumour cell membrane 2 7 1 A 2 7 1
Tumour cell cytoplasm 0 2 8 0 0 1 9
Tumour cell nuclei 0 0 10 0 0 10
T able 1 4 * . D istribution  o f  E- and P-cadherin and C -term inus (3-catenin in 10 paraffin-
em bedded well d ifferen tia ted  SCC.
*  Represents results o f 2 experiments. Results were reproducible and 
consistent in each specimen.
++: strongly positive. +/-: weakly positive (no. o f negative tumour cells > 10%). Neg: negative.
* In normal and pseudoepitheliomatous skin. 
a Basal and suprabasal cells.
b Basal cells only.
3.15. Immunohistochemical staining of E- and P-cadherin in formalin fixed and 
paraffin-embedded moderately differentiated SCC (n=5)
In normal epidermis, E- and P-cadherin pattern o f staining was identical to that seen in 
normal epidermis o f well differentiated SCC (Table 15), which was strongly preserved 
in all the five cases. E-Cadherin staining was reduced in tumour cell membranes in 4/5 
of the cases (particularly in parts o f tumour which showed poorer differentiation with 
conspicuous nuclear pleomorphism and mitoses) when compared with the normal 
epidermis and cases o f well-differentiated SCC. Staining was completely negative in 
one case (Table 15) (Fig. 41). There was no positive E-cadherin membrane staining on 
the outer aspects o f the tumour lobules and the concentric laminated whorls were 
weakly positive.
P-Cadherin staining in tumour cell membranes was present in 2/5 o f the cases, but in 
reduced staining intensity when compared with the basal layer o f  normal epidermis and 
cases o f well-differentiated SCC (Table 15) (Fig. 42). Staining was negative in 3 cases 
compared with the adjacent normal and pseudoepitheliomatous skin. Variable 
cytoplasmic staining o f both antibodies was noted in normal and pseudoepitheliomatous
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epidermal cells ranging from weakly positive to complete absence. The nuclei ot 
tumour cells were universally negative with both antibodies.
3.16. Immunohistochemical staining of C-terminus P-catenin in formalin fixed and 
paraffin-embedded moderately differentiated SCC (n=5)
Four o f the five specimens examined showed strongly positive C-terminus p-catenin 
membrane staining in normal and pseudoepitheliomatous skin and one case stained 
weakly (Table 15) with an identical distribution as described above. The normal cells 
showed variable cytoplasmic diffusion and the nuclei were universally negative.
Three o f five tumours showed reduction o f C-terminus P-catenin staining in tumour cell 
membranes which was more profound in areas o f the tumour which showed poorer 
differentiation, conspicuous nuclear pleomorphism and mitoses (Table 15). Two 
examples o f moderately differentiated SCC showed complete absence o f  staining (Fig. 
40). C-Terminus P-catenin membrane staining in the concentric laminated whorls, horn 
cysts, and the scattered individually keratinised cells was decreased more extensively 
than in well differentiated SCC. The tumour downgrowths were largely negative. 
Variable degrees o f diffuse cytoplasmic distribution were observed in tumour cells and 
their nuclei were consistently negative.
E-CADHERIN P-CADHERIN P-CATENIN
++ +/- Neg +*f : +/- Neg ++ +/- Neg
Epidermal cell membrane* 5 a 0 0 5 b 0 0 4 a 1 0
Epidermal cell cytoplasm 0 4 1 0 2 3 0 1 4
Epidermal cell nuclei 0 0 5 0 0 5 0 0 5
Tumour cell membrane 0 3 2 0 3 2 0 3 2
Tumour cell cytoplasm 0 4 1 0 3■ 0 1 4
Tumour cell nuclei 0 0 5 0 0 5 0 0 5
Table 15+ . Distribution of E- and P-cadherin and C-terminus p-catenin in 5 paraffin-embedded 
moderately differentiated SCC.
♦  Represents results of experiments. Results were reproducible and 
consistent in each specimen.
++: strongly positive. +/-: weakly positive (no. o f negative tumour cells > 10%). Neg: negative.
In normal and pseudoepitheliomatous skin. 
a Basal and suprabasal cells. 
b Basal cells only.
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Figure 40. C -Term inus p-catenin staining in 
M oderately d ifferentiated SCC . C om plete 
absence o f  staining. x320.
Figure 39. C-Term inus p-catenin staining in 
w ell-differentiated SCC. T um our cells show 
reduction in m em brane staining. x400.
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Figure 41. E-Cadherin staining in M oderately 
d iffe re n tia ted  S C C . C o m p le te  a b sen ce  o f  
staining. x320.
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Figure 42. P-Cadherin staining in M oderately 
differentiated SCC. Tum our cells show some 
reduction in m em brane staining. x320.
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Figure 43. E- and P-cadherin staining in keratoacanthom a . (A) E-cadherin. (B) P-cadherin. In 
com parison with the pseudoepitheliom atous skin, tum our cells show reduction in m em brane staining 
intensity (arrow s). x320.
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3.17. Immunohistochemical staining of E- and P-cadherin in formalin fixed and 
paraffin-embedded keratoacanthoma (n=3)
In all cases, the patterns of expression of E- and P-cadherin were identical to those 
observed either in normal or in pseudoepitheliomatous skin of well differentiated SCC 
(Table 16). E-Cadherin membrane staining in the tumour cells was weakly positive in 
all the cases (Fig. 43A) especially in the squamous epithelium at the lower border of the 
tumours. The characteristic central keratin plug (crater) was negative. The staining of 
E-cadherin in tumour cell cytoplasms and nuclei was negative.
Tumour cell membrane staining of P-cadherin along the tumour lower border was 
present in all cases examined, but in reduced staining intensity when compared with the 
basal layer of the normal epidermis (Table 16) (Fig. 43B). There was no staining seen 
in the tumour cell cytoplasms and nuclei.
3.18. Immunohistochemical staining of C-terminus P-catenin in formalin fixed and 
paraffin-embedded keratoacanthoma (n=3)
C-Terminus p-catenin distribution in normal and pseudoepitheliomatous skin in 
keratoacanthoma was similar to that seen in well differentiated SCC. Tumour cell 
membrane staining of C-terminus p-catenin was present, but in reduced staining 
intensity in all cases in comparison with the normal epidermis (Table 16) (Fig. 44). The 
reduction of staining was observed in the proliferative epithelium at the floor of the 
lesion. The staining of C-terminus p-catenin in tumour cell cytoplasms and nuclei was 
negative.
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E-CADHERIN P-CADHERIN (3-CATENIN
++ +/- Neg ++ +/- Neg ++ +/- Neg
Epidermal cell membrane* 3 a 0 0 2 * 1 0 3 a 0 0
Epidermal cell cytoplasm 0 0 3 0 0 3
0 0 3
Epidermal cell nuclei 0 0 3 0 0 ■?; 0 0 3
Tumour cell membrane 0 3 0 0 3 0 0 3 0
Tumour cell cytoplasm 0 0 3 0 0 3 0 0 3
Tumour cell nuclei 0 0 3 0 0 3 0 0 3
T able 1 6 * . Distribution of E- and P-cadherin and C-terminus (3-catenin in 3 paraffin- 
embedded keratoacanthoma.
♦ Represents results o f 1 experiment.
++: strongly positive. +/-: weakly positive (no. o f negative tumour cells > 10%). Neg: negative.
* In normal and pseudoepitheliomatous skin. 
a Basal and suprabasal cells.
b Basal cells only.
3.19. Immunohistochemical staining of E- and P-cadherin in formalin fixed and 
paraffin-embedded Bowen’s disease (n=10)
In all cases, the pattern o f staining in normal epidermis o f both cadherins was identical 
to that described above except one, where P-cadherin membrane staining in normal cells 
was weakly positive (Table 17).
Eight o f ten lesions demonstrated strongly positive membrane staining o f E-cadherin 
which was distributed in full thickness o f the dysplastic epithelium (carcinoma in situ) 
including the intraepidermal portions o f the cutaneous adnexae (Table 17) (Fig. 45). 
The parakeratotic cells in the stratum comeum were negative. Most o f the large 
dysplastic cells displaying mitotic figures, including abnormal forms, stained strongly 
positive with E-cadherin. E-Cadherin membrane staining was present in 2/10 o f the 
cases, but in reduced staining intensity when compared with the normal epidermis (Fig. 
46). The reduction was more pronounced towards the dermal aspect o f the lesion. All 
the lesions showed weakly positive cytoplasmic staining and their nuclei were negative.
P-Cadherin membrane staining was strongly positive in 8/10 o f the cases (Table 17) 
(Fig. 47). The staining started to involve most o f the dysplastic epithelium layers (full 
thickness) at the demarcation between normal and dysplastic cells. The dermal aspects
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(basal and suprabasal) of the lesions stained more strongly than the bulk of the 
dysplastic epithelium. Two of ten lesions demonstrated reduction of P-cadherin 
membrane staining (Fig. 48). In contrast with the strongly stained lesions, P-cadherin 
membrane staining was restricted to the basal cell layer whereas the disorganised, 
dysplastic epithelium was negative. Again, as for E-cadherin, the staining of P-cadherin 
in the cytoplasm was weak and completely negative in nuclei.
3.20. Immunohistochemical staining of C-terminus P-catenin in formalin fixed and 
paraffin-embedded Bowen’s disease (n=10)
The staining of C-terminus P-catenin in the membranes of normal cells was strongly 
positive in 8/10 of the cases, while two examples showed weak positivity (Table 17). In 
the normal cell cytoplasms, C-terminus p-catenin staining was weak and completely 
negative in nuclei.
C-Terminus p-catenin staining in lesional cell membranes was strongly positive in 8/10 
of the cases (Table 17) (Fig. 49) with the large dysplastic cells expressing positive 
staining. C-Terminus p-catenin membrane staining was present in lesional cells in 2/10 
of the cases, but in reduced staining intensity when compared with the normal 
epidermis. This was more pronounced in the dermal aspects of the lesion. All cases 
showed weakly cytoplasmic staining. The two examples of Bowen’s disease which 
demonstrated reduction in their lesional cell membranes, have shown C-terminus p- 
catenin nuclear staining (Fig. 50).
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Figure 44. C-Terminus p-catenin staining in 
keratoacanthom a. Tumour cells show 
reduction in membrane staining. x320.
Figure 45. E-Cadherin staining in Bowen’s 
disease. Strong staining and full thickness 
distribution in lesion. x320.
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Figure 46. E-Cadherin staining in Bowen’s 
disease. Some lesional cells show reduction 
in membrane staining intensity (arrow). x250.
Figure 47. P-Cadherin staining in Bowen’s 
disease. Strong membrane staining involving 
full thickness. x320.
v
Figure 48. P-Cadherin staining in Bowen’s 
disease. Restriction of staining to the basal 
cells. x320.
Figure 49. C-Terminus p-catenin staining in
B o w en ’s disease. S trong  s ta in ing  and full
thickness distribution in lesion. x320.
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E-CADHERIN P-CADHERIN (3-CATENIN
++ +/- Neg ++ +/- Neg ++ +/- Neg
Epidermal cell membrane 10a 0 0 Q ^ 1 0 8 a 2 0
Epidermal cell cytoplasm 0 10 0 o 9 1 0 10 0
Epidermal cell nuclei 0 0 10 0 o N»—* o 0 0 10
Lesional cell membrane 8 2 0 8 2 0 8 2 0
Lesional cell cytoplasm 0 10 0 0 10 0 0 10 0
Lesional cell nuclei 0 0 10 n 0 10 0 2 8
Table 1 7 * . Distribution of E- and P-cadherin and C-terminus P-catenin in 10 paraffin-
embedded Bowen’s disease.
♦Represents results o f 2 experiments apart from p-catenin which was repeated 3 times. Results
were reproducible and consistent in each specimen.
++: strongly positive. +/-: weakly positive (no. o f negative tumour cells > 10%). Neg: negative. 
a Basal and suprabasal cells. 
b Basal cells only.
3.21. Immunohistochemical staining of E- and P-cadherin in formalin fixed and 
paraffin-embedded actinic keratosis (n=10)
All examples demonstrated strongly positive E-cadherin staining in normal epidermis 
and skin appendages with weak cytoplasmic staining and negative nuclei (Table 18). 
Membrane staining o f P-cadherin in normal basal cells was preserved in 9/10 and 
weakly positive in one example. There were variable degrees o f cytoplasmic P-cadherin 
staining in normal cells ranging from weakly positive to complete absence. The nuclei 
in the basal cells were negative.
There was strongly positive cell membrane staining o f E-cadherin in 9/10 o f the cases 
(Table 18) (Fig. 51) which was demonstrated in the full thickness o f both the dysplastic 
and the uninvolved epithelia. The alternating bands o f hyperkeratosis and parakeratosis 
which covered the normal and dysplastic epithelium, respectively, were negative. 
E-Cadherin staining was present in lesional cell membranes in only one case, but in 
reduced staining intensity when compared with the normal epidermis (Table 18) (Fig. 
52). The reduction o f the staining was towards the dermal aspect o f the lesion. All the 
cases have shown reduced cytoplasmic staining and their nuclei were negative.
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Dysplastic cell membrane staining of P-cadherin was strongly positive in 8/10 of the 
cases (Fig. 53). A notable feature was the presence of positive P-cadherin staining in 
only the basal layer of uninvolved epithelium, then involvement of the full thickness of 
epithelium which showed dysplasia (Table 19). This pattern of P-cadherin staining in 
actinic keratosis seems to be correlating with the alternating bands of dysplasia (covered 
by parakeratotic cells) and normal epithelium (covered by hyperkeratotic cells) (Fig. 
54).
Two of ten lesions showed decreased P-cadherin membrane staining in the dysplastic 
epidermis. There was reduced staining intensity of P-cadherin in the cytoplasms of 
lesional cells and the staining was completely negative in the nuclei.
3.22. Immunohistochemical staining of C-terminus p-catenin in formalin fixed and 
paraffin-embedded actinic keratosis (n=10)
Eight of ten cases showed strongly positive C-terminus p-catenin in normal epidermis as 
previously described. The staining of C-terminus P-catenin in normal epidermis was 
reduced in two cases and there was variable degrees of cytoplasmic staining ranging 
from reduced intensity to complete absence. There was no nuclear staining observed in 
normal cells in all cases (Table 18).
C-Terminus p-catenin staining was strongly positive in dysplastic and normal 
epithelium in 9/10 of the cases (Table 18) (Fig. 55). The characteristic alternating bands 
of parakeratosis and hyperkeratosis were universally negative in all the cases. One case 
has shown presence of staining in the lesional cell membranes, but in reduced intensity 
when compared with the normal epidermis and other cases (Fig. 56). There was 
variable cytoplasmic staining in the lesional cells but the nuclei were negative.
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Figure 50. C -T erm inus p -ca ten in  nu c lear 
s ta in in g  in B o w e n ’s d is e a s e . N o te  th e  
a c c o m p a n y in g  d e c re a se  in m em b ran e  p - 
catenin. x250.
Figure 51. E -C adherin  sta in ing  in actin ic 
keratosis. S trong staining and full thickness 
d istribution in lesion. x320.
Figure 52. E -C adherin  sta in ing  in actinic 
keratosis. Some lesional cells show reduction 
in m em brane staining intensity. x250.
Figure 53. P-C adherin  s ta in ing  in actin ic 
keratosis. S trong m embrane staining involving 
full thickness. x250.
Figure 54. P -C adherin  sta in in g  in actin ic  
keratosis. N ote involvement o f  full thickness 
in dysplastic epithelium  and restriction to basal 
cells in uninvolved epithelium . x250.
Figure 55. C-Terminus p-catenin staining in
actin ic  kera tosis .  S trong  s ta in ing  and  full
thickness distribution in lesion. x320.
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E-CADHERIN P-CATENIN
+ + +/- Neg 1__LT r +/- Neg
Epidermal cell membrane 10a 0 0 8 8 2 0
Epidermal cell cytoplasm 0 10 0 0 7 3
Epidermal cell nuclei 0 0 10 0 0 10
Lesional cell membrane 9 1 0 9
j 0
Lesional cell cytoplasm 0 10 0 0 9 1
- ■si?-:-
Lesional cell nuclei 0 0 10 0 0 10
Table 1 8 * . D istribution o f  E -cadherin and C -term inus P-catenin in 10 paraffin-em bedded
actinic keratosis.
*  Represents results of 2 experiments. Results were reproducible and 
consistent in each specimen.
++: strongly positive. +/-: weakly positive (no. o f negative tumour cells > 10%). Neg: negative. 
a Basal and suprabasal cells. 
b Basal cells only.
P-CADHERIN
++ +/- Neg
Epidermal cell membrane* 9 a 1 0
Epidermal cell cytoplasm 0 8 2
Epidermal cell nuclei 0 0 10
Uninvolved epidermal cell membrane** 10a 0 0
Dysplastic epidermal cell membrane*** 8 b 2 0
Lesional cell cytoplasm 
Lesional cell nuclei
0
0
10
0
0
10
Table 19*. D istribu tion  o f  P-cadherin in 10 paraffin-em bedded actin ic  keratosis.
*  Represents results o f 2 experiments. Results were reproducible and 
consistent in each specimen.
++: strongly positive. +/-: weakly positive (no. of negative tumour cells > 10%). Neg: negative.
* Adjacent to lesion. 
a Basal cells only.
** Covered by hyperkeratosis.
*** Covered by parakeratosis. 
b Full thickness.
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3.23. Immunohistochemical staining of £ - and P-cadherin in formalin fixed and 
paraffin-embedded psoriasis (n=5)
In all cases, the expression pattern of E-cadherin was identical to normal epidermis 
(Table 20) (Fig. 57). The basal cell layer was staining relatively weaker than the 
spinous layer, however, this was noted in many examples of normal skin. E-Cadherin 
staining was weakly positive in lesional cell cytoplasms and negative in the nuclei in all 
the cases examined. In addition, there was no staining seen in stratum comeum. 
P-Cadherin was distributed in the full thickness of the psoriatic skin in all the five 
lesions examined (Table 20) (Fig. 58). Its staining was weakly positive in the lesional 
cell cytoplasms and negative in the nuclei.
3.24. Immunohistochemical staining of C-terminus p-catenin in formalin fixed and 
paraffin-embedded psoriasis (n=5)
All examples demonstrated strongly positive C-terminus p-catenin staining in lesional 
cell membranes identical to normal epidermis (Table 20) (Fig. 59). Although the 
staining was preserved in all epidermal layers of the acanthotic lesion, it was more 
pronounced in the spinous cells. The orthohyperkeratotic and parakeratotic layers 
overlying the lesions were negative. The staining of C-terminus p-catenin was weakly 
positive in lesional cytoplasms and negative in the nuclei.
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E-CADHERIN P-CADHERIN P-CATENIN
++ +/- Neg ++ +/- Neg ++ +/- Neg
Epidermal cell membrane 5 a 0 0 5 ‘
0 0 5 a 0 0
Epidermal cell cytoplasm * 0 5 0 0 2 3
0 5 0
Epidermal cell nuciei 0 0 5 0 5 0 0 5
Lesional cell membrane 5 0 0 5 0 0 5 0 0
Lesional celt cytoplasm 
Lesional cell nuclei
0
0
5
0
0
5 4 - - 4- 4 - 00 50 05
Table 2 0 * .  D istribution o f  E- and P-cadherin and C -term inus p-caten in  in 5 paraffin-em bedded
psoriasis.
*  Represents results o f 2 experiments. Results were reproducible and 
consistent in each specimen.
++: strongly positive. +/-: weakly positive (no. o f negative tumour cells > 10%). Neg: negative. 
a Basal and suprabasal cells.
3.25. Immunohistochemical staining of E- and P-cadherin in formalin fixed and 
paraffin-embedded lichen simplex chronicus (n=5)
The expression pattern o f E-cadherin in lichen simplex chronicus was identical to 
normal epidermis in all the five cases examined (Table 21) (Fig. 60). P-Cadherin 
staining was strongly positive in the membranes o f lesional cells throughout the full 
thickness o f the epidermis excluding the hyperkeratotic stratum corneum (Fig. 61), 
however, in one case, the staining was restricted to the basal cell layer (Table 21). 
There were variable degrees o f diffuse cytoplasmic distribution o f P-cadherin in lesional 
cells, but no nuclear staining was noted.
3.26. Immunohistochemical staining of C-terminus P-catenin in formalin fixed and 
paraffin-embedded lichen simplex chronicus (n=5)
In all cases examined, there was strongly positive C-terminus P-catenin staining in 
lesional cell membranes identical to normal epidermis (Table 21) (Fig. 62). The 
staining was more pronounced in the membranes o f spinous cells, weakly positive in the 
cytoplasms and uniformly negative in the nuclei.
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Figure 56. C-Term inus p-catenin staining in 
actin ic  kera tosis. R eduction  o f  m em brane 
s ta in in g  is m ore m arked  in in te rfo llic u la r  
epithelium. x320.
Figure 57. E-C adherin staining in psoriasis. 
Strong staining and full thickness distribution 
in lesion. x320.
Figure 58. P-Cadherin staining in psoriasis. 
Involvement o f  full thickness. x320.
Figure 59. C -Term inus p-catenin staining in 
psoriasis. S trong staining and full thickness 
distribution in lesion. x320.
■ ,  .
Figure 60. E-C adherin  s ta in ing  in lichen
simplex chronicus . Strong staining and full
thickness distribution in lesion. x320.
Figure 61. P -C adherin  s ta in in g  in lichen 
s im p le x  c h ro n ic u s .  In v o lv e m e n t o f  fu ll 
thickness excluding parakeratotic layer. x320.
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E-CADHERIN P-CADHERIN P-CATENIN
++ +/- Neg ++ +/- Neg ++ +/- Neg
Epidermal cell membrane 5 a 0 0 5 a 0 0 5 a 0 0
Epidermal cell cytoplasm 0 5 0 0 4 1 0 5 0
Epidermal cell nuclei 0 0 5 0 o 5 0 0 5
Lesional cell membrane 5 0 0 5 0 0 5 0 0
Lesional cell cytoplasm 0 5 0 0 4 1 0 5 0
Lesional cell nuclei 0 0 5 0 0 5 0 0 5
Table 21 +  . D istribution  o f  E- and P-cadherin and C -term inus (3-catenin in 5 paraffin-
em bedded lichen sim plex chronicus.
♦  Represents results o f 2 experiments. Results were reproducible and 
consistent in each specimen.
++: strongly positive. +/-: weakly positive (no. o f negative tumour cells > 10%). Neg: negative. 
a Basal and suprabasal cells.
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Figure 62. C-Terminus p-catenin staining in 
Lichen simplex chronicus. Strong staining and 
full thickness distribution in lesion. x320.
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Results II
Immunoperoxidase Staining of melanocytic lesions
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3.27. Immunohistochemical staining of E- and P-cadherin in formalin fixed and
paraffin-embedded benign naevi (n=6)
The membrane staining of E-cadherin in melanocytic naevus cells in the epidermis was 
strongly positive in 4/6 of the cases (Table 22) (Fig. 63). Two of six lesions showed 
reduction of E-cadherin epidermal naevus cell membrane staining particularly in the 
junctional component of the naevus in comparison with the normal epidermis (Table 
22). In these, the staining of junctional melanocytes was uneven with some 
melanocytes showing preserved membrane staining. E-Cadherin cytoplasmic staining 
of epidermal naevus cells was ranging from strongly positive to weak intensity. The 
membrane staining of E-cadherin in the dermal naevus cells was reduced in 5/6 of the 
cases (Fig. 64)and strongly positive in one example. The reduction of E-cadherin 
membrane staining tended to be correlated with maturation and decrease in dermal 
melanocytes size with depth. The minimal cytoplasm of the dermal melanocytes stained 
weakly positive with E-cadherin. There was no E-cadherin nuclear staining observed 
either in epidermal or dermal naevus cells.
P-Cadherin membrane staining in epidermal melanocytes was strongly positive in 5/6 of 
the cases (Table 22) (Fig. 65). The staining was relatively stronger when compared with 
P-cadherin membrane staining in basal normal keratinocytes. In the junctional 
component, there was decreased P-cadherin membrane staining in one case. Three of 
six benign naevi showed strong membrane staining of P-cadherin in their dermal 
components when compared with the normal epidermis while 3/6 of the naevi expressed 
reduced membrane staining (Table 22) (Fig. 65). There were highly variable degrees of 
P-cadherin cytoplasmic staining in both epidermal and dermal components ranging from 
strong staining intensity to complete absence. P-Cadherin nuclear staining was not 
observed in all naevi.
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3.28. Imm unohistochem ical staining of C-term inus p-catenin in form alin  fixed and
paraffin-em bedded benign naevi (n=6)
C-Terminus p-catenin staining was strongly positive in the membranes o f melanocytic 
naevus cells in the epidermis in 5/6 o f the cases following the same pattern as E- 
cadherin (Table 22) (Fig. 66). One benign naevus showed relative reduction of 
membrane staining in the junctional melanocytes, although, there were some 
melanocytes expressing strongly positive membrane staining within the junctional 
component. C-Terminus p-catenin staining in the membranes o f dermal melanocytes 
was strongly positive in two naevi, but four cases have shown gradual reduction of 
membrane staining which was more pronounced in the small matured melanocytes in 
the deeper parts o f the lesions. The strongly positive membrane staining in the 
epidermal melanocytes was accompanied by strong cytoplasmic staining which tended 
to decrease in the dermal component (Table 22) (Fig. 66). The nuclei o f epidermal and 
dermal melanocytes were negative.
E-Cadherin P-Cadherin P-Catenin
++ +/- Neg ++ +/- Neg ++ +/- Neg
Epidermal keratinocyte 
membrane
6 a 0 0 6 b 0 0 6 8 0 0
Epidermal keratinocyte 
cytoplasm
0 6 0 0 4 2 0 5 1
Epidermal keratinocyte 
nuclei
0 0 6 0 0 6 0 0 6
Epidermal melanocytic 
naevus cell membrane
4 2 0 5 1 0 5 1 0
Epidermal melanocytic 
naevus cell cytoplasm
1 5 0 2 3 1 4 1 1
Epidermal Melanocytic 
naevus cell nuclei
0 0 6 0 0 6 0 0 6
Dermal naevus cell 
membrane
1 5 0 'x 'i n3 3 0 2 4 0
Dermal naevus cell 
cytoplasm
0 6 0 2 3 1 3 1 2
Dermal naevus cell nuclei 0 0 6 0 0 6 0 0 6
Table 2 2 * .  Distribution o f  E- and P-cadherin and C-terminus P-catenin in 6 paraffin- 
em bedded benign naevi.
♦  Represents results of 2 experiments. Results were reproducible and 
consistent in each specimen.
++: strongly positive. +/-: weakly positive (no. of negative tumour cells > 10%). Neg: negative. 
a Basal and suprabasal cells. 
b Basal cells only.
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3.29. Immunohistochemical staining of E- and P-cadherin in formalin fixed and 
paraffin-embedded blue naevi (n=6)
The overlying epidermis of all the blue naevi examined was normal with no coexistent 
junctional activity. E-Cadherin staining was reduced in the membranes of the dermal 
melanocytes in 5/6 of the cases (Table 23) (Fig. 67) and completely negative in one 
case. The reduction in membrane staining was associated more with the bipolar, 
dendritic spindle melanocytes in the deeper parts of the naevus. The cytoplasmic 
staining of E-cadherin in naevus cells was faint and diffuse, but their nuclei were 
negative.
In comparison with the basal cells of the normal epidermis, P-cadherin membrane 
staining of the naevus cells was reduced and largely faint in 2/6 of the cases while it was 
completely absent at all cellular levels in 4/6 of the cases (Table 23) (Fig. 68A).
3.30. Immunohistochemical staining of C-terminus p-catenin in formalin fixed and 
paraffin-embedded blue naevi (n=6)
The dermal melanocyte membranes and cytoplasm stained weakly positive with C- 
terminus p-catenin in 3/6 of the cases and they were completely negative in the other 3 
naevi (Table 23) (Fig. 68B). In comparison with E-cadherin, C-terminus p-catenin 
membrane staining in blue naevi was lighter. There was no nuclear staining observed.
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Figure 63. E -C adherin  sta in ing in benign 
naevus. S trong  s taining in junc tiona l  and 
dermal naevus cells. x20 0 .
Figure 64. E-C adherin  s ta ining in benign 
n a e v u s .  In c o m p a r i s o n  w ith  th e  n o rm a l  
epidermis and junc tiona l  com ponent, some 
d e rm a l  n a e v u s  ce lls  sh o w  re d u c t io n  in 
membrane staining intensity (arrows). x2 0 0 .
Figure 65. P-Cadherin  staining in benign 
naevus. Positive staining in basal keratinocytes 
and strong staining in junctional and upper 
dermal nests. N ote  d ecrease  in m em brane  
staining intensity with m atura tion  (arrow). 
x l2 5 .
■ ■ w
Figure 66. C-Terminus [3-catenin staining in 
benign naevus. Strong staining in junctional 
and dermal naevus cells. x2 0 0 .
Figure 67. E -C a d h e r in  s ta in in g  in b lue 
naevus. In comparison with normal epidermis, 
dermal melanocytes show marked reduction 
in membrane staining intensity. x20 0 .
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E-Cadherin P-Cadherin (3-Catenin
++ +/- Neg ++ +/- Neg ++ +/- Neg
Epidermal keratinocyte 
membrane
6 a 0 0 6 b 0 0 6 a 0 0
Epidermal keratinocyte 
cytoplasm
0 5 1 0 3 3 0 5 1
Epidermal keratinocyte 
nuclei
0 0 6 0 0 6 0 0 6
Dermal naevus cell 
membrane
0 5 1 0 2 4 0 3 3
Dermal naevus cell 
cytoplasm
0 5 1 0 1 5 0 3 3
Dermal naevus cell nuclei 0 0 6 0 0 6 0 0 6
Table 2 3 + .  Distribution o f  E- and P-cadherin and C-terminus (3-catenin in 6 paraffin-
em bedded blue naevi *.
+ Represents results of 2 experiments. Results were reproducible and 
consistent in each specimen.
* No epidermal component.
++: strongly positive. +/-: weakly positive (no. of negative tumour cells > 10%). Neg: negative. 
a Basal and suprabasal cells. 
b Basal cells only.
3.31. Immunohistochemical staining of E- and P-cadherin in formalin fixed and 
paraffin-embedded atypical naevi (n=6)
All atypical naevi examined were compound, showing architectural dysplasia. 
E-Cadherin membrane staining was reduced in epidermal melanocytes in 3/6 o f the 
cases (Table 24) and strongly positive in other cases. In cases with epidermal 
melanocytes expressing reduced membrane E-cadherin staining, the reduction was noted 
in the atypical melanocytes at the tips o f epidermal ridges showing lentiginous 
hyperplasia. Those cells were present singly and in small clusters, but in a rather 
disorganised appearance. In all the cases, a relative reduction o f membrane E-cadherin 
in the intradermal component particularly in spindle shaped cells in the deeper parts of 
the lesions was seen (Fig. 69A and B). Epidermal and dermal melanocytes expressed 
variable E-cadherin cytoplasmic staining ranging from strongly positive to weaker 
intensity, but their nuclei were negative.
The staining o f P-cadherin in the membranes o f atypical melanocytes in the epidermis 
was similar to that o f E-cadherin, however, it was slightly stronger in intensity when 
compared with basal keratinocytes. Three o f six cases showed strongly positive
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membrane P-cadherin staining in epidermal atypical melanocytes while there was 
reduction in staining in 3/6 cases (Table 24) (Fig. 70A). Atypical dermal melanocytes 
expressed reduced membrane P-cadherin staining in 5/6 of the cases particularly in 
matured deep cells (Fig. 70B). One case has shown strongly positive membrane 
staining of P-cadherin in the dermal component. P-Cadherin staining was variable in the 
cytoplasms but universally negative in the nuclei.
3.32. Immunohistochemical staining of C-terminus p-catenin in formalin fixed and 
paraffin-embedded atypical naevi (n=6)
Strongly positive membrane staining was seen in 5/6 lesions with the C-Terminus P- 
catenin antibody. Staining was reduced in one (Table 24) in epidermal melanocytes (Fig. 
71 A). Intradermally, there was strong membrane C-terminus P-catenin staining in two 
examples and reduction in 4/6 of the cases (Fig. 7IB) which was obvious in the delicate 
spindle shaped melanocytes. Similar to E-cadherin, epidermal and dermal melanocytes 
expressed variable cytoplasmic staining ranging from strongly positive to weaker 
intensity, and their nuclei were negative.
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A  B
Figure 68. P-Cadherin and C-Terminus p-catenin staining in blue naevus. (A) P-cadherin. (B) p- 
catenin. Complete absence o f  staining. x200.
A  B
Figure 69. E-Cadherin staining in atypical naevus. (A) In comparison with normal epidermis and 
junctional component, some dermal melanocytes show reduction in membrane staining intensity 
(arrow). (B) dermal melanocytes show marked reduction in membrane staining intensity. x200.
, • ' ■ v . t
B
Figure 70. P-Cadherin staining in atypical naevus. (A) Strong staining in junctionally nested 
melanocytes (arrow).(B) In comparison with normal epidermis and junctional component, some 
dermal melanocytes show reduction in membrane staining intensity (arrow). (A) x250, (B) x200.
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E-Cadherin P-Cadherin (3-Catenin
++ +/- Neg ++ +/- Nog ++ +/- Neg
Epidermal keratinocyte 
membrane
6 a 0 0 5 b 1 0■ 5 a
1 0
Epidermal keratinocyte 
cytoplasm
0 6 0 0 2 4 0 5 1
Epidermal keratinocyte 
nuclei
0 0 6 0 0 6 0 0 6
Epidermal melanocytic 
naevus cell membrane
3 3 0 3 3 0\ 5 1 0
Epidermal melanocytic 
naevus cell cytoplasm
2 4 0 0 3 3 2 4 0
Epidermal melanocytic 
naevus cell nuclei
0 0 6 0 0
, -C, 
/ ’ /■
6
'
0 0 6
Dermal naevus cell 
membrane
0 6 0 1 5 0 2 4 0
Dermal naevus cell 
cytoplasm
0 6 0 0 4 2
'
0 6 0
Dennal naevus cell nuclei 0 0 6 0 0 6 0 0 6
T able 2 4 * .  Distribution o f  E- and P-cadherin and C-term inus P-catenin in 6 paraffin-
em bedded atypical naevi.
♦  Represents results of 2 experiments. Results were reproducible and 
consistent in each specimen.
++: strongly positive. +/-: weakly positive (no. of negative tumour cells > 10%). Neg: negative. 
a Basal and suprabasal cells. 
l> Basal cells only.
3.33. Immunohistochemical staining of E- and P-cadherin in formalin fixed and 
paraffin-embedded Spitz naevi (n=6)
E-Cadherin staining in the membranes o f melanocytic naevus cells in the epidermis was 
reduced in all cases (Table 25). This was observed mainly in both spindle and 
epithelioid melanocytes in the junctional component. Similarly, the membrane staining 
of the dermal melanocytes was reduced in both cell population in all the cases (Fig. 
72A). E-Cadherin membrane staining reduction was more pronounced in matured 
melanocytes with increasing depth o f the lesion. There was highly variable cytoplasmic 
staining o f E-cadherin in Spitz naevi ranging from weakly positive to complete absence. 
No nuclear staining was detected either in epidermal or dermal melanocytes.
In contrast to E-cadherin, the membrane staining o f P-cadherin in junctional 
melanocytes was strongly positive in 2/6 o f the cases. Four o f six Spitz naevi showed 
reduced P-cadherin membrane staining in both epithelioid and spindle cells in the
147
junctional component (Table 25) (Fig. 72B), however, the reduction was not universal. 
All Spitz naevi expressed uneven P-cadherin membrane staining in their dermal 
components with deeper areas showing marked reduction (Fig. 73). Melanocyte 
cytoplasmic staining of P-cadherin in both epidermal and dermal components ranged 
from weakly positive to complete absence. There was no P-cadherin nuclear staining in 
all the cases.
3.34. Immunohistochemical staining of C-terminus p-catenin in formalin fixed and 
paraffin-embedded Spitz naevi (n=6)
The membrane staining of C-terminus p-catenin in the junctional component of Spitz 
naevi was reduced in 5/6 of the lesions and strongly positive in one naevus (Table 25) 
(Fig. 74). The reduction of C-terminus p-catenin was observed in the membranes of 
junctional melanocytes which are showing either spindle or epithelioid morphology. In 
addition, there were small pale non-stained naevoid cells. However, within this region 
there were melanocytes of both cell populations staining strongly particularly small 
clusters of large epithelioid cells. Within the dermis, all cases have shown reduction of 
melanocyte membrane C-terminus p-catenin staining increasing with depth and in cells 
acquiring spindle cell appearance (Fig. 74). Cytoplasmic staining was variable in 
epidermal and dermal melanocytes and their nuclei were negative.
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Figure 71. C-Terminus p-catenin staining in atypical naevus. (A) Strong staining in naevus cells 
in junctional and dermal components.(B) In comparison with normal epidermis and junctional 
component, dermal melanocytes show marked reduction in membrane staining intensity (arrow). 
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Figure 72. E- and P-cadherin staining in Spitz naevus. (A) Marked reduction o f  E-cadherin 
m embrane staining in naevus cells when compared with overlying normal keratinocytes. (B) 
Reduction in P-cadherin m em brane staining intensity in junc tiona l  component (arrow ) when 
compared with overlying normal keratinocytes. x320.
------ -------------------- ----------------------
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Figure 73. P -C ad h e r in  s ta in in g  in S p itz  
naevus. Marked reduction o f  dermal naevus 
ce ll  m e m b r a n e  s t a in in g  c o m p a r e d  w ith  
overlying normal keratinocytes. x320.
Figure 74. C-Terminus p-catenin staining in 
Spitz naevus. Marked reduction o f  p-catenin 
m e m b ra n e  s ta in in g  in n aev u s  cells  when 
c o m p a r e d  w ith  o v e r ly in g  n o rm a l  
keratinocytes. x320.
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(3-CateninE-Cadherin
Epidermal melanocytic 
naevus cell membrane 
Epidermal melanocytic 
naevus cell cytoplasm 
Epidermal melanocytic 
naevus cell nuclei_________
Dermal n; 
membran<
Dermal naevus cell nuclei 0
Table 2 5 + .  Distribution o f  E- and P-cadherin and C-terminus [3-catenin in 6 paraffin- 
em bedded Spitz naevi.
★Represents results of 2 experiments. Results were reproducible and 
consistent in each specimen.
++: strongly positive. +/-: weakly positive (no. of negative tumour cells > 10%). Neg: negative. 
a Basal and suprabasal cells. 
b Basal cells only.
3.35. Immunohistochemical staining of E- and P-cadherin in formalin fixed and 
paraffin-embedded primary melanoma (n=6)
Five o f six melanomas have shown reduction o f E-cadherin staining in the membranes 
o f malignant melanocytes (Table 26) (Fig. 75 A) which were confined to the epidermis 
(in situ) (Clark level I) and in those located at the junctions infiltrating the papillary 
dermis (Clark level II). This reduction was seen in melanomas with radial and vertical 
growth phases, although, it was more pronounced in melanoma cells in their vertical 
growth phase. One o f six cases showing vertical growth phase, expressed total loss of 
E-cadherin membrane staining o f malignant melanocytes present in the epidermis. 
These melanocytes were atypical with small epithelioid appearance. The reduction of 
membrane E-cadherin staining was not correlated with increasing C lark’s level. Four 
o f six cases showed reduction o f E-cadherin membrane staining in the invasive dermal 
nested melanocytes. O f these, one was infiltrating the reticular dermis and 
subcutaneous fat (Clark level IV/V) with E-cadherin membrane staining still detected
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but rather weak (Fig. 75B). E-Cadherin membrane staining was completely negative in 
malignant melanocytes infiltrating the papillary dermis (Clark level II) in 2/6 of the 
cases (Fig. 76). Of these, one was showing vertical growth phase and the other showing 
radial growth. Malignant melanocyte cytoplasmic staining of E-cadherin in both 
epidermal and dermal components ranged from weakly positive to complete absence. 
There was no E-cadherin nuclear staining in all the cases.
P-Cadherin membrane staining was strongly reduced in the membranes of epidermal 
malignant melanocytes (Clark level I and II) in 5/6 of the cases (Table 26) (Fig. 77) 
especially in vertical growth phase melanomas. One melanoma with vertical growth 
phase showed negative P-cadherin staining in epidermal malignant melanocytes and in 
cells just invading the papillary dermis (Clark level II). Three of six malignant 
melanomas (two vertical and one radial growth phase) expressed marked reduction of P- 
cadherin membrane staining in their solely dermal malignant melanocytes. Of these, 
one was showing vertical growth phase extending up to subcutaneous tissue (Clark level 
IV/V). There was complete absence of P-cadherin staining in dermal cells in 3/6 of the 
cases (Fig. 77) which were only Clark level II. Similar to E-cadherin, the cytoplasmic 
staining of P-cadherin in both epidermal and dermal components of melanomas ranged 
from weakly positive to complete absence. There was no P-cadherin nuclear staining in 
all the cases.
3.36. Immunohistochemical staining of C-terminus p-catenin in formalin fixed and 
paraffin-embedded primary melanoma (n=6)
All malignant melanomas examined (four vertical and two radial growth phase) showed 
weakly positive C-terminus p-catenin membrane staining in the epidermal and 
junctional malignant cells (Clark level I) (Table 26) (Fig. 78A). The membrane staining 
of C-terminus p-catenin was markedly reduced in the dermal malignant melanocytes in 
3/6 of the cases (all showing vertical growth phase). Of these, one malignant melanoma 
with Clark level IV/V). There was loss of C-terminus p-catenin staining in the dermal 
malignant cells in 3/6 of the cases (Fig. 78B). The staining of C-terminus p-catenin in
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cytoplasms o f epidermal and dermal malignant melanocytes was variable ranging from 
reduced staining intensity to complete absence and it was negative in the nuclei in all the
cases.
E-Cadherin P-Cadherin (3-Catenin
++ +/- Neg ++ +/- Neg ++ +/- Neg
Epidermal keratinocyte 
membrane
6 a 0 0 6 k 0 0 5 a 1 0
Epidermal keratinocyte 
cytoplasm
0 6 0 0 3 3 0 5 1
Epidermal keratinocyte 
nuclei
0 0 6 0 0 6 0 0 6
Epidermal melanoma cell 
membrane
Epidermal melanoma cell 
cytoplasm
Epidermal melanoma cell 
nuclei
0
0
0
5
5
0
1
1
6
0 S 1 
0 0 6
0
0
0
6
6
0
0
0
6
Dermal melanoma cell 
membrane
0 4 2 0 3 3 0 3 3
Dermal melanoma cell 
cytoplasm
0 4 2 0 2 4 0 3 3
Dermal melanoma cell 
nuclei
0 0 6 0 0 6 0 0 6
Table 2 6 + .  Distribution o f  E- and P-cadherin and C-terminus P-catenin in 6 paraffin-
em bedded primary melanoma.
+ Represents results of 2 experiments. Results were reproducible and 
consistent in each specimen.
++: strongly positive. +/-: weakly positive (no. of negative tumour cells > 10%). Neg: negative. 
a Basal and suprabasal cells. 
b Basal cells only.
3.37. Immunohistochemical staining of E- and P-cadherin in formalin fixed and 
paraffin-embedded metastatic melanoma (n=6)
In three o f six cases examined there was no normal epidermis attached to the tumours 
which were located in the dermis and/or in the subcutis.
There was strongly positive E-cadherin membrane staining in metastatic melanocytes in 
1/6 o f the cases (Table 27) (Fig. 79A) particularly stronger at the peripheries o f the 
tumour mass. The metastatic melanocytes in this case were localised in the dermis in 
nests o f different sizes and displaying epithelioid appearance with abundant cytoplasm, 
nuclear pleomorphism and prominent nucleoli.
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Figure 75. E-Cadherin staining in malignant melanoma. (A) In com parison  with epidermis, 
junctional melanoma cells show marked reduction in membrane staining intensity (arrow). (B) 
marked reduction in staining o f  deeper melanoma cells (arrow). x250.
Figure 76. E-Cadherin staining in malignant 
melanoma. Com plete  absence o f  staining in 
deep dermal malignant melanocytes. x320.
Figure 77. P-Cadherin staining in malignant 
melanoma. In comparison with the strong and 
a c c e n tu a te d  s ta in in g  in o ve r ly ing  norm al 
keratinocytes, melanoma cells (arrow) show 
m a rk e d  r e d u c t io n  in m e m b ra n e  s ta in in g  
intensity. x320.
A  B
Figure 78. C-Terminus p-catenin staining in malignant melanoma. (A) M arked reduction o f  
malignant melanocyte membrane staining com pared with overlying normal keratinocytes. (B) 
Complete absence o f  staining in deeper aspects o f  tumour showing melanin pigment. x320.
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E-Cadherin membrane staining of metastatic melanocytes was largely reduced in 3/6 of 
the cases. Those tumours were composed of sheets of small malignant melanocytes 
showing nuclear pleomorphism and mitotic activity. Two metastatic melanomas were 
completely negative (Fig. 79B). The staining in the cytoplasm of malignant 
melanocytes ranged from weakly positive to complete absence and was negative in the 
nuclei.
Similar to E-cadherin, there was strong preservation of P-cadherin membrane staining in 
the dermal metastatic melanocytes in the same case (Table 27). Two metastatic 
melanomas showed marked reduction of P-cadherin membrane staining especially in the 
inner aspects of the tumour mass where cells displaying obvious atypia. The staining of 
P-cadherin was completely absent in three tumours (Fig. 80). P-Cadherin staining in the 
cytoplasms of metastatic cells was largely reduced and universally negative in the nuclei 
of all cases.
3.38. Immunohistochemical staining of C-terminus P-catenin in formalin fixed and 
paraffin-embedded metastatic melanoma (n=6)
C-Terminus P-catenin membrane staining was strongly positive in one case following 
the same pattern as E-cadherin (Table 27) (Fig. 81). Two of six cases showed marked 
reduction of C-terminus p-catenin membrane staining particularly in melanocytes 
displaying apparent malignant features. There was complete absence of C-terminus p- 
catenin membrane staining in 3/6 of the cases (Fig. 82). All cases expressed variable 
cytoplasmic staining ranging from weak staining intensity to complete absence. In all 
cases, there was no C-terminus P-catenin nuclear staining detected.
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E-Cadherin P-Cadherin p-Catenin
Epidermal keratinocyte* 
membrane
Epidermal keratinocyte 
cytoplasm
Epidermal keratinocyte
Metastatic melanoma cell 
membrane
cytoplasm
++ 
3 a
0
0
1
0
+/-
0
3
0
3
4
Neg
0
0
3
2
2
++ +/- Neg 
3 b 0 0
0 2 1 
0 2 4
++ 
3 a
0
0
1
0
+/-
0
3 
0 
2
4
Neg
0
0
3
3
2
Metastatic melanoma cell 
nuclei
0 0 6
kOo 0 0 6
Table 2 7 * .  Distribution o f  E- and P-cadherin and C-terminus (3-catenin in 6 paraffin-embedded 
metastatic m elanom a .
♦  Represents results of 2 experiments. Results were reproducible and 
consistent in each specimen.
++: strongly positive. +/-: weakly positive (no. of negative tumour cells > 10%). Neg: negative.
Three cases have no epidermis. 
a Basal and suprabasal cells. 
b Basal cells only.
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Figure 79. E -C adherin  s ta in ing  in m etas ta t ic  m elanom a. (A ) M any m etasta tic  m alignant 
melanocytes in the dermis show strong membrane staining similar to normal epidermis. (B) complete 
absence o f  staining. (A) x250, (B) x320.
Figure 80. P-Cadherin staining in metastatic 
m elanom a. C o m p le te  ab sen ce  o f  s ta in ing . 
x320.
Figure 81. C-Terminus p-catenin staining in 
m e ta s t a t i c  m e la n o m a .  M a n y  m e ta s ta t i c  
m alignant melanocytes in the dermis show 
strong membrane staining similar to normal 
epidermis. x250.
 .
Figure 82. C-Terminus p-catenin staining in 
metastatic  melanoma. Com plete  absence o f  
staining. x320.
F igu re 83. N e g a t iv e  c o n t r o l  fo r  
i m m u n o h is to c h e m ic a l  s t a in in g .  A 
rep re sen ta t iv e  negative  con tro l .  All other 
controls were consistently negative. x320.
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Results III
Immunofluorescent staining and double immunolabelling of the major
adherens junction components 
in Normal Skin and Basal Cell Carcinoma.
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3.39. Immunofluorescence staining of major adherens junction components in 
normal epidermis adjacent to tumour
As summarised in Table 28, Rhodamine-Phalloidin revealed weak and diffuse staining 
for actin filaments in the basal and prickle cell layers, whereas in the granular cell layer 
a very strong binding of phalloidin was evident (Fig. 84A). However, in the normal 
epidermis immediately above the main BCC mass, actin bundles were distributed in all 
the cell layers, except stratum comeum, mainly present at the periphery of the cells 
(particularly granular layer which contained prominent bundles of actin filaments) (Fig. 
84B). Sometimes actin staining was seen in the centre of the cells especially in the 
granular layer. In only one example of the normal epidermis adjacent to the tumour, 
bundles of stress fibers were concentrated at the apical region of the normal 
keratinocytes and arranged vertically so that they appear to be leading upwards (Fig. 85).
In the hair follicle (Table 29), the cells of the external root sheath were shown to express 
prominent actin filaments especially in their outermost cells along the basal cell surface 
(Fig. 86). The actin filaments in those cells were concentrated peripherally, but some 
were shown to have a radial arrangement transverse to the follicle axis (Fig. 86). Actin 
staining was weakly positive in internal root sheath cells and hair matrix, negative in 
hair papilla and shaft but was present in fibroblasts arranged in layers in the periadnexal 
fibrous tissue sheath (Fig. 86). The fibroblasts in this area showed parallel actin 
filaments (stress fibers) running transversally to the longitudinal axis of the hair follicle. 
The arrector pili muscle inserted in the periadnexal fibrous tissue sheath showed strong 
actin staining (Fig. 87).
Similar to the immunohistochemical staining using Extra-avidin technique, the 
immunofluorescence staining of E-cadherin, a - and P-catenin in normal epidermis was 
limited to the viable layers (Table 28) (Figs. 88, 89, 90, and 91). Their staining was 
uniform and exhibited preserved and even enhanced membranous reactivity. The 
strongest staining of E-cadherin, a- and p-catenin was observed in normal keratinocytes 
membranes at the level of cell-cell junctions in the spinous layer while it was generally 
weak in the granular layer and absent from the basal poles of basal cells.
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P-Cadherin (Table 28) was expressed in the membranes o f the basal layer cells at cell­
cell junctions particularly at the apical poles and lateral margins o f the cells in 
agreement with the Extra-avidin technique results (Fig. 92). In addition, P-cadherin 
membrane staining was observed in the external root sheath cells and hair matrix while 
there was complete absence o f staining in the internal root sheath cells, dermal papilla 
and hair shaft (Fig. 93).
a-A ctinin staining (Table 28) was particularly prominent in the suprabasal cells o f the 
normal epidermis including stratum corneum. In viable cells, a-actinin staining was 
largely cytoplasmic and was often enriched at cell peripheries (Fig. 94). Very weak or 
even absent a-actinin staining was noted in the basal cell layer. No a-actinin nuclear 
staining was seen.
Stratum comeum Granular Spinous Basal
Actin3 ++ + /- -
E-Cadherin b ~ + /- ++ + /-
P-Cadherin b ~ -
_ ++
fi-Catenin b - + /- + 4- + /-
a-Catenin b + /- ++ + /-
a-Actinin c ++ ++ -
T a b le  28. Im m unofluorescence staining o f  major adherens junction  com ponents
in layers o f  normal epiderm is adjacent to tum our *.
* Represents a minimum of 5 staining runs showing reproducible 
and consistent results. 
a Mainly present at the periphery of the cells. 
h In cell membrane at the level of cell-cell junctions. 
c Largely cytoplasmic with enrichment at cell peripheries.
++ : strongly positive. + /-  : weakly positive (homogeneously weak). -  : negative.
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Figure 84. Immunofluorescence staining o f  actin in normal skin. (A) adjacent to BCC: prominent 
actin bundles in the peripheries o f  granular layer cells and weak actin bundles staining in spinous 
layer, basal cells are negative. (B) Immediately above BCC: Note actin bundles in all epidermal 
layers except stratum corneum. Scale bars = 25jnm.
Figure 85. Immunofluorescence staining o f  
actin in normal skin adjacent to BCC. Note 
concen tra t io n  at ap ica l  region o f  norm al 
keratinocytes and vertical arrangement.
Scale bar = 25pm.
Figure 86. Immunofluorescence staining o f  
actin in normal hair follicle. Prominent actin 
bundles in O R S cells with peripheral and radial 
a rrangem ent.  N ote  sta in ing  in periadnexal 
fibrous tissue sheath. Scale bar = 25pm.
Figure 87. Immunofluorescence staining o f  
actin in normal pilosebaceous unit. Note actin 
staining in ORS cells and arrector pili muscle. 
Scale bar = 250pm.
Figure 88. Double immunolabelling o f  E- 
cadherin (green) with actin (red) in normal 
epidermis. Note E-Cadherin staining in viable 
layers. No co-localisation. Scale bar = 25pm.
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Figure 89. Double im m unolabelling o f  
ca ten in  (green) with actin  (red) in norm al 
e p id e r m is .  A c t in  b u n d le s  s t a in in g  in 
peripheries o f  g ranular  layer cells. N ote  f}- 
ca ten in  s ta in in g  in v iab le  laye rs .  N o  c o ­
localisation. Scale bar = 25jjm .
Figure 91. Double immunolabelling o f  oc* 
ca tenin  (green) with actin  (red) in norm al 
ep id e rm is .  N o te  the  d o u b le - s ta in e d  ce lls  
(yellow) in granular layer. Scale bar =50^m .
Figure 90. Double immunolabelling o f  a~  
catenin  (green) with ac tin  (red) in norm al 
epidermis. Note a-catenin  staining in viable 
lay e rs .  S om e ce lls  sh o w  c o - lo c a l i s a t io n  
(yellow). Scale bar =50^m .
Figure 92. Double immunolabelling o f  P- 
cadherin (green) with actin (red) in normal 
epidermis. Note restriction o f  P-cadherin to 
basal cells. N o co-localisation. Scale bar = 
25|im.
Figure 93. Double immunolabelling o f  P- 
cadherin (green) with actin (red) in hair follicle. 
Strong staining o f  P-cadherin in O R S and hair 
matrix cells. N o obvious co-localisation. Scale 
bar = 100pm.
Figure 94. Double immunolabelling o f  a -  
actin in  (green) with actin  (red) in norm al 
ep ide rm is .  In tense  a - a c t in in  c y to p la sm ic  
staining in the suprabasal cells. Some cells 
show  co -loca lisa t ion  (yellow ). S ca le  bar 
= 5 0 p m .
161
Actin
External root sheath cells ++
Internal root sheath cells + /-
Hair matrix + /-
Hair papilla -
Hair shaft -
Connective tissue sheath + /-
T a b le  29. Im m unofluorescence staining o f  filamentous actin with Rhodam ine-Phallo id in  in 
normal hair follicle *.
* Represents 3 staining runs showing reproducible and consistent results.
++: strongly positive. + /-  : weakly positive (homogeneously weak). -  : negative.
3.40. Immunofluorescence staining of major adherens junction components in 
Basal cell carcinoma (BCC).
There was a dramatic increase o f actin filament staining intensity in tum our cells at 
connection sites with the normal epidermis when compared with that o f normal 
keratinocytes (Tables 30 and 31) (Fig. 95). At this area, however, the actin filaments 
(stress fibers) distribution in the tumour downgrowths was uneven in which some 
strands and cells showed prominent actin polymerisation but staining was less 
pronounced in others. This observation was particularly more pronounced in tumours 
with infiltrative growth pattern. In addition, the lobules o f these tumours showed a 
distinctive pattern o f actin filament staining. Actin polymerisation was more 
pronounced centrally accompanied by reduced or even absent E-, P-cadherin, a - , and (3- 
catenin staining when compared with that o f the normal epidermal keratinocytes (Figs. 
96-98). In contrast, at the peripheries, actin polymerisation was rarely observed in the 
palisading cells which expressed strong E-, P-cadherin, a -, and p-catenin staining (Figs. 
96-99). The spindle shaped tumour cells located towards the peripheral aspects o f the 
lobules (not palisading cells) demonstrated thick, dense and long actin filaments (stress 
fibers) arranged mostly in parallel bundles traversing the longitudinal axis o f the cells 
(Fig. 100). The staining o f actin filaments in the tumour cells towards the inner aspects 
o f the lobules was very strong in comparison with the tumour palisading cells and 
normal epidermis but their arrangement was variable. Such actin filaments (stress
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fibers) were thick and randomly oriented. In some lobules o f infiltrating growth pattern 
tumours, actin polymerisation was more pronounced in certain aspects (dermal or 
sideways) than others which seemed to be the direction o f the tum our growing edge 
(Figs. 96 and 100).
In tum our lobules showing less aggressive behaviour (nodular) (Table 31), strong 
staining o f actin was evident which was homogenous and evenly distributed. In these, 
the actin staining was located peripherally beneath the cell membrane where single actin 
filaments were rarely observed. This staining pattern o f actin filaments was 
accompanied by the presence o f  E-, P-cadherin, a -, (3-catenin and a-actin in  staining but 
in reduced staining intensity when compared with the normal epidermis (Figs. 101-103). 
Staining for actin filaments was present in the loose stroma surrounding tumour lobules 
(Table 31) but in a reduced staining intensity and somewhat different assemblage when 
compared with tumour cells (Figs. 104 and 105). Actin filaments in these cells formed 
fine networks o f stress fibers converging at several points in a disoriented arrangement. 
The characteristic retraction artefacts separating tumour lobules from their associated 
stroma were negative (Fig. 105).
Connection with 
normal epidermis
Central Peripheral
Actin a ++ ++ + /- ++ to + /-
E-Cadherin b +/-* + /- ++ -
P-Cadherin b 
(3-Catenin b
++ to +/_ 
+ / -
++ to + /-
+ /-
4-4
++ -
a-Catenin b 
a-Actinin c — 1 —
+ /-
+ /-
++
+/- -
T a b le  30. Im m unofluorescence staining o f  major adherens junc tion  com ponents  in tum our
lobules o f  BCC with infiltrative growth pattern *.
* Represents a minimum of 5 staining runs showing reproducible 
and consistent results. 
a Mainly thick, dense and long actin filaments arranged mostly in parallel bundles 
traversing the longitudinal axis of the cells 
b In cell membrane at the level of cell-cell junctions. 
c Largely cytoplasmic with enrichment at cell peripheries.
++ : strongly positive. + /-  : weakly positive (homogeneously weak).. -  : negative.
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Figure 95. Actin staining at connection o f  
in fil tra tive  BCC with ep iderm is .  N o te  the 
dram atic  increase o f  actin filament staining 
intensity (double arrow) when compared with 
that o f  normal keratinocytes (single arrow). 
Scale bar =100^m .
Figure 96. Double immunolabelling o f  E- 
cadherin (green) with actin (red) in infiltrative 
BCC. Note actin  polym erisation  in central 
aspect o f  lobule accompanied by reduced E- 
cadherin  m em brane  staining in co n tras t  to 
palisading cells. Scale bar = 25|jm.
Figure 97. Double im m unolabelling  o f  P- 
cadherin (green) with actin (red) in infiltrative 
BCC. Actin polymerisation in central aspect 
o f  lobule accompanied by reduced P-cadherin 
membrane staining in contrast to palisading 
c e l ls .  S o m e  c e l ls  s h o w  c o - l o c a l i s a t i o n  
(yellow). Scale bar =  25|nm.
Figure 99. Double im m unolabelling o f  a~  
catenin (green) with actin (red) in infiltrative 
B C C . S o m e  p e r ip h e r a l  c e l l s  sh o w  c o ­
localisation (yellow). Scale bar =10pm .
Figure 98. Double im m unolabelling o f  p- 
catenin (green) with actin (red) in infiltrative 
BCC. Note prominent actin polymerisation in 
in f i l t ra t ing  cells  a c co m p an ied  by m arked  
reduction o f  p-catenin staining. Scale  bar 
=50|jm .
Figure 100. Actin staining in infiltrative BCC. 
Note the pronounced actin polymerisation in 
the infiltrating cells where they demonstrate 
thick and dense actin  bundles. S cale  bar 
= 10pm.
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Figure 101. Double immunolabelling o f  E- and P-cadherin (green) with actin (red) in nodular 
BCC. (A) E-cadherin and actin. (B) P-cadherin and actin. Note actin staining in the peripheries o f  
tumour cells where some show co-localisation (yellow). Scale bars = 25pm.
A  B
Figure 102. Double immunolabelling o f  p- and a-catenin (green) with actin (red) in nodular 
BCC. (A) p-catenin and actin: no co-localisation. (B) ^-catenin and actin: some peripheral tumour 
cells show co-localisation (yellow). Scale bars = 25pm.
Figure 103. Double immunolabelling o f  a -  
actinin (green) with actin (red) in nodular BCC. 
Note actin polymerisation in central aspect o f  
lobule  acco m p an ied  by reduced  ot-actinin 
membrane staining in contrast to palisading 
cells which show co-localisation (yellow). 
Scale bar = 25pm.
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Figure 104. Double immunolabelling o f  E- 
cadherin (green) with actin (red) in stromal 
c e l ls .  N o te  s t r o n g  a c t in  s t a i n i n g  and  
d iso r ie n te d  a r ra n g e m e n t .  N o  E -c a d h e r in  
staining. Scale bar = 25pm.
StromaCentral PeripheralConnection with 
normal epidermis
Actm + / - ++ to + /-++
E-Cadherin b .++ to + /-
P-Cadherin ++ to + /-
+/-p-Catenin ++ to +/
++ to +/a-Catenin
ilS ll
a-Actimn
T a b le  31. Im m unofluorescence staining o f  m ajor adherens junc tion  com ponents  in tum our
lobules o f  BCC with nodular growth pattern *.
* Represents a minimum of 5 staining runs showing reproducible 
and consistent results. 
a Mainly present at the periphery of the cells. 
b In cell membrane at the level of cell-cell junctions. 
c Largely cytoplasmic with enrichment at cell peripheries.
++ : strongly positive. + /-  : weakly positive (homogeneously weak). -  : negative.
3.41. Double immunolabelling of major adherens junction components for actin. 
Normal skin adjacent to tumour
When double immunolabelling using E-, P-cadherin, a -, and (3-catenin antibodies and 
TRITC-labelled Phalloidin was performed, the staining o f these antibodies (green) 
appeared to be separate from actin staining (red) particularly in the granular cell layer 
which showed a very strong binding o f phalloidin (Figs. 88-90 and 92). There was no 
co-localisation observed between these antibodies and actin filament bundles in the 
normal epidermis. Occasionally, however, granular layer cells showed double 
immunolabelling o f a-catenin and actin (Fig. 91) which was not seen in epidermal cells 
from granular layer downwards. When double immunolabelling o f the a-actinin 
antibody and TRITC-labelled Phalloidin was performed, a portion o f actin filaments 
staining appeared to co-localise with a-actinin staining at the plane o f the plasma 
membrane o f spinous layer cells (Fig. 94). In this particular specimen o f normal skin 
adjacent to the tumour, strong actin filament staining was observed throughout the 
normal epidermis including basal layer cells. Actin filaments (stress fibers) were 
concentrated at the apical region o f the normal keratinocytes and arranged vertically so
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that they appear to be leading upwards. This observation of actin filaments arrangement 
and distribution was in contrast to what has been noted in many other specimens of 
normal skin.
Basal Cell Carcinoma
The double immunolabelling of the tumour cells showed no co-localisation of E-, P- 
cadherin, a- and P-catenin with actin filament bundles as the staining of these 
antibodies and actin was separated (Figs. 96 and 98). However, in few tumour cells, a 
portion of E-, P-cadherin and a-catenin staining may appeared to coincide with actin 
staining at the plane of plasma membrane (Figs. 97, 99, 101 and 102B). This was 
particularly observed in double immunolabelling of a-catenin and Rhodamine- 
Phalloidin where small punctate areas of co-localisation were seen in the palisading 
cells of tumour lobules of both infiltrative and nodular BCC (Fig. 99). Although most 
of the tumour cells demonstrated separate localisation of a-actinin and actin filament 
bundles, occasional double-stained cells were present in both the central and peripheral 
aspects of the tumour lobules (Fig. 103).
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3.42. Double immunolabelling of E- and P-cadherin
Normal skin adjacent to tumour
Double immunolabelling of the normal epidermis adjacent to the tumour using anti-P- 
and anti-E-cadherin antibodies revealed the specific and normal pattern of distribution 
of the two antigens with areas of co-localisation (Fig. 106). E-Cadherin (red) was 
distributed in the full thickness of the epidermis excluding the stratum comeum while P- 
cadherin (green) was confined to the basal and the first suprabasal epidermal cells and 
negative in the membranes of the upper epidermal cells. These results are in agreement 
with those of Extra-avidin staining. Areas of co-localisation of E- and P-cadherin at 
cell-cell junction were observed in the membranes of the basal and the first suprabasal 
epidermal cells as indicated by bright yellow colour (Fig. 107). Similar observation was 
also noted in the normal hair follicle (Fig. 108). The two positive controls which were 
included in double immunolabelling by omitting the 1st primary antibody, i.e. P-cadherin 
and then omitting the 2nd primary antibody, i.e. E-cadherin yielded consistent results 
(Fig. 110A and B). Negative control by omitting both antibodies was negative (Fig. 
111).
Basal Cell Carcinoma
Double immunolabelling of tumour lobules in nodular BCC showed preservation of 
membranous P-cadherin (green) in almost all tumour cells (Fig. 109A). E-Cadherin 
membrane staining was present, but in reduced intensity compared with normal 
epidermis (Fig. 109A). In many tumour cells, staining of E-cadherin appeared to 
coincide with P-cadherin in the plasma membrane area at cell-cell junctions cells as 
indicated by the yellow colour (Fig. 109A and B). However, there was no observation 
of tumour cells expressing only E-cadherin.
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Figure 105. Actin staining in stromal cells. 
Less intense stromal staining when compared 
with that o f  tumour cells. Negative retraction 
artifact. Scale bar = 10|jm.
Figure 106. Double immunolabelling o f  P- 
cad h er in  (g reen )  and  E -cad h e r in  ( red )  in 
normal epidermis. N ote co-localisation o f  both 
antibodies in basal and first suprabasal layers 
o f  epidermis (yellow). Scale bar =  25|jm.
Figure 107. Double immunolabelling o f  P- 
cad h e r in  (g reen )  and  E -c a d h e r in  (red )  in 
normal epidermis. Higher power o f  basal and 
first suprabasal layers o f  epidermis showing 
co-localisation o f  both antibodies (yellow). 
Scale bar =50j^m.
Figure 108. Double immunolabelling o f  P- 
cadherin (green) and E-cadherin (red) in hair 
follicle. Note the double-stained cells (yellow) 
in the ORS cells and in basal layer o f  visible 
normal epidermis. Scale bar = 25|jm.
A  B
Figure 109. Double immunolabelling o f  P-cadherin (green) and E-cadherin (red) in nodular BCC.
(A) N o te  strong P-cadherin  m em brane  s ta ining in almost all tum our cells in which several 
demonstrate co-localisation (yellow). (B) Higher power view showing similar observation. No 
tumour cell demonstrate E-cadherin only. (A) Scale bar = 25^m , (B) Scale bar =50|jm .
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A  B
Figure 110. Positive controls o f  Double immunolabelling o f  P-cadherin and E-cadherin. (A) 
I m m u n o f lu o r e s c e n c e  s t a in in g  o f  E - c a d h e r in  on ly  a f te r  o m is s io n  o f  P - c a d h e r in .  (B )  
Immunofluorescence staining o f  P-cadherin only after omission o f  E-cadherin. Scale bars = 1 Ojjm.
Figure 111. N e g a t iv e  co n tro l  o f  D o u b le  F igu re 112. N e g a t iv e  c o n t r o l  o f  
im m u n o la b e l l in g  o f  P - c a d h e r in  a n d  E- I m m u n o f lu o r e s c e n c e  s t a in in g .  A 
cadherin. rep re sen ta t iv e  negative  con tro l.  All o ther
controls were consistently negative.
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Results IV
Immunofluorescent staining and double immunolabelling of the major 
adherens junction components in Keratinocyte culture.
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3.43. Culture of keratinocytes in low calcium concentration
Keratinocytes grown in medium with 0.1 mM Ca2+ for 10 days, fixed and stained for E-, 
P-cadherin, P-catenin and actin, have a single-layered loose clustered morphology 
(Table 32) (Fig. 113). After 3 days of wounding the culture surfaces (Fig. 114), the 
keratinocytes grown in low concentration of Ca2+ migrated in a single-layered sheet and 
closed the gap partially. These cells were fixed in 10% formalin and stained for P- 
cadherin and actin which revealed weak membrane P-cadherin staining in some colonies 
particularly at the basal aspect (Table 32) (Fig. 115A), sometimes with punctate pattern 
of membranous distribution (Fig. 115B). Staining of filamentous actin with 
Rhodamine-Phalloidin showed uneven distribution throughout the colonies (Fig. 116). 
Positive actin filaments staining was diffuse throughout the cytoplasm, aligned with the 
longer axis of the cell (Table 32) (Fig. 117), and mainly present at the periphery and the 
lateral cell margins.
Similar to P-cadherin, E-cadherin and p-catenin staining in the membranes of cultured 
keratinocytes was weak throughout most of the colonies (Table 32). However, some 
over-stained small colonies revealed positive E-cadherin and p-catenin in cell 
membranes and intercellular bridges (Figs. 118 and 119). In addition, there was no 
obvious p-catenin nuclear staining.
In these cultures, the wound was only partially filled and actin filaments staining was 
similar to that of the cells stained with P-cadherin and actin.
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Low Calcium 
(0.1 mM)a
High Calcium 
h
(1.5 mM)
Actin Difftise ++
E-Cadherin + /- ++
P-Cadherin +/— ++
(3-Catenin + /- ++
Wound* Partially Closed** Closed***
Status of cells Loose Tight
Table 32. Im m unofluorescence staining o f  some m ajor adherens junc tion  com ponents  and
status o f  cells in keratinocyte cultures o f  low and high calcium concentration.
a Keratinocytes grown in medium with 0.1 mM Ca2+ for 10 days. 
b Keratinocytes grown for further 3 days in medium with 1.5 mM Ca2+.
++ : strongly positive. + / -  : weakly positive (homogeneously weak).
* Approximately 0.5mm wide.
** After 3 days of wounding.
*** After 3 days of wounding.
3.44. Culture of keratinocytes in high calcium concentration
When the calcium concentration in the growth medium was raised from 0.1 to 1.5 mM, 
more close association o f the colonial cells was observed after fixation and staining for 
E-, P-cadherin, p-catenin and actin (Table 32). Strongly positive E-cadherin membrane 
staining was seen in almost all o f the closely associated colonial cells when compared 
with the staining in low calcium cultures (Fig. 120). This was particularly observed in 
the areas o f completely filled wound. Furthermore, there was bright staining of 
numerous small, pinpoint structures scattered in the background o f the slide (Fig. 120). 
Strong actin filaments staining, although uneven, was apparent in the cells stained for E- 
cadherin particularly at the basal cells o f the completely filled wound (Table 32). They 
were arranged, in some cells, in small groups o f short fibres (Fig. 120). The variable 
and uneven staining o f actin filaments and the cell adhesion molecules throughout the 
low and high calcium keratinocyte cultures could be due to poor antibody penetration or 
inadequate cell extraction using Triton x-100.
P-Cadherin membrane staining in the basal layer o f the partially filled wound was 
stronger when compared with the staining in low calcium cultures (Fig. 121). The same
173
observations were also seen when staining of p-catenin was performed which showed 
no obvious nuclear staining (Fig. 122).
3.45. Double immunolabelling
When double immunolabelling of the keratinocytes colonies using each of the 
antibodies P-, E-cadherin and P-catenin with TRITC-labelled Phalloidin was performed, 
no double-stained cells were observed (Figs. 123-128).
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Figure 113. Immunofluorescence staining o f  
P - c a d h e r in  ( le f t )  a n d  a c t in  ( r i g h t )  in 
keratinocyte colonies grown in low calcium 
medium for 10 days. N ote the loose colony­
l ike  m o r p h o lo g y  a n d  w e a k  P - c a d h e r in  
membrane staining. Scale bar =100|jm.
Figure 114. Vertical and horizontal wounding 
o f  keratinocyte culture.
A
Figure 115. Immunofluorescence staining o f  P-cadherin in keratinocyte colonies grown in low 
calcium medium for 10 days. (A) weak P-cadherin membrane staining.(B) Higher power showing 
punctate pattern o f  P-cadherin membrane staining. (A) Scale bar = 100pm,
(B) Scale bar = 25^m.
Figure 116. Immunofluorescence staining o f  
actin in keratinocyte colonies grown in low 
calcium medium for 10 days. Note the uneven 
d is t r ib u t io n  o f  ac t in  s ta in in g .  S ca le  ba r  
=250 |jm .
Figure 117. Immunofluorescence staining o f  
P - c a d h e r in  ( l e f t )  a n d  a c t in  ( r i g h t )  in 
keratinocyte colonies grown in low calcium 
medium for 10 days. Note the concentration 
o f  actin at cell periphery. Scale bar =50^m .
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Figure 118. Immunofluorescence staining o f  
E - c a d h e r in  ( le f t )  an d  a c t in  ( r i g h t )  in 
keratinocyte colonies grown in low calcium 
medium for 10 days. Weak E-cadherin staining 
in over-stained cells. Scale bar =50pm .
Figure 119. Immunofluorescence staining o f  
p-catenin (left) and actin (right) in keratinocyte 
colonies grown in low calcium medium for 10 
days. Weak p-catenin staining in over-stained 
cells. Scale bar =1 00pm.
* w  v ,I ' • O  ',
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Figure 120. Immunofluorescence staining o f  
E - c a d h e r in  ( le f t )  an d  a c t in  ( r i g h t )  in 
keratinocyte colonies grown in high calcium 
medium. Strong E-cadherin membrane staining 
in completely filled wound area. Note bright 
s ta in in g  o f  n u m e ro u s  p in p o in t  s t ru c tu re s  
scattered in background, (right) strong actin 
filament staining arranged in small groups o f  
short fibres. Scale bar =1 00pm.
Figure 121. Immunofluorescence staining o f  
P - c a d h e r in  ( le f t )  an d  a c t in  ( r i g h t )  in 
keratinocyte colonies grown in high calcium 
m e d iu m . S t r o n g  P -c a d h e r in  m e m b r a n e  
staining in partially filled wound area. Note 
strong actin filament staining arranged in small 
groups o f  short fibres. Scale bar = 100pm.
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Figure 122. p-Catenin Immunofluorescence 
staining in keratinocyte colonies grown in high 
c a lc iu m  m e d iu m . S t r o n g e r  p - c a t e n in  
membrane staining in partially filled wound 
area. Scale bar =1 00pm.
Figure 123. Double immunolabelling o f  E- 
c a d h e r in  ( g re e n )  w ith  a c t in  ( r e d )  in 
keratinocyte colonies grown in low calcium 
medium. No co-localisation. Scale bar =50pm.
Figure 124. Double immunolabelling o f  E- 
c a d h e r in  ( g re e n )  w ith  a c t in  ( r e d )  in 
keratinocyte colonies grown in high calcium 
m ed iu m . N o  c o - lo c a l i s a t io n .  S c a le  b a r  
= 100pm.
Figure 125. Double immunolabelling o f  P- 
c a d h e r in  ( g re e n )  w ith  a c t in  ( r e d )  in 
keratinocyte colonies grown in low calcium 
m ed iu m . N o  c o - lo c a l i s a t io n .  S c a le  ba r  
= 100pm.
Figure 126. Double immunolabelling o f  P- 
c a d h e r in  ( g re e n )  w i th  a c t in  ( r e d )  in 
keratinocyte colonies grown in high calcium 
medium. N o co-localisation. Scale bar =10pm.
*  M
Figure 127. Double immunolabelling o f  p- 
catenin (green) with actin (red) in keratinocyte 
colonies grown in low calcium medium. No 
co-localisation. Scale bar =10pm .
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Figure 128. Double immunolabelling o f  (3- 
catenin (green) with actin (red) in keratinocyte 
colonies grown in high calcium medium. No 
co-localisation. Scale bar =100|jm.
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Results V
BCC culture
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3.46. BCC culture
Eight fresh excisional specimens of BCC (3 infiltrative, 4 nodular and 1 superficial) 
were used in 5 experiments.
Experiment 1: Two contracted dermal equivalents were seeded with tumour single cell 
suspensions derived from an infiltrative BCC as described in the methods section. The 
first dermal equivalent was seeded with 5 x 105 tumour-derived cells/ml of MEM and 
the second with 2.5 x 105. In this experiment, the MEM added to the negative control 
was cell-free. Both dermal equivalents showed massive degradation after 48 hours of 
incubation at 37°C in a humidified atmosphere of 5% CO2 in air (Fig. 129).
Experiment 2: Similar results were obtained when experiment 1 was repeated using 
cells from a second infiltrative BCC (Fig. 130A). The degraded dermal equivalents 
were fixed in 10% formalin and stained with H&E which showed remnants of the 
degraded collagen gel and some viable single cells retaining epithelioid features but 
mostly composed of pyknotic, non-viable cells (Fig. 130B). The cells in one dermal 
equivalent which was seeded with 5 x 105 tumour-derived cells/ml of MEM and left in 
culture conditions for a longer period (1 week), eventually died.
Experiment 3: This was carried out using cells from infiltrative and nodular BCC 
specimens. Tissue culture flasks coated with a layer of neat FCS for 2-3 min and/or 
with Type I collagen and seeded with the same numbers of tumour-derived cells in 
MEM and in KGM failed to yield cell growth. In addition, seeding of tumour cells, 
derived from the original tumours, mixed with or without normal keratinocytes onto 
fibroblast-free and standard dermal equivalents gave similar negative results (data not 
shown).
Experiment 4: In contrast to the above, BCC-derived cells from nodular and superficial 
BCC were washed and resuspended quickly in MEM for 3 times in an attempt to wash 
some of the exogenous collagenase. In addition, more dermal equivalents seeded with 
variable numbers of BCC-derived cells were used. Six dermal equivalents were seeded 
with the following numbers of cells:
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• 4 x 105 tumour-derived cells/ml of MEM.
• 2 x 105 tumour-derived cells/ml of MEM.
• 1 x 105 tumour-derived cells/ml of MEM.
• 0.5 x 105 tumour-derived cells/ml of MEM.
• 0.25 x 105 tumour-derived cells/ml of MEM.
• 3 x 106 normal keratinocytes/ml of MEM.
Following incubation at 37°C in a humidified atmosphere of 5% CO2 in air for 5 days as 
submerged cultures, no degradation of dermal equivalents was noted (Fig. 131 A). After 
the seeded dermal equivalent were raised to the air/liquid interface for further 6 days, 
they were fixed in 10% formalin and stained with H&E. Most of these cultures revealed 
non-proliferating basaloid cells with epithelioid morphology singly scattered on the 
surface of the dermal equivalent and, in some, showing signs of cell death such as 
dyskeratosis and pyknosis (Fig. 13IB). However, in the dermal equivalent seeded with 
1 x 105 tumour-derived cells/ml of MEM, H&E stained sections showed a viable lobular 
mass of basaloid cells reminiscent of BCC cells with a small necrotic core (Fig. 132A).
Experiment 5: Similar results were obtained when experiment 4 was repeated using 2 
nodular BCC specimens.
The dermal equivalents seeded with normal keratinocytes have developed a multilayered 
and stratified epidermis following incubation for 5 days as submerged cultures and 
raised to the air/liquid interface for a further 7 days (Fig. 132B).
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Figure 129. Dermal equivalents seeded with 
infiltrative BCC single cell suspension. (1) and 
(2) show massive degradation (arrow) after 48 
hou rs  o f  incu b a t io n .  (3 )  nega tive  con tro l  
seeded with cell-free M EM .
A  B
Figure 130. Dermal equivalents seeded with infiltrative BCC single cell suspension from a second 
specimen. (A) (1) (2) (3) and (4) (see text) show massive degradation (arrows) after 48 hours o f  
incubation. (5) negative contro l seeded with neonatal fo reskin  kera t inocy tes  show ing  no 
degradation. (B) H& E o f  degraded dermal equivalent showing mostly non-viable cells. x320.
B
Figure 131. Dermal equivalents seeded with nodular BCC single cell suspension. N o  degradation 
after 5 days o f  incubation (see text). Negative control seeded with neonatal foreskin keratinocytes 
showing no degradation. (B) H& E o f  dermal equivalent after 11 days o f  culture showing singly 
scattered epithelioid non-proliferating cells. x320.
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Figure 132. (A) H&E o f  dermal equivalent seeded with l x 10 5 tumour-derived cells/ml o f  MEM 
after 11 days o f  culture showing a viable lobular mass o f  basaloid cells reminiscent o f  BCC cells 
with a small necrotic core. (B) H & E o f  dermal equivalent seeded with normal keratinocytes. (A) 
x320, (B) x l2 5 .
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Chapter 4: Discussion
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4.1. Expression of cadherins, catenins and associated proteins in normal epidermis
In the present study, the expression of several adherens junction components and 
associated proteins [E- and P-cadherin, a - and p-catenin and APC (see Appendix C)] 
was analysed in human normal epidermis adjacent to tumours. Using frozen sections 
and cultured keratinocytes, previous studies have reported that normal keratinocytes and 
melanocytes express both P-cadherin and E-cadherin on their cytoplasmic membranes 
where they maintain adhesion between these cells by homophilic binding (Tang et al., 
1994; Lewis et al., 1994; Horiguchi et al., 1994). This present study has confirmed and 
extended previous work in which it demonstrated that the expression of E- and P- 
cadherin in normal epidermis is specific and follows a well-defined pattern in both 
frozen and routinely processed paraffin-embedded specimens.
E-Cadherin was expressed normally in cellular membranes of all viable epidermal layers 
with an increased expression in the suprabasal layers as compared with the basal cells. 
It was also expressed in outer root sheath cells of hair follicles, flattened germinative 
cells of sebaceous glands, and in both secretory and ductal units of sweat glands. These 
results confirmed the findings of Fujita et al (1992) and Fuller et al (1996) in frozen 
tissues.
P-Cadherin distribution in normal epidermis differed from E-cadherin in that it was 
restricted to the membranes of basal layer cells and the outermost cells of the skin 
appendages. This observation is in agreement with previous reports on P-cadherin 
expression in frozen tissues of adult human skin (Fujita et al., 1992) and the mouse 
upper lip skin (Hirai et al., 1989). In addition, E- and P-cadherin were expressed on the 
membranes of normal epidermal melanocytes. The distribution of E-cadherin in all 
viable epidermal layers emphasises the possible main role of this cell adhesion molecule 
in the maintenance of the human normal epidermis. In addition it may function to 
organise and maintain the epidermal-melanin unit hence both normal keratinocytes and 
melanocytes express E-cadherin. This could also be applied to P-cadherin, since the 
normal melanocytes are usually located along the basal layer of the epidermis. 
Furthermore, the restricted expression of P-cadherin to the basal cells of the normal 
epidermis perhaps associates with the maintenance of the epidermal proliferative 
compartment segregating it from the upper non-proliferating strata. The dual expression
185
of E- and P-cadherins in basal cells may have properties in common concerning specific 
regulatory mechanisms. For example, their ability of regulating intercellular junction 
organisation in the basal layer. In addition, basal cells may require either cadherin to 
initiate epidermal stratification where E-cadherin may play the dominant role especially 
in suprabasal layers because of its broad distribution and P-cadherin is not needed due to 
its complete absence. Although there is a possibility of co-localisation of E- and P- 
cadherin in basal cell-cell junctions, either of them may still have unique function(s) in 
the basal cell layer.
Previous studies in many normal epithelial cells have suggested that a - and p-catenin 
are mainly localised at the membranes of the cell-cell borders. Strong expression of p- 
catenin especially on cell-cell boundaries has been demonstrated in human oesophagus 
(Takayama et al., 1996; Kimura et al., 1999), stomach (Takayama et al., 1996), human 
and rat colon (Takayama et al., 1996; Inomata et al., 1996; Takahashi et al., 1998; Back 
et al., 1999), normal breast mammary duct tissue (Hashizume et al., 1996), 
nasopharyngeal epithelium (Zheng et al., 1999) and capillary endothelial cells of the 
thyroid gland (Garcia-Rostan et al., 1999). Similar staining pattern was also reported for 
a-catenin in human breast, oesophagus, stomach and colon (Shiozaki et al., 1994; 
Hashizume et al., 1996; Glukhova et al., 1999).
In my work, the staining pattern of a- and P-catenin in normal epidermis was largely 
similar to that of E-cadherin. They were localised in a linear pattern along the lateral 
and upper surfaces of basal keratinocytes at the sites of cell-cell junctions where the 
normal keratinocytes in suprabasal layers expressed a -  and P-catenin around their 
peripheries. In addition, membranous a- and p-catenin is also present in the outer root 
sheath cells of the hair follicles, acinar germinative cells of the sebaceous glands and in 
sweat glands cells. However, they are absent at the basal cell surface, in stratum 
comeum, inner sheath cells of the hair follicle and the hair shaft. These results are in 
agreement with recent reports on a- and p-catenin expression in normal epidermis (Tada 
and Hashimoto, 1998; Silye et al., 1998). The similar distribution of the catenins and E- 
cadherin may be explained by the direct association of these proteins in AJ at the cell 
membrane level where catenins mediate the connection of the E-cadherin with the actin
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filament network. Furthermore, the coexistence of catenin expression and cellular 
localisation with E- and P-cadherin in normal epidermis is in agreement with the 
presence of a normally functioning cadherin/catenin complex. In this study, there was 
good agreement between the E- and P-cadherin, a - and P-catenin staining of the 
membranes in paraffin-embedded and frozen samples.
4.2. E- and P-cadherins expression in non-melanoma cutaneous tumours
Destabilisation of cell-cell junctions allows initiation of the invasive process and the 
progression of carcinoma (Behrens et al., 1989; Frixen et al., 1991; Vleminckx et al., 
1991). The cell adhesion molecule, cadherin, was first reported by Takeichi (1977). E- 
Cadherin is considered to be the major adhesion molecule found in AJ where it is 
expressed on most cell types that form solid tissues (Takeichi, 1988; Tang et al., 1994). 
During the past several years, a number of reports have suggested a relationship between 
reduced expression of E-cadherin and metastasis in a wide variety of tumours, including 
skin (Schipper et al., 1991; Pizarro et al., 1994; Fuller et al., 1996; Cowley and Smith, 
1996; Cano et al., 1996; Silye et al., 1998; Montonen et al., 1998), breast (Rasbridge et 
al., 1993; Oka et al., 1993; Glukhova et al., 1995), gastric (Guilford et al., 1998; Jawhari 
et al., 1999), pancreatic (Perl et al., 1998), bladder (Giroldi et al., 1999), nasopharyngeal 
(Zheng et al., 1999), colorectal (Kinsella et al., 1993) and prostate cancers (Cheng et al., 
1996). In addition, Mutations of the E-cadherin gene have recently been discovered in a 
variety of carcinomas including human gastric carcinoma and cell lines (Becker et al., 
1994; Oda et al., 1994), carcinomas of the endometrium and ovary (Risinger et al., 
1994). These studies strongly support the proposed role of E-cadherin as an invasion 
suppressor molecule.
The present study investigated E and P-cadherin cellular distribution in different 
histological types of human cutaneous tumours. In order to do this, it was necessary to 
develop techniques for cadherin immunostaining of routinely processed, paraffin- 
embedded specimens. As down-regulation or complete loss of E-cadherin occurs in 
association with human epithelial cancers, the present work aims to assess whether the
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decrease in membranous distribution of E- and P-cadherins in skin cancer is accentuated 
in dedifferentiated tumours.
The results have shown that E-cadherin staining was reduced in BCC tumour cell 
membranes in almost all of the routinely processed cases (93.8%) and in all the frozen 
samples compared with the normal epidermis. There was good agreement between 
results on routinely processed tissues and on freshly frozen material. Among the 10 
cases of routinely processed, well-differentiated SCC, 8 cases (80%) have shown 
reduced E-cadherin tumour cell membrane staining. Of these, one was completely 
negative. E-Cadherin membrane staining was also reduced in all keratoacanthomas and 
moderately differentiated SCC, of which 2 cases were completely negative. In non- 
malignant lesions, Bowen’s disease, actinic keratosis, psoriasis and lichen simplex 
chronicus, E-cadherin membrane staining was largely similar to normal epidermis. This 
was despite the epidermal dysplasia frequently seen in Bowen’s disease and actinic 
keratosis.
Pilomatrixoma is a tumour expressing characteristics of the hair matrix where early 
lesions may show quite brisk mitotic activity, but this is never abnormal and is 
indicative of a rapid growth phase rather than malignant potential (McKee, 1996a). 
Downregulation or loss of E-cadherin membrane staining in some of the pilomatrixoma 
(5/10) was expected because they were composed mainly of fully matured cells 
dispersed in sheets of keratinous debris. However, in early lesions of pilomatrixoma 
(5/10) composed of viable cells, E-cadherin membrane staining was preserved despite 
the large size and numerous mitotic figures.
Although, the reduction of E-cadherin membrane staining was uneven throughout some 
BCC lobules, particularly in some routinely processed samples, it was observed in all 
different histological subtypes of BCC including the small lobules of superficial BCC 
projecting from the lower margin of the epidermis. However, the reduction of E- 
cadherin membrane staining was more pronounced in BCC cases with invasive growth 
pattern such as infiltrative, metatypical and spindle cell BCC.
A notable feature was the observation of preserved E-cadherin membrane staining in the 
palisading cells of the BCC tumour lobules expressing reduced membrane staining 
centrally, which was not seen in SCC variants. Fuller and colleagues (1996) reported
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reduced E-cadherin expression almost in all cases of BCC (28/30) and in 12/16 cases of 
variable differentiation SCC of which 4 cases were completely negative. Unfortunately, 
in the previous study, it was not stated which variant of SCC was completely negative.
E-Cadherin plays an important role in the progression of human SCC of head and neck 
where downregulation of its expression is associated with de-differentiation and 
metastasis of tumour cells in vivo (Schipper et al., 1991). In their study, Schipper and 
colleagues (1991) found that E-cadherin expression is inversely correlated both with the 
loss of differentiation of the tumour and with lymph node metastasis. Therefore, it is 
suggested that the cell-cell adhesion maintained by E-cadherin as an invasion suppressor 
is lost in the poorly differentiated tumours. A recent study by Koseki and colleagues 
(1999) suggested that E-cadherin expression tended to be preserved in well- 
differentiated SCC of the skin and reduced or absent in poorly differentiated tumours 
correlating with regional lymph node metastasis. In addition, De Bruin and colleagues 
(1999) observed significant reduction in E-, N-, and P-cadherin protein expression in an 
invasive SCC cell line. An earlier study by Pizarro and colleagues (1994) on frozen 
specimens of BCC reported that reduction of E-cadherin expression was related to the 
growth pattern and the local invasiveness of BCC by showing reduced E-cadherin 
membrane staining in infiltrative subtypes of BCC only (10/15). In contrast to the data 
demonstrated in this present study, they reported that E-cadherin expression was 
preserved in all frozen specimens of superficial and nodular BCC.
My experiments have shown that the reduction in tumour cell membrane E-cadherin in 
comparison with the normal epidermis is a characteristic in all subtypes of BCC and 
variants of SCC, particularly those tumours with aggressive behaviour, but not in non- 
malignant lesions. In addition, the decrease in membranous distribution of E-cadherins 
in superficial, nodular BCC and well-differentiated SCC progressed further in 
dedifferentiated tumours such as infiltrative, metatypical and spindle cell BCC and 
moderately differentiated SCC. Therefore, in BCC and SCC, the downregulation or loss 
of E-cadherin expression is directly proportional to the loss of differentiation of the 
tumour. However, less aggressive tumours such as superficial BCC still demonstrate 
reduced E-cadherin membrane staining despite their small size, whereas other tumours 
larger in size, for example pilomatrixoma, show preserved E-cadherin expression. This
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may support the view that BCC is a true malignancy rather than an epithelioma. Thus, 
E-cadherin expression in different histological subtypes of BCC and in various variants 
of SCC may be used as a useful prognostic marker. The preserved E-cadherin 
membrane staining in the palisading cells of the BCC tumour lobules may indicate that 
E-cadherin is one of multiple biological factors involved in the prevention of free 
stromal invasion and metastasis. However, this function of E-cadherin, if present, is lost 
in both well- and moderately-differentiated SCC hence there was no preservation of E- 
cadherin expression in the tumour cells at the peripheries of SCC lobules. In addition, 
this may explain, at least in part, the higher metastatic rate of SCC and its more 
aggressive behaviour in comparison with BCC. Although BCC has a low metastatic 
potential (Domarus and Stevens, 1984; Lo et al., 1991), it is capable of gross tissue 
destruction (Leffell et al., 1991; Ko et al., 1992; McKee, 1996a). Therefore the results 
of this present work are consistent with the observation that the reduction of E-cadherin 
is associated with tumour invasion at least locally. They also support the potential 
function of this protein as a biochemical marker for tumour progression. In addition, 
this study supports the suggestion of Fuller and colleagues (1996) in differentiating 
malignant from benign lesions by assessing their degree of E-cadherin expression as a 
potential clinical application.
My results have shown preservation of P-cadherin membrane staining in the majority of 
BCC cases and some SCC cases which simultaneously expressed reduced E-cadherin 
staining. In addition, I have observed that the reduction in P-cadherin tumour cell 
membrane staining was correlated with tumours showing aggressive growth pattern 
particularly in BCC (Table 6). In earlier reports of P-cadherin expression in non- 
cutaneous tumours, P-cadherin was detected in 7/8 adenocarcinomas of the colon (in 
abstract form) by Abbasi and colleagues (1992) and found to be preserved in 44 cases of 
carcinoma of the lung (Shimoyama et al., 1989). Furthermore, in a study by 
Shimoyama and Hirohashi (1991), P-cadherin was reported to be present in gastric 
carcinomas in more than half of the 54 cases examined. Therefore, my findings may 
suggest a possible contribution of P-cadherin to the maintenance of the epithelioid 
phenotype of the carcinoma cells, hence its continued expression. Furthermore, the 
downregulation or loss of E-cadherin but not of P-cadherin particularly in BCC and 
SCC tumours raises the possibility of stepwise loss of cadherins. Thus, during the
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process of tumour progression and invasion, E-cadherin may be lost first then P- 
cadherin loss follows when the tumour acquires very aggressive behaviour and is about 
to metastasise.
Cano and colleagues (1996) detected aberrant suprabasal localisation of P-cadherin in 
chemically induced benign skin papillomas and in invasive cells of progressing 
papillomas derived from wild-type, heterozygous and homozygous p53 null mice with 
genetically pre-determined risks for malignant conversion. They concluded that the 
observation of altered localisation of P-cadherin where it is expressed suprabasally in 
contrast to its normal distribution could be considered as a marker for malignant 
transformation. However, one of the interesting observations of this present study is the 
strong membranous expression of P-cadherin in the full thickness of Bowen’s disease, 
psoriasis and lichen simplex chronicus and the correlation of such staining with the 
alternating dysplastic bands of actinic keratosis. In addition, increased suprabasal 
localisation of P-cadherin is observed in the pseudoepitheliomatous epidermis adjacent 
to keratoacanthomas and variants of SCC. This phenomenon was observed in almost 
all studied cases. From my results, it is not clear what could be the biological 
significance of this observation. The speculation of the suprabasal expression of P- 
cadherin being a marker for malignant transformation in Bowen’s disease and actinic 
keratosis could be for the first instance true as these cases may develop into an invasive 
SCC (Marks et al., 1988a; 1988b; MacKie, 1992). However, this is not applicable to the 
hyperproliferative lesions characterised by epidermal hyperplasia such as psoriasis and 
lichen simplex chronicus as the increased risk of cancer in these cases, particularly in 
psoriasis, was linked only to certain treatment modalities (Frentz and Olsen, 1999). 
Furthermore, in a previous report, Hirai and colleagues (1989) showed that during skin 
morphogenesis the expression of P-cadherin seemed to be associated with the 
proliferating activity of cells. Therefore, my data demonstrates suprabasal P-cadherin 
expression in benign hyperplasia which may indicate that this molecule is proliferation- 
associated rather than a marker for malignant transformation, as suggested by Cano and 
colleagues (1996).
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4.3. E- and P-cadherins expression in melanocytic tumours
In comparison with the overlying normal epidermal keratinocytes, my results have 
demonstrated decreased E- and P-cadherin staining in dermal nests of primary 
melanomas in both radial and vertical growth phases and metastatic melanomas which 
ranged from reduced staining intensity to complete absence. However, in one case of 
metastatic melanoma, E- and P-cadherin expression was strongly preserved. This 
particular example could represent a reestablishment of E- and P-cadherin function in 
cell-cell adhesion maintenance. In other melanocytic lesions examined, E- and P- 
cadherin membrane staining was reduced in the dermal components, although E- 
cadherin staining was more marked than that of P-cadherin. Although the staining of 
both cadherins in dermal naevus cells was heterogeneous in distribution, it was in 
contrast to the membrane staining of E- and P-cadherin in melanocytic naevus cells in 
the epidermis.
In malignant melanoma, a differential loss of E-cadherin expression was recently noted 
by Silye and colleagues (1998). In their study, membranous E-cadherin expression was 
detected in all benign naevi, although heterogeneous in junctional naevus cell nests. My 
data is in agreement with that of Silye and colleagues (1998) where they reported an 
absence of E-cadherin staining in the membrane in dermal nests of melanomas in their 
radial growth phase and in Clark level II and III lesions. However, my findings are in 
contrast to their report of detectable staining present in a considerable proportion of 
melanomas in their vertical growth phase, in Clark level IV and V lesion and in 
metastasising melanomas. Moreover, Cowley and Smith (1996) reported that cadherin 
expression, and particularly E-cadherin expression, was much greater in malignant 
melanomas than in benign melanocytic naevi. The findings of these studies (Cowley 
and Smith, 1996; Silye et al.,1998) are clearly in contrast to the invasion suppressor role 
described for E-cadherin (Frixen et al., 1991).
In a study by Seline and colleagues (1996), human melanoma cell lines from early 
primary lesions were found to express more E- and P-cadherin than do melanoma lines 
established from patients with more advanced or metastatic disease following ultraviolet 
radiation.
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Although the number of primary melanomas was relatively small, my data indicated that 
the loss of cadherin expression in melanoma lesions may allow for enhanced 
detachment from the epidermis with subsequent invasion and metastasis. This is also 
supported by my data on metastatic melanomas which showed marked reduction in 
cadherin expression emphasising that the decrease in membranous distribution of E- 
cadherins in primary melanomas progressed further in metastatic lesions.
The reduction of E-cadherin expression in the dermal components of some benign 
melanocytic lesions may be explained by the neural crest origin of melanocytes which 
failed to form cadherin maintained clusters as they migrate from the neural crest. This 
also may be applicable to blue naevi because they represent arrested melanocytic 
migration and they are confined solely to the deeper aspect of the reticular dermis.
4.4. a- and P-catenin expression in non-melanoma cutaneous tumours
Recent work has suggested that there is a close association between abnormal 
expression and/or structural abnormalities of P-catenin as well as E-cadherin and 
tumour development as demonstrated in many cancers including human oesophageal 
carcinomas (Nakanishi et al., 1997), gastric carcinomas (Jawhari et al., 1997), colorectal 
polyps (Valizadeh et al., 1997), colon tumours (Takayama et al., 1996) and rat colon 
tumours (Takahashi et al., 1998). On the other hand, a-catenin membranous expression 
was found to be frequently reduced in tumours of the breast, oesophagus, stomach, 
colon, and malignant melanoma (Shiozaki et al., 1994; Hashizume et al., 1996; Silye et 
al., 1998). The findings of these studies support the idea that downregulation of 
membranous a- and p-catenin is associated with malignant transformation in these 
cancers. This may affect the E-cadherin-mediated adhesion system, as p-catenin forms 
a complex with E-cadherin in normal human epithelium and cancerous tissues 
(Takayama et al., 1996; Jawhari et al., 1999) while a-catenin in turn, connects this 
membrane-associated complex to the actin cytoskeleton (Knudsen et al., 1995; Rimm et 
a l, 1995) (Fig. 2).
193
One of my aims was to investigate the cellular distribution of a- and P-catenin in 
different histological types of human cutaneous tumours in relation to their cadherin (E- 
and P) expression and whether the cadherin/catenin complex in these tumours is altered 
in comparison with the normal epidermis. Therefore, my study considered whether the 
decrease in membranous distribution of the catenins, particularly P-catenin, in skin 
cancer progressed further in tumours with more aggressive behaviour. Additionally, it 
was of interest to examine whether any decrease in membranous p-catenin was 
accompanied by a redistribution to the cell nucleus, where p-catenin can act as a 
transcriptional co-activator leading to increased expression of TCF/LEF-regulated target 
genes (Huber et al., 1996; Molenaar et al., 1996; Behrens et al., 1996). For instance, 
recent work has shown that p-catenin has a potential signalling role in colon cancer 
(Munemitsu et al., 1995; Korinek et al., 1997; Morin et al., 1997) as a consequence of 
Wnt pathway activation (Rubinfeld et al., 1997; Fearon and Dang, 1999).
My data has shown consistent and strong correlation between p-catenin and E-cadherin 
membranous immunostaining in the tumour cells of almost all the cutaneous tumours 
examined. Although, in this study, a-catenin expression was investigated only in BCC 
frozen specimens, the results demonstrated that the reduction in tumour cell membrane 
a- catenin is also associated with that of p-catenin and E-cadherin. Although p-catenin 
and E-cadherin expression in breast carcinoma, for example, was severely reduced, 
Hashizume and colleagues (1996) related these observations to the histological type and 
growth pattern rather than the invasiveness and metastatic potential of the tumours.
In my study, the observation of reduced membranous E-cadherin, a - and p-catenin in 
BCC, SCC and malignant melanoma tumour cells in comparison with the normal 
epidermis strongly suggests a disturbance of AJ composition in these tumours. 
Furthermore, my data has shown that the membranous staining of p-catenin in all the 
cutaneous tumours examined, is almost identical to that of E-cadherin, suggesting that 
P-catenin forms a complex with E-cadherin in vivo. In addition, my data also suggest 
that membranous p-catenin downregulation is associated with malignant transformation 
in cutaneous tumours probably contributing to their development and progression. This
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is to say that membranous p-catenin was decreased in superficial, nodular BCC and 
well-differentiated SCC and decreased further in tumours with more aggressive 
behaviour such as infiltrative, metatypical and spindle cell BCC and moderately 
differentiated SCC in direct proportion to the loss of differentiation in these tumours. 
Therefore, the reduction in tumour cell membrane staining of P-catenin in comparison 
with the normal epidermis is another characteristic in BCC and SCC.
Similarly to E-cadherin, immunostaining of p-catenin in cutaneous tumours, particularly 
in BCC and SCC, may have prognostic value. Consistent with the report of Shiozaki 
and colleagues (1994) who demonstrated frequent reduction of a-catenin expression in 
primary tumours of oesophagus, stomach and colon, my results suggest that the 
reduction in tumour cell membrane a-catenin in BCC may be a characteristic feature 
acquired through malignant transformation. Since the functions of E-cadherin are 
modulated by catenins (Nagafuchi et al., 1988; Kintner, 1992; Nagafuchi et al., 1994), 
functional or structural abnormalities of a-catenin might take place in BCC with 
reduced a-catenin expression interfering with cadherin-mediated cell-cell adhesion.
4.5. P-catenin expression in melanocytic tumours
In malignant melanoma, using routinely processed, paraffin-embedded tissues, Silye and 
colleagues (1998) have shown diffuse cytoplasmic immunostaining for both a- and p- 
catenin in 35 cases with no correlation between tumour thickness or level of invasion, 
although, it was not stated whether this observation was accompanied by reduction in 
membrane staining. In a similar distribution pattern to E-cadherin, my results have 
demonstrated decreased membranous p-catenin staining in dermal nests of primary 
melanomas in both radial and vertical growth phases and metastatic melanomas when 
compared with the overlying normal epidermal keratinocytes. However, the staining 
intensity ranged from reduced to a complete absence. In addition, the other benign 
melanocytic lesions demonstrated reduced p-catenin staining particularly in the dermal 
components. The case of metastatic melanoma which showed strongly preserved E- and
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P-cadherin expression also showed strong staining of membranous p-catenin suggesting 
possible re-establishment of AJ composition.
My data on primary and metastatic melanomas indicated that the downregulation of p- 
catenin expression was associated with malignant transformation and progressed further 
in dedifferentiated tumours, strongly suggesting a disturbance of AJ composition in 
these tumours. This may be preceded by an enhanced detachment from the epidermis 
with subsequent invasion and metastasis. Furthermore, my data has shown that the 
membranous staining of p-catenin in all the melanocytic tumours examined, is almost 
identical to that of E-cadherin, suggesting that P-catenin forms a complex with E- 
cadherin in vivo. However, the reduction of p-catenin expression in the dermal 
components of some benign melanocytic lesions could be due to the failure of the 
migrating melanocytes to form normally functioning AJ.
Mutations in p-catenin were found in malignant melanoma and melanoma cell lines 
(Rubinfeld et al., 1997; Rimm et al., 1999). These mutations that prevent 
phosphorylation result in activation of Wnt signalling pathway because of increased 
cytoplasmic p-catenin (Rubinfeld et al., 1997). Rimm and colleagues (1999) detected 
nuclear and/or cytoplasmic staining in 10 of 18 cytology specimens and 8 of 47 surgical 
specimens of primary melanoma. They have interpreted these findings as a possible 
activation of p-catenin reflecting focal and transient activation of the Wnt signalling 
pathway within the tumour. In my study, although cytoplasmic staining of P-catenin 
was present in primary and metastatic melanomas, nuclear staining was not observed. 
Although the number of primary and metastatic melanomas was relatively small, my 
findings do not exclude the possibility of p-catenin activation by mutations as reported 
by previous studies (Rubinfeld et al., 1997; Rimm et al., 1999).
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4.6. Nuclear localisation of P-catenin in cutaneous tumours
Signalling via Wnt/Wg and Shh glycoproteins is critical for normal development of 
Drosophila melanogaster, Xenopus laevis and mammals, while dysregulation of their 
signal transduction pathway contributes to human cancer (Nusse and Varmus, 1992; 
Gumbiner, 1995; Moon et al., 1997; Cadigan and Nusse, 1997). During development 
there is interaction between the Shh/Ptc and Wnt/Wg signalling pathways (Von Ohlen 
and Hooper, 1997). There is accumulating evidence showing that the dysregulation of 
the Shh/Ptc signalling pathway leads to the development of hereditary and sporadic 
BCC (Stone et al., 1996; Gailani et al., 1996; Johnson et al., 1996; Hahn et al., 1996a; 
Unden et al., 1997; Oro et al., 1997; Aszterbaum et al., 1998; Smyth et al., 1999; 
Nagano et al., 1999). However, the role of the Wnt/Wg signalling pathway in epidermal 
tumourigenesis remains unclear. In addition to its function in intercellular adhesion by 
associating with E-cadherin (Nagafuchi et al., 1988; Ozawa et al., 1989; McCrea et al., 
1991; Nagafuchi et al., 1994), p-catenin is a key component of the Wnt pathway 
(reviewed by Gumbiner, 1995; Miller and Moon, 1996; Willert and Nusse 1998; 
Polakis, 1999). Activation by Wnt redistributes P-catenin to the nucleus to form a 
complex with T cell factor (Tcf) and lymphoid enhancer factor (Lef) transcription 
factors (Huber et al., 1996; Behrens et al., 1996; Molenaar et al., 1996; Korinek et al.,
1997). Mutations in p-catenin have been described in various malignancies and cancer 
cell lines including rat and human colon tumour tissues and cell lines (Morin et al., 
1997; Takahashi et al., 1998; Mann et al., 1999), thyroid carcinoma tissue (Garcia- 
Rostan et al., 1999), human prostate cancer tissue and cell lines (Voeller et al., 1998) 
and hepatocellular carcinoma tissue (Miyoshi et al., 1998). These mutations in p- 
catenin resulted in frequent cytoplasmic and/or nuclear localisation of the protein which 
was observed in familial adenomatous polyposis tissue (Inomata et al., 1996), intestinal 
polyps of Peutz-Jeghers and juvenile polyposis syndromes (Back et al., 1999), anaplastic 
thyroid carcinoma (Garcia-Rostan et al., 1999) and rat colon tumours (Takahashi et al.,
1998). Cytoplasmic and/or nuclear localisation of p-catenin may indicate its activation 
which appears to be frequent in melanoma (Rimm et al., 1999) and gastric carcinoma 
cell lines (Jawhari et al., 1999) reflecting activation of the Wnt/Wg signalling pathway 
in these tumours. Similarly, Kimura and co-workers (1999) demonstrated the
197
accumulation of free soluble p-catenin in the cytoplasm and nuclei of oesophageal 
cancer cells by fractionation technique. In adenomatous colonic tumours, the nuclear 
translocation of p-catenin and the increase in its transcriptional activity could also be 
due to disturbance in its metabolism due to lack of the normal APC gene product or a 
mutated APC gene product (Korinek et al., 1997; Back et al., 1999). Thus, p-catenin 
may act as an oncogene contributing to the causes and aggressive behaviour of many 
tumours. Furthermore, accumulation of non-membrane associated P-catenin in the 
cytoplasm resulting from mutations in APC or in p-catenin itself was found to be 
followed eventually by a later mutational inactivation of the p53 tumour suppressor 
during the later stages of tumour progression (Damalas et al., 1999).
Transgenic mice expressing an activated p-catenin were found to be predisposed to 
develop skin tumours resembling pilomatrixomas and trichofolliculomas (Gat et al.,
1998). Furthermore, human pilomatrixomas and trichofolliculomas have been found to 
contain P-catenin-stabilising mutations which result in LEF-1 transactivation (Chan et 
al., 1999) (Fig. 133).
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Figure 133. Schematic of p-catenin, depicting the location of the GSK3b-dependent phosphor­
ylation sites in the N-terminal segment and the armadillo repeats. Shown are the sequences of the 
wild-type, conserved N-terminal segment from human (Hu), mouse (Mu), Xenopus laevis (Xe), 
Drosophila melanogaster (Dr) and the corresponding location of pilomatrixoma mutations and 
previously described mutations from other types of human tumours and cell lines (Chan et al.,
1999).
My data extends the work of Chan and colleagues (1999) by showing nuclear p-catenin 
staining in pilomatrixoma using antibodies to the N and C terminal domains. However, 
my immunohistochemical analysis has also shown that P-catenin can be detected in the 
tumour cell nuclei of some BCC. The nuclear staining of p-catenin seen in two cases of 
Bowen’s disease was only with C-terminus antibody. In almost all cases, the nuclear p- 
catenin staining was accompanied by decrease in membrane staining. The staining 
pattern seen with both antibodies in pilomatrixoma and frozen BCC specimens was 
almost identical. Positive nuclear staining was seen less frequently in paraffin- 
embedded BCC with the N terminal compared with the C terminal antibody. However, 
all paraffm-embedded BCC expressing nuclear N-terminus p-catenin have shown C- 
terminus p-catenin nuclear staining.
Cytoplasmic and/or nuclear accumulation of P-catenin has been observed in familial 
adenomatous polyposis tissue (Inomata et al., 1996), rat colon carcinoma tissue 
(Takahashi et al., 1998), intestinal polyps of Peutz-Jeghers and juvenile polyposis 
syndromes (Back et al., 1999), oesophageal cancer tissue (Kimura et al., 1999), gastric 
carcinoma cell lines (Jawhari et al., 1999) and anaplastic thyroid carcinoma (Garcia- 
Rostan et al., 1999).
The detection of nuclear P-catenin staining in Bowen’s disease and BCC in addition to 
pilomatrixoma is novel as it suggests that dysregulation of P-catenin cellular distribution 
may be common to several pathways leading to epidermal carcinogenesis. However, p- 
catenin nuclear staining was seen in only a minority of BCC and Bowen’s disease cells 
and was not observed in SCC, keratoacanthoma, actinic keratosis and the non-malignant 
lesions.
While activation of p-catenin by mutation may be a primary event in pilomatrixoma, it 
seems more likely that in BCC and Bowen’s disease nuclear localisation of P-catenin 
would be secondary to activation of the Wnt pathway or possibly due to redistribution of 
p-catenin as a result of disruption in AJ.
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4.7. Gli-1 expression in normal epidermis and BCC
Dysregulation of the Shh/Ptc signalling pathway (Fig. 5) has been shown to underlie 
BCC (Hahn et al., 1996a; Johnson et al., 1996; Lam et al., 1999).
Gli-1 is a member of the Gli family of zinc-finger transcription factors which includes 
the drosophila cubitus interruptus (ci) which shows significant homology to Gli-1 
(Kinzler et al., 1987; Kinzler et al., 1988; Von Ohlen et al., 1997). Gli-1 has been 
identified as a downstream mediator of the Shh response (Dominguez et al., 1996; 
Alexandre et al., 1996; Lee et al., 1997; Hynes et al., 1997; Altaba, 1998). In 
drosophila, ci is needed for the transcriptional activation of the Hh signalling pathway 
target genes, Wg and ptc, and the repression of others, such as Hh itself (Aza-Blanc et 
al., 1997; Akimaru et al., 1997; Ingham, 1998).
In a study by Dahmane and colleagues (1997), ectopic expression of Gli-1 in the 
embryonic frog epidermis has been shown to result in the development of tumours that 
express endogenous Gli-1. They also showed that Shh and the Gli genes are normally 
expressed in hair follicles, and that human sporadic BCC consistently express Gli-1 but 
not Shh or Gli-3. Taken in consideration that Gli-1, but not Gli-3, mediates Shh 
signalling, these findings together with the fact that the Ptc gene is mutated in hereditary 
and some sporadic BCC raised the possibility that Gli-1 could be expressed and underlie 
the development of sporadic adult BCC. Furthermore, Oro et al (1997) demonstrated 
that overexpression of Shh in transgenic mice is sufficient to induce BCC-like tumours. 
Specific Ptc overexpression was also found in human sporadic BCC, suggesting that an 
abnormality of the Ptc-mediated signalling pathway plays an important role in the 
development of this tumour (Unden et al., 1997; Nagano et al., 1999). Any mutations 
leading to the expression of Gli-1 in basal cells are predicted to induce BCC formation 
(Dahmane et al, 1997). Green and colleagues (1998), have established by using reverse 
transcription-polymerase chain reaction (RT-PCR) that Gli-1 is differentially expressed 
in human BCC but not normal interfollicular skin. Using in situ hybridisation, they 
demonstrated Gli-1 transcripts within BCC tumour islands which would be consistent 
with the hypothesis that activation of Hh/Ptc signalling in keratinocytes is accompanied 
by the accumulation of Gli-1 transcripts. Moreover, Gli-1 was not found to be 
expressed in normal human skin and hair follicles (Green et al., 1998) in contrast to the
201
findings of Dahmane et al (1997). Thus, the differential expression of Gli-1 in BCC 
could be associated with the inactivation of Ptc gene in this tumour in which Gli-1 
expression is increased by the activation of the Hh/Ptc signalling pathway (Green et al.,
1998). Although Gli-1 has been shown to be localised to the cytoplasmic compartment 
in BCC (Dahmane et al., 1997; Ghali et al., 1999), it is found largely in the nucleus in 
COS cells transfected with the glioma-derived cDNA (Dahmane et al., 1997; Aza-Blanc 
et al., 1997) and in a minority of BCC cases stained with Gli-1 N and C-terminal 
antibodies (Ghali et al., 1999).
My immunohistochemical analysis of normal epidermis and paraffin-embedded BCC 
with antibodies to the N and C terminal domains has shown that Gli-1 protein can be 
detected in normal epidermis, although weakly heterogeneous, and in BCC using these 
antibodies. Although the number of cases differs slightly, the staining pattern seen with 
both antibodies was almost identical in which it was present in normal keratinocytes 
towards the edges of the normal specimens and completely negative in the epidermis 
immediately above the main BCC mass in all the specimens. Although some hair 
follicles stained weakly positive in their outer root sheath cells, this was not consistently 
seen reflecting possible epitope masking.
In BCC tumour cells, my results have shown positive staining with both antibodies 
which was almost solely nuclear in contrast with the findings of Ghali and colleagues 
(1999) and with a previous report using a polyclonal antibody to the DNA binding 
domain of Gli-1 (Dahmane et al., 1997). They have detected cytoplasmic Gli-1 staining 
in BCC. However, my observation of nuclear localisation of Gli-1 is consistent with 
previous reports of nuclear localisation in COS cells transfected with a Gli-1 construct 
(Dahmane et al., 1997; Aza-Blanc et al., 1997).
The similarities and differences in Gli-1 staining between my data and that of Ghali and 
colleagues (1999) are listed in Table 33, however, when I tried the staining protocol 
used in their report, the results were unsatisfactory (see results section).
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' 4',i •; -ft My data Ghali et al., 1999
sue used Routinely processed BCC tissue Routinely processed BCC tissue
lining method Extra Avidin-biotin-peroxidase 
complex technique___________
Avidin-biotin-peroxidase comple> 
technique 
Goat polyclonal
lotechnol
% hydrogen pe 
methanol for 10
benzid
Cytoplasmic
tibody used Goat polyclonal IgG
tibody source Cruz Biotechnology (Santa Cruze, 
CA)___________________________
;thod o f antigen retrieval 
>cking o f endogenous 
roxidase activity________
Pressure cooking
3% hydrogen peroxide in distilled 
water for 15 min
tibody dilution 1:200
1 hour at 37°C
VIP peroxidase substrate kit
reaction
Antibody localisation in 
BCC
Nuclear
T able 33. Im m unohistochem ical s ta in ing  o f  Gli-1 in BCC. S im ilarities and d ifferences betw een 
m y data and that o f  G hali et al., 1999.
In my results, the positive nuclear staining was seen less frequently with the N terminal 
compared with the C terminal antibody, but all BCC expressing nuclear N-terminus Gli- 
1 have shown C-terminal antibody nuclear staining. This may simply suggest an epitope 
masking phenomenon, however, inherent differences in the tumours cannot be excluded. 
No correlation was detected between the Gli-1 tumour cell nuclear staining and the 
aggressive behaviour o f the tumour.
During the development of drosophila, the Gli-1 homologue, cubitus interruptus, 
represses Hh and other target genes in the anterior compartment to allow for anterior 
development (Dominguez et al., 1996; Aza-Blanc et al., 1997). As the cell origin of 
BCC remains controversial, the weak Gli-1 nuclear staining in the basal cells o f the 
normal epidermis may be an early event indicating a low transient epidermal expression 
o f Gli-1 as there could be a requirement for certain level o f Gli-1 to initiate tumour 
formation in these cells pointing to a possible basal cell origin and a potential diagnostic 
tool o f this common tumour.
More importantly, in contrast to the recent report o f  predominant cytoplasmic 
localisation o f Gli-1 in BCC (Ghali et al., 1999), the data presented in my work o f  Gli-1 
nuclear localisation in BCC strongly supports the evidence which indicates that Gli-1, 
and its drosophila homologue cubitus interruptus, may be a transcriptional activator 
(Aza-Blanc et al., 1997; Ingham, 1998; Alexandre et al., 1996; Von Ohlen and Hooper,
203
1997; Forbes et al., 1993; Akimaru 1997). While the explanation of Gli-1 functions in 
skin as a transcriptional activator or a repressor remains to be completely cleared, my 
data suggests that nuclear localisation of Gli-1 in BCC provide further evidence for the 
activation of the Shh/Ptc signalling pathways in this tumour. In addition, the data of 
Ghali and colleagues (1999) on cytoplasmic Gli-1 in BCC may also indicate activation 
of this pathway. However, the significance of the nuclear staining in the normal 
epidermis and BCC tumour cells in addition to the observation of Ghali and colleagues 
(1999) of cytoplasmic localisation of Gli-1 in BCC needs to be resolved by further 
studies as it could be important in establishing the functions of Gli-1 as a repressor or 
activator.
204
4.8. Actin and major adherens junctions components in normal epidermis, hair 
follicle and BCC
Distribution of actin filaments, E- and P-cadherin, a- and p-catenin, and a-actinin in 
BCC and adjacent normal skin was examined by immunofluorescent staining.
In normal epidermis, the results of immunofluorescent staining of E- and P-cadherin, a- 
and p-catenin were similar to immunoperoxidase which were consistent with the 
presence of a normally functioning cadherin/catenin complex in AJ.
The use of TRITC-labelled Phalloidin allowed the detection of actin filaments in human 
skin upon immunofluorescent staining. Keratinocytes in human normal epidermis have 
been shown to express weak staining of actin filaments which were arranged in parallel 
bundles beneath the cell membrane (Metze et al., 1996). In my work, apart from the 
strong immunofluorescent staining in the granular layer, actin filaments were rarely seen 
in the normal epidermis. These findings are consistent with previous reports (McNutt, 
1976; Kumakiri and Hashimoto, 1978; Jones et al., 1989; Metze et al., 1996).
In the hair follicle, Sugiyama and colleagues (1983) have used electron microscopy to 
demonstrate actin-like microfilaments in the ORS cells. By using Phalloidin-TRITC, 
my data has demonstrated that the ORS cells contain prominent actin filaments 
concentrated at the periphery of the cells with occasional radial arrangement. These 
filaments may play a role in the cytoskeletal function to maintain the normal polygonal 
shape of the cell by the association with the cell membrane. Additionally, the 
periadnexal connective tissue sheath and arrector pili muscle also contain prominent 
actin filaments which could represent staining of smooth muscle actin. Similar findings 
in ORS cells have recently been reported by Furumura and Ishikawa (1996) and (in 
abstract form) by Chan and co-workers (1997).
Although actin filaments were not seen in the basal cells of the normal epidermis, such 
actin filaments in the hair follicle and stromal surroundings may be involved in the 
adhesive system between the epithelial follicle and the surrounding dermal components. 
a-Actinin is a major component of the AJ (Arikawa and Williams 1991; Knudsen et al., 
1995; reviewed by Cowin and Burke, 1996). Although the immunofluorescent staining 
of a-actinin in normal epidermal cells was largely cytoplasmic, the enrichment of this
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protein often seen at normal cell peripheries is in agreement with previous 
immunohistochemical studies on epithelial cells (Graig and Pardo, 1979; Geiger et al., 
1979; Sanger et al., 1983; Drenckhahn and Franz, 1986). The double immunolabelling 
results of E- and P-cadherin, a- and P-catenin with TRITC-labelled Phalloidin in normal 
epidermis revealed separate localisation of these proteins from actin filaments which is 
consistent with indirect association of these proteins with the actin-based cytoskeleton. 
However, my data provides evidence of co-localisation between a-actinin and actin 
filaments at the plane of plasma membrane in some normal cells. This co-localisation 
emphasises the close association of a-actinin with actin filaments and its important role 
for the anchorage of actin filaments to the plasma membrane.
Cell movement is thought to be driven largely by the polymerisation of actin monomers 
into filaments near the plasma membrane (Machesky and Way, 1998). Differences in 
actin filaments distribution and cell shape have been examined in cultured human 
epidermal keratinocytes (Kubler et al., 1991). In their study, Kubler and colleagues 
have shown that in the basal cells at the edges of the colonies, the actin filaments were 
concentrated at the leading edges of the cells whereas further from the substratum, 
transcellular actin filaments were not visible and instead they were concentrated at the 
lateral cell membranes with short bridges apparently connecting individual cells at AJ as 
evidenced by the presence of vinculin.
The presence of actin in human cancer cells, including BCC, has been studied 
previously by means of immunofluorescent staining using anti-actin antibodies and 
electron microscopy (Gabbiani et al., 1976; McNutt, 1976; Kumakiri and Hashimoto, 
1978; Jones et al., 1989). Anti-actin antibodies detect the total actin and do not 
necessarily demonstrate the distribution of filamentous actin in tissue. The studies of 
(Gabbiani et al., 1976; McNutt, 1976; Kumakiri and Hashimoto, 1978; Jones et al., 
1989) have demonstrated an increase in actin-like microfilaments in BCC tumours. 
Such microfilaments were also found in epidermal cells during wound healing (Martin 
and Lewis, 1992). Although the actin microfilaments found in BCC in the previous 
studies were located within fingerlike cytoplasmic extensions, they were also located at 
the periphery of individual cells and their density was highest at tumour borders. In 
addition, using anti-actin antibodies, Low and colleagues (1981) have reported no
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substantial change of immunofluorescent staining for actin in BCC and other tumours 
cell lines compared to normal control tissues. Similar findings have been reported by 
Kitano (1988) using Rhodamine-phalloidin. However, in a previous study, McNutt 
(1976) reported that the most striking increase in actin filament is in the most infiltrative 
subtypes of BCC such as the morphoeic BCC.
By using TRITC-labelled Phalloidin, my data has shown that actin polymerisation into 
filament bundles dramatically increases in tumour cells as they penetrate into the dermis 
from their connections with the normal epidermis. Nodular BCC is characterised by 
lobular masses of various shapes and sizes embedded in the dermis. The tumour lobules 
of this subtype have a rounded smooth outline and well-developed palisading similar to 
the superficial subtype (Lever and Schaumburg-Lever, 1990a; McKee, 1996a). My data 
has shown actin polymerisation into filament bundles in nodular BCC, however, actin 
bundles were located peripherally beneath the cell membrane where single actin 
filaments were rarely observed. This may explain the stability of cell shape seen in 
nodular BCC. In contrast to nodular BCC and normal epidermis, actin filament 
polymerisation was strikingly increased in infiltrative subtypes. The growth pattern of 
infiltrative BCC is characterised by narrow tongues and aggregates of malignant 
epithelium that extend deeply into the adjacent fibrous stroma with spindly irregular 
configuration and poorly developed peripheral palisading (du Vivier and McKee, 1993a; 
MacKie, 1996a). These results, combined with the data on reduced E-cadherin, a- and 
p-catenin, and a-actinin in BCC, suggest that increased actin filaments polymerisation 
(stress fibers) is related to the infiltrative growth pattern. In addition, the highest density 
of actin stress fibers in certain lobular aspects of the infiltrative BCC may indicate the 
direction of the growing edge of the tumour. My data has shown the presence of bright 
actin filament immunofluorescent staining in the stromal cells surrounding the tumour. 
This provides evidence of a myofibroblast phenotype resembling that seen in the 
periadnexal fibrous tissue sheath pointing to a possible adhesive system between the 
tumour lobules and its surrounding stroma.
My data has shown differences in the actin immunofluorescent staining between normal 
epidermal cells and tumour cells of BCC, particularly infiltrative subtype, reflecting a 
dramatic increase in actin filaments polymerisation (stress fibers) in tumour cells. In
207
general, BCC has a low metastatic potential (Domarus and Stevens, 1984; Lo et al., 
1991) and nodular BCC, in particular, retain normal basal polarity (Lever and 
Schaumburg-Lever, 1990a). Therefore, both the increase in actin filaments 
polymerisation and the decrease of E-cadherin, a - and P-catenin and a-actinin observed 
in this current study of BCC are probably related to invasiveness rather than rapid 
growth and potential for metastasis. Thus, in addition to the decrease of E-cadherin, a- 
and p-catenin and a-actinin, the striking increase in actin filaments polymerisation 
(stress fibers) in tumour cells, not seen in normal epidermis and nodular BCC, could be 
related to enhanced tumour cell motility as they lose cell-cell contacts and thus the 
invasive growth pattern seen in infiltrative BCC.
The double immunolabelling results of most tumour cells in nodular and infiltrative 
BCC have shown separate localisation of E- and P-cadherin, a- and P-catenin from actin 
filaments particularly in the central aspects of the tumour lobules. However, my data 
demonstrated that a portion of E- and P-cadherin, a-catenin and a-actinin was co­
localised with actin filaments, especially in peripheral tumour cells, at the plane of the 
plasma membrane. The co-localisation of a-catenin and a-actinin with the actin 
filaments, seen mostly in peripheral cells, could be explained by the interactive role of 
a-catenin where it connects the membrane associated complex (E-cadherin and p- 
catenin) to the actin-based cytoskeleton by either direct association with actin filaments 
via its amino and carboxyl termini or indirectly by association with a-actinin, another 
actin binding protein (Knudsen et al., 1995; Rimm et al., 1995; reviewed by Cowin and 
Burke, 1996). In addition, the co-localisation of E- and P-cadherin with actin filaments 
in some tumour cells may indicate a direct physical association, however the functional 
significance of such co-localisation remains to be determined.
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4.9. Co-localisation of E-cadherin with P-cadherin in normal epidermis and BCC
One of the documented features of normal human skin is the expression of two 
cadherins. Normal epidermal keratinocytes and melanocytes express both P-cadherin 
and E-cadherin on their cytoplasmic membranes where they maintain adhesion between 
these cells by homophilic binding (Fujita et al., 1992; Tang et al., 1994; Horiguchi et al., 
1994; Lewis et al., 1994). The overall staining patterns of E- and P-cadherin observed 
in this current study, either by immunoperoxidase or immunofluorescent staining, were 
as reported previously. E-Cadherin was distributed in the full thickness of the epidermis 
excluding the stratum comeum (Shimoyama et al., 1989; Horiguchi et al., 1994; Moles 
and Watt, 1997), with an increased expression in the suprabasal layers as compared with 
the basal cells (Cano et al., 1996), whereas P-cadherin was restricted to the basal 
proliferative compartment (Hirai et al., 1989; Cano et al., 1996; Moles and Watt, 1997). 
In the hair follicle, both cadherins were strongly expressed in the outer root sheath cells 
(Fuller et al., 1996; Cano et al., 1996; Muller-Rover et al., 1999). In view of these 
findings, this present study considered of great interest the investigation of possible co­
localisation between E- and P-cadherin in the basal and suprabasal cells of the normal 
epidermis and relate it to their expression and possible co-localisation in BCC by double 
immunolabelling.
My experiments have demonstrated that E-cadherin is co-localised with P-cadherin at 
the membranes of the basal and the first layer of the suprabasal epidermal cells. Similar 
observation was also noted in the outer root sheath cells of the normal hair follicle 
which was within limits of resolution.
This finding of coexpression in the proliferating region of the normal epidermis is of 
interest because of the evidence that cadherins are considered to be important regulators 
of skin morphogenesis and cell sorting (Nose et al., 1988; Hirai et al., 1989; Takeichi, 
1991; Takeichi, 1995) and may regulate keratinocytes growth, differentiation (Zhu and 
watt, 1996) and human epidermal stratification (Jensen et al., 1997). In view of the 
results of these studies, the co-expression of E- and P-cadherin in epidermal basal cells 
suggests that cadherins in this particular region are involved not only in maintaining 
cell-cell adhesion and regulating intercellular junction organisation but may also be 
involved in other specific regulatory mechanisms. Cadherins may play a role in the
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downregulation of integrin expression that is associated with terminal differentiation 
(Hodivala and Watt, 1994). Therefore, they may regulate integrins expression in the 
cell-extracellular matrix adhesion. Moreover, the co-localisation of E- and P-cadherin 
was taken to higher resolution which showed that they were not segregated in basal cell 
membranes. These results suggest that E- and P-cadherin could be in the same junction 
plaque.
Because the expression of P-cadherin seemed to be associated with the proliferating 
activity of cells (Hirai et al., 1989), it is restricted to the basal cells of the normal 
epidermis segregating the epidermal proliferative compartment from the upper non­
proliferating strata. Additionally, although my data demonstrated co-localisation of E- 
cadherin and P-cadherin in the membranes of basal and suprabasal cells, either of them 
may still have unique function(s) in this region.
In BCC, double immunolabelling data has revealed co-localisation of both cadherins in 
a substantial number of tumour cells. However, the majority of tumour cells 
demonstrated preservation of membranous P-cadherin only. More interestingly, 
throughout the tumour lobules there were no tumour cells expressing only E-cadherin. 
E-Cadherin is considered to be the major adhesion molecule found in normally 
functioning AJ (Takeichi, 1988). In addition, its loss occurs in association with human 
epithelial cancers (Fuller et al., 1996; Perl et al., 1998; Cano et al., 1996). Therefore, in 
my work, the double immunolabelling data of E- and P-cadherin in BCC further support 
the earlier discussion, mentioned above, regarding the possibility of stepwise loss of 
cadherins in which E-cadherin may be lost first then P-cadherin loss follows when the 
tumour acquire very aggressive behaviour and is about to metastasise.
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4.10. Double IF staining of E- and P-cadherin and P-catenin with actin in 
keratinocyte cultures
AJ of cell-cell type, distinct from desmosomes, are present in human normal epidermis 
and cultured keratinocytes (Kaiser et al., 1993). Normal keratinocytes express both P- 
cadherin and E-cadherin, which are the cell-cell adhesion molecules of the AJ, on their 
cytoplasmic membranes where they maintain adhesion between these cells by 
homophilic binding (Fujita et al., 1992; Tang et al., 1994; Horiguchi et al., 1994; Lewis 
et al., 1994). As revealed by electron microscopy, focal contacts representing cell- 
substrate adhesion are found in vitro at sites of attachment of fibroblasts to the culture 
surface (Abercrombie et al., 1971).
Proteins known to be associated with AJ such as E-cadherin, P-catenin, vinculin and 
actin can be detected by immunofluorescence at the periphery of the cells in normal 
epidermis and cultured keratinocytes suggesting the presence of AJ in keratinocytes in 
vivo and in vitro (O’Keefe et al., 1987; Kubler et al., 1991; Kaiser et al., 1993; 
Horiguchi et al., 1994; Haftek et al., 1996). In keratinocyte culture, the formation of AJ 
is rapidly induced by shifting the calcium from low to physiologic concentrations 
(O’Keefe et al., 1987; Kubler et al., 1991; Lewis et al., 1994; Cooley et al., 1996).
Using immunofluorescent staining and confocal laser microscopy, my experiments have 
demonstrated that keratinocyte cultured in low calcium (0.1 mM Ca2+) grew in a loose 
colonial morphology and showed weak E-, P-cadherin and p-catenin membrane 
immunofluorescent staining and a diffuse polymerisation of actin filaments. In contrast, 
when the cultures were exposed to higher calcium concentration (1.5 mM Ca2+), cells 
showed stronger staining of the cell adhesion molecules and associated more closely. 
However, in the high calcium condition, actin filaments, where positive, were prominent 
throughout the colonies and particularly in the basal cells at the borders of the wound 
where strong E-, P-cadherin and p-catenin membrane immunofluorescent staining was 
seen at or just behind the leading edge of the migrating cells. In addition, most of the 
cells behind the leading edge showed prominent actin filaments which were distributed 
at the lateral cell membrane in a pattern similar to that in nodular BCC. However, in 
keratinocytes grown in high calcium, the distribution of actin filaments was 
accompanied by strong E-, P-cadherin and p-catenin membrane immunofluorescent
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staining in agreement with a recent report on E-cadherin and filamentous actin staining 
in keratinocytes and dendritic cells (Jakob et al., 1999). This may indicate that the cells 
grown in low calcium which moved individually were less motile as they migrated into 
the wound but failed to close it completely. In contrast, the cells grown in high calcium, 
particularly at the leading edge, migrated in a sheet-like colony and closed the wound 
completely. In addition, they showed increased actin polymerisation in which 
prominent bundles of actin filaments were arranged in groups of short stress fibers 
similar to that in infiltrating BCC cells which may indicate that the cells grown in high 
calcium conditions are more motile than those grown in low calcium conditions.
The strong immunofluorescent membrane staining of P-catenin in high calcium 
conditions and its absence in the nucleus were similar to the immunoperoxidase staining 
in the normal epidermis. In addition, stratification of keratinocytes was more obviously 
noted in colonies grown in high calcium concentration when compared with those 
grown in low calcium in agreement with previous reports (Hodivala and Watt, 1994; 
Lewis et al., 1994).
There is evidence that the proper function of classic cadherins is a prerequisite for 
desmosomes assembly in keratinocytes upon calcium elevation (Amagai et al., 1995). 
My data indicated that AJ were properly assembled in high calcium conditions hence the 
presence of strong E-, P-cadherin and p-catenin membrane staining when compared to 
the low calcium conditions. This is consistent with the notion that cadherin/catenin 
complex is the functional unit for the Ca2+-dependent cell-cell adhesion. 
Cadherin/catenin complexes have specialised roles in establishing and maintaining the 
structural and functional organisation of polarised epithelial cells (Nathke et al., 1994). 
In my experiments, the tight adhesion of cells in high calcium cultures, in contrast to the 
loose colonial morphology in low calcium conditions, and the strong membrane staining 
of the cell adhesion molecules may emphasise the possible important function of the 
cell-cell AJ in the maintenance of the structural integrity of the epithelial sheet. In 
addition, the double immunolabelling results of E-, P-cadherin and p-catenin with 
TRITC-labelled Phalloidin in both low and high calcium keratinocyte cultures revealed
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separate localisation of these proteins from actin filaments implying an indirect 
association of these proteins with the actin-based cytoskeleton.
E-Cadherin is considered to be the major adhesion molecule found in normally 
functioning cell-cell type AJ (Takeichi, 1988; Tang et al., 1994). Lewis and colleagues 
(1994) provided evidence that in the presence of anti-E-cadherin antibody, P-cadherin is 
detected at the cell-cell borders prior to any of the other cell adhesion molecules which 
suggested that P-cadherin may substitute for E-cadherin with regard to its regulatory 
role. In my work, at cell-cell contacts, the strong P-cadherin membrane staining in high 
calcium conditions, similar in intensity to that of E-cadherin, may suggest that it is not a 
minor component of the AJ. In addition, the observation of numerous small and bright 
structures of E-cadherin immunofluorescent staining, reminiscent of focal adhesion and 
not seen in a low calcium conditions, at the cell-substrate interface may suggest that the 
distribution of E-cadherin in keratinocyte cultures is different from that in normal 
epidermis. Further studies are needed since this observation may indicate an 
involvement of E-cadherin in cell-substrate contacts in vitro and a possible interaction 
with the integrins since they are expressed primarily at these junctions (Carter et al., 
1990; reviewed by Hynes, 1992; Sheppard, 1996; Aplin et al., 1998) and they may be 
involved in cytoskeletal interactions (Tamura et al., 1990).
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4.11. BCC culture
Although BCC is a slow-growing tumour which metastasises exceptionally rarely 
(Domarus and Stevens, 1984; Lo et al., 1991), it is capable of gross tissue destruction 
(Leffell et a l, 1991; Ko et al., 1992; McKee, 1996a).
Unlike other cutaneous tumours such as SCC and malignant melanoma, attempts to 
grow BCC in primary cultures have not been found to be successful (Van Scott et al., 
1961; Flaxman, 1972; Cooper et al., 1977; Bradbeer et al., 1988; Asada et al., 1992). In 
most of BCC culture reports, tumour cells, dispersed from BCC-containing skin, were 
usually seeded in serum-free keratinocyte growth medium directly into plastic tissue 
culture flasks, tissue culture wells or Petri dishes which may or may not be coated with 
type I or type IV collagen (Hernandez et al., 1985; Barsky et al., 1987; Brysk et al., 
1992; Grando et al., 1996). Using a simple feeder-layer technique, Asada et al (1992) 
reported cultures of 73% of all BCC explants which showed characteristic and 
reproducible patterns of growth, keratin expression and ultrastructural differentiation 
distinguishing them from epidermal basal cells. Hernandez and colleagues (1985) 
reported an establishment of epithelial cell colonies from about 50% of cultured nodular 
BCC using tissue culture plates coated with type IV collagen, which enhances the 
attachment of the cultured cells. From our laboratory experience, coating the surfaces 
of the tissue culture flasks with a layer of neat FCS for few minutes was found to 
enhance the attachment of keratinocytes to the surfaces more quickly. By using similar 
materials and methods to the previous report (Hernandez et al., 1985), my preliminary 
data has shown that tumour cells failed to attach to culture surfaces coated with FCS 
and/or with collagen where they eventually died within 5-7 days of culture. This result 
could be due to the presence of some FCS in the culture condition as BCC cells in 
culture have been reported to differentiate when cultured in serum-containing media or 
as explant cultures (Bradbeer et al., 1988; Asada et al., 1992) probably due to an 
elevated Ca concentration. Although Brysk and colleagues (1992) reported 
establishing undifferentiated cultures of BCC in a serum-free and low-Ca2+ (0.1 mM) 
medium, they observed the formation of comified envelopes and the expression of a 
differentiated phenotype (as with normal cells) when the Ca2+ concentration of the 
keratinocyte growth medium was increased. In addition, as normal human keratinocytes 
may possibly suppress the growth of BCC cells (Grando et al., 1996), the presence of
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these cells in addition to other dermal components in my experiments might have 
inhibited BCC cell attachment and/or growth.
Following these unsatisfactory results and as a new approach, my study attempted to 
introduce a tissue-culture model system for BCC by seeding tumour-derived cells onto 
dermal equivalents. Degradation of dermal equivalents which was observed in the 
preliminary experiments using a specimen of an infiltrative BCC occurred over a short 
period of time. In their study of nodular BCC, Hernandez and colleagues (1985) 
reported that BCC-derived epidermal cell colonies released an Interleukin-1-like 
mediator which may increase fibroblast proliferation and production of both collagenase 
and hyaluronic acid. Therefore, they suggested that BCC in vivo may regulate 
fibroblasts functions and mediate some of the changes in its surrounding connective 
tissue matrix. Previous reports have suggested that the source of high interstitial 
collagenase type I in BCC could be from the fibroblasts composing the abnormal 
connective tissue stroma surrounding the tumours (Bauer et al., 1977; 1979). However, 
sclerosing BCC, but not superficial and nodular, tumour cells produce type IV 
collagenase (Barsky et al., 1987). Therefore, the massive degradation of dermal 
equivalents, observed in my experiments, could be due to several reasons: firstly, due to 
the production of collagenase by infiltrative BCC cells, secondly due to a fibroblast- 
derived collagenase activity released either from BCC stromal cells or dermal equivalent 
fibroblasts upon interaction with BCC cells. The absence of dermal equivalent 
degradation using superficial and nodular BCC in comparison with the data using 
infiltrative BCC may support the observations of Barsky and colleagues (1987) 
indicating that the various subtypes of BCC differ in their degrading properties in vitro 
and may explain the more aggressive behaviour of infiltrating BCC clinically.
Grando and co-workers (1996) introduced a calcium shift from 0.9 to 1.6 mM to allow 
selective elimination of normal keratinocytes from the primary mixed-cell cultures of 
BCC. Although during incubation with high calcium concentration some cells flattened, 
elongated and stratified, they reported that the BCC cells neither comified nor died and 
when returned to low calcium concentration they continued to grow. In my work, the 
observation of viable tumour cells after 11 days of BCC culture, although not 
proliferating, may allow future studies using dermal equivalents as a potential model for
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BCC culture. This can be pursued further by the culture of pure BCC cells, derived 
primarily from superficial and nodular tumours, using dermal equivalents and the 
purifying technique of Grando and colleagues (1996).
21 6
Chapter 5: Conclusions
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Conclusions
1. There was good agreement between the E- and P-cadherin, a- and p-catenin staining 
of the membranes in routinely processed, paraffin-embedded and frozen samples.
2. The restricted expression of P-cadherin to the basal cells of the normal epidermis 
may indicate a possible association with the maintenance of the epidermal 
proliferative compartment. Expansion into suprabasal layers in benign hyper­
proliferation and pre-malignant lesions may indicate that this molecule is 
proliferation-associated rather than a marker for malignant transformation.
3. Double immunolabelling of E- and P-cadherin revealed co-localisation of both 
cadherins in the basal and first suprabasal layer of the normal epidermis. Such co­
localisation may have properties in common concerning specific regulatory 
mechanisms. The co-localisation of E- and P-cadherin was taken to higher resolution 
which showed that they were not segregated in basal cell membranes which suggests 
that E- and P-cadherin could be in the same junction plaque.
4. The reduction in tumour cell membrane E-cadherin, a- and p-catenin in comparison 
with the normal epidermis is a characteristic in BCC and SCC, particularly those 
tumours with aggressive behaviour, but not in non-malignant lesions.
5. The decrease in membranous distribution of E- and P-cadherin, a - and P-catenin in 
superficial, nodular BCC, well-differentiated SCC and malignant melanoma 
progressed further in dedifferentiated and metastatic tumours in a direct proportion 
relationship.
6. The preserved E-cadherin membrane staining in the palisading cells of the BCC 
tumour lobules may indicate that E-cadherin is one of multiple biological factors 
involved in the prevention of free stromal invasion and metastasis. However, this 
function of E-cadherin, if present, is lost in both well- and moderately-differentiated
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SCC hence there was no preservation of E-cadherin expression in the tumour cells at 
the peripheries of SCC lobules.
7. Downregulation or loss of E-cadherin but not of P-cadherin, particularly in BCC and 
SCC tumours with less aggressive behaviour, in addition to the double 
immunolabelling results of E- and P-cadherin in BCC may point to a stepwise loss of 
the cadherins during tumour progression in which E-cadherin may be lost first then 
P-cadherin loss follows when the tumour acquire very aggressive behaviour and is 
about to metastasise.
8. The detection of nuclear p-catenin staining in Bowen’s disease and BCC in addition 
to pilomatrixoma is novel as it suggests that dysregulation of p-catenin cellular 
distribution may be common to several pathways leading to epidermal 
carcinogenesis.
9. The nuclear localisation of P-catenin in tumour cells of pilomatrixoma in comparison 
with the normal epidermis is characteristic of this tumour.
10. While activation of p-catenin by mutation may be a primary event in pilomatrixoma, 
it seems more likely that in BCC and Bowen’s disease nuclear localisation of p- 
catenin would be secondary to activation of the Wnt pathway or possibly due to 
redistribution of P-catenin as a result of disruption in AJ.
11.Gli-1 nuclear localisation in BCC strongly supports the evidence which indicates that 
Gli-1 may be a transcriptional activator in which it provides evidence for the 
activation of the Shh/Ptc signalling pathways in this tumour.
12.The dramatic increase in actin filaments polymerisation (stress fibers) in infiltrative 
BCC when compared with the nodular subtype and normal epidermis indicates a 
relation to the infiltrative growth pattern of BCC rather than rapid growth. This was 
accompanied by decreased membrane staining of the cell adhesion molecules E-
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cadherin, a- and P-catenin and a-actinin emphasising enhanced tumour cell motility 
and thus invasion.
13.The double immunolabelling results of normal skin and most tumour cells in nodular 
and infiltrative BCC have shown separate localisation of E- and P-cadherin, a- and 
p-catenin from actin filaments. However, a portion of E- and P-cadherin, a-catenin 
and a-actinin was co-localised with actin filaments at the plane of the plasma 
membrane. The co-localisation of a-catenin and a-actinin with the actin filaments 
could be explained by the interactive role of a-catenin where it connects the 
membrane associated complex (E-cadherin and p-catenin) to the actin-based 
cytoskeleton.
14.Results of keratinocyte culture indicate that the cells grown in low calcium were less 
motile (similar to nodular BCC) as they showed weak and diffuse actin staining and 
migrated into the wound but failed to close it completely, while the cells grown in 
high calcium were more motile as they showed increased actin filament 
polymerisation (similar to infiltrative BCC) and migrated in a sheet-like colony and 
closed the wound completely.
15.AJ were properly assembled in high calcium conditions hence the presence of strong 
E-, P-cadherin and p-catenin membrane staining when compared to the low calcium 
conditions.
16.The tight adhesion of cells in high calcium cultures may emphasise the possible 
important function of the cell-cell AJ in the maintenance of the structural integrity of 
the epithelial sheet.
17.The double immunolabelling results of E-, P-cadherin and p-catenin with TRITC- 
labelled Phalloidin in both low and high calcium keratinocyte cultures revealed 
separate localisation of these proteins from actin filaments implying an indirect 
association of these proteins with the actin-based cytoskeleton.
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18.The observation of numerous small and bright structures of E-cadherin 
immunofluorescent staining, reminiscent of focal adhesion and not seen in a low 
calcium conditions, at the cell-substrate interface may suggest that the distribution of 
E-cadherin in keratinocyte cultures is different from that in normal epidermis.
19.The massive degradation of dermal equivalents could be due to several reasons: 
firstly, due to the production of collagenase by infiltrative BCC cells, secondly due to 
a fibroblast-derived collagenase activity released either from BCC stromal cells or 
dermal equivalent fibroblasts upon interaction with BCC cells.
20.The absence of dermal equivalent degradation using superficial and nodular BCC in 
contrast to the massive degradation using infiltrative BCC strongly suggest that the 
various subtypes of BCC differ in their degrading properties in vitro and may explain 
the more aggressive behaviour of infiltrating BCC clinically.
21.In general, the results of BCC culture were not satisfactory, however, modification of 
the technique used in my work may allow future studies using dermal equivalents as 
a potential model for BCC culture.
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Appendix A
Routine tissue processing, embedding and section cutting
At the Department of Dermatology, University of Glasgow, the following steps are
undertaken for routine specimen preparation, processing, embedding and cutting:
1. Tissue specimens are carefully identified and placed immediately into 10% formalin 
which is the routine fixative used in this department.
2. Usually, tissue specimens are left in the fixative solution for a minimum of 12 hours, 
but small specimens may only need 6 hours and larger specimens a longer period of 
fixation.
3. After fixation, the tissue specimen is removed from the container and double checked 
by the consultant dermatopathologist that it corresponded with the details given on 
the request form.
4. Tissue specimen is described macroscopically with rough diagram and details of the 
specimen cut up is produced according to the provisional diagnosis and macroscopic 
information.
5. Specimen is orientated in small plastic cassettes ready for processing.
6. Tissue processing (dehydration and clearing) is carried out overnight by the use of an 
enclosed pumped fluid type automated machine. Dehydration is the removal of 
aqueous fixative and any tissue water whereas clearing is the use of xylene which is 
totally miscible with both the dehydrating agent that precede it, and the embedding
agent that follows it. Processor used: Shandon " Citadel 2000”
cycle used: step 1 50% meths 1 hour
step 2 80% meths 1 hour
step 3 8% phenol meths 2 hours
step 4 8% phenol meths 3 hours
step 5 Alcohol 2 hours
step 6 Alcohol 2 hours
step 7 Alcohol 2 hours
step 8 50% Alcohol/Histoclear 1 hour
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step 9 Histoclear
step 10 Histoclear
step 11 Wax I
step 12 Wax II
1 hour
1 hour
2 hours
3 hours
(step 12 - Wax II is under vacuum)
7. Next morning, the tissue specimen is removed from the machine and embedded in 
paraffin wax at 60°C. Embedding of tissues is carried out using the Shandon 
Histocentre 2. Cassettes are removed from the tissue processor and placed in the 
holding pan of the Histocentre. There are three sizes of moulds which are used to 
accommodate the specimen. The mould is filled with wax and the specimen is 
orientated in the base of the mould. The tissue is placed with the face to be sectioned 
down and with the epidermis to the top (North Side) of the mould. The mould is 
sledded over to the cold plate and left to harden for approximately 15 minutes.
8. Paraffin sections are routinely cut within this department on a Leitz (UK) 1501 rotary 
microtome. Paraffin sections were cut as follows:-
• Excess wax should be removed from the tissue cassette to ensure that the 
specimen is held rigidly when inserted into the block holder.
• The cassette to be cut should be secured in the block holder and the section 
thickness required is set. For routine purposes sections are usually cut at 3 pm.
• Sections are cut by a clockwise rotation of the microtome arm, leaving either a 
single section or a ribbon of sections, resting on the knife.
• The sections are lifted by means of forceps and a section brush, and floated out 
on a water bath of fresh distilled water at 56°C.
• The sections are lifted from the water bath onto a glass slide, with the epidermis 
side to the right hand edge. This is accomplished by half immersing the slide in 
the water bath, just touching the floating section, and using an upward and 
slightly forward motion, lifting the section onto the centre of the slide.
• The slides are allowed to dry on a 60°C hot plate before being baked for 30 min 
at 80°C.
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Appendix B
1. Coating slides with Silane
To prevent detachment of tissue from slides during pre-treatment and washing steps, 
glass microscope slides should be Silane coated. Slides were immersed in alcohol for 
10 seconds then incubated in 1% Silane (Sigma chemical Co, St. Louis, Mo, USA) in 
acetone for 10-15 seconds and then immersed in acetone for 10 seconds. Finally, the 
slides were washed in running tap water tap for 1 min and incubated overnight at 37°C.
2. Staining in Vector VIP (chromagen) substrate kit for peroxidase
When the working solution of the Vector VIP substrate kit is prepared, it can be used for 
staining tissue sections or nitrocellulose, nylon, or other membranes. Vector VIP 
reagents are supplied in dropper bottles. It produces a purple reaction product which is 
also suitable for electron microscopy. The substrate solution should be prepared 
immediately before use on tissue sections in immunohistochemical staining.
The substrate solution is prepared as follows:
1. To 5 ml of TB pH 7.6, 3 drops of reagent 1 was added and mixed well.
2. Three drops of reagent 2 was added and mixed well.
3. Three drops of reagent 3 (chromagen) was added and mixed well.
4. Three drops of the hydrogen peroxide solution was added and mixed well.
Tissue sections were incubated with the substrate at room temperature until suitable 
staining has developed. Generally, 2-15 min provides good staining intensity. Tissue 
sections were then washed in running tap water for 5 min before counter-staining and 
mounting.
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Appendix C
Preliminary experiments
Preliminary experiments with immunohistochemical staining of the antibodies used in 
this study (Table 2) in routinely processed, paraffin-embedded and frozen material in 
addition to keratinocyte culture were carried out to reach the final and the best staining 
results. Briefly, these were:
1. Routinely processed, paraffin-embedded tissue:
First, the immunoperoxidase staining of the antibodies used in this work was undertaken 
in untreated sections of normal skin. Several antibody dilutions, incubation times and 
temperatures were tested. The staining results were patchy with frequent over-stained 
cells and high background staining. Similar results were obtained when the experiments 
were repeated using routinely processed sections of tumours. Accordingly, the staining 
of the antibodies was conducted on pre-treated sections. The pre-treatment of the 
sections (see methods) was by one of the following methods:
• Subjecting sections to microwaving for 10, 20, and 30 min in 10 mM citrate buffer 
pH 6.0 or in Tris buffer at pH 9.
• Enzymatic digestion using 0.1% pronase Type XV in TB pH 7.6 for 15-20 min at 
room temperature or 0.1% Trypsin Type II-S and 0.1% calcium chloride in distilled 
water for 30 min at 37°C.
• Extraction with 0.5% (v/v) Triton x-100 in DPBS for 5-10 min using gentle agitation.
Variable concentrations of the antibodies listed in Table 2 were tried. In addition, 
several incubation times and temperatures and different normal sera (rabbit, horse, 
swine and human) were tested with each pre-treatment method. The staining quality has 
improved slightly particularly with the microwaving for 30 min in which more specific 
staining was obtained. The best results were obtained with superheating using pressure 
cooking which proved to be effective and reliable method of antigen retrieval showing
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several advantages over other antigen retrieval methods (see table 3 for final 
conditions). In addition, the use of the antibodies (E- and P-cadherin, p-catenin and Gli- 
1) with pressure cooking followed by immunoperoxidase staining of these antibodies in 
routinely processed, paraffin-embedded material will allow the use of the archival tissue 
for future studies of these antibodies in skin and other tissues.
2. Frozen tissue and keratinocyte culture:
The immunoperoxidase staining of E-cadherin and P-catenin in untreated frozen BCC 
revealed good results particularly after fixation in fresh acetone for 1 hour at -20°C and 
incubation overnight at 4°C. Although the antibody concentrations and the incubation 
times and temperatures of E-cadherin and p-catenin were different in each type of tissue 
used (Table 3), there was good agreement between results on routinely processed tissues 
and on freshly frozen material of BCC. However, for E-cadherin and p-catenin staining 
in keratinocyte cultures, sections needed to be fixed in 10% formalin and extracted with 
0.5% (v/v) Triton x-100 in DPBS for 5-10 min using gentle agitation for better results. 
Staining of other antibodies (P-cadherin, a-catenin, a-actinin and Phalloidin) in frozen 
sections of BCC and keratinocyte cultures was performed primarily in untreated 
sections. The results were unsatisfactory. The main pitfall was the presence of many 
over-stained cells. This was resolved by fixing the sections for P-cadherin and a- 
catenin in fresh acetone for 1 hour at -20°C and those for a-actinin and phalloidin in 
10% formalin. In addition, all sections were extracted with 0.5% (v/v) Triton x-100 in 
DPBS for 5-10 min using gentle agitation (Table 3).
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Appendix D
Staining of vinculin, a-actinin and APC
To investigate the possibility that vinculin, a-actinin and APC could be demonstrated in 
paraffin-embedded and cryostat sections of normal epidermis and BCC, several antigen 
retrieval methods were tested. These included (for formalin-fixed, paraffin-embedded 
sections only) pressure cooking either in a 10 mM TB pH 9 or in 10 mM CB pH 6, 
microwaving for 10, 20, and 30 min in the same buffers, enzymatic digestion using
0.1% pronase Type XV in TB pH 7.6 for 15-20 min at room temperature, extraction 
with 0.5% (v/v) Triton x-100 in DPBS for 5-10 min using gentle agitation (for both 
formalin-fixed, paraffin-embedded and cryostat sections) and using no pre-treatment. 
Variable antibody concentrations, incubation times and temperatures and different sera 
were tested.
The main pitfall of the immunostaining results was the associated massive background 
staining involving the dermal collagen bundles, smooth muscles and adipose tissue. 
Several attempts of technical modifications were carried out to reduce the background 
staining. Extended times of incubating the sections with 3% hydrogen peroxide solution 
and normal rabbit and horse sera at different dilutions were tried. In addition to 
manipulating the antibody concentrations, incubation times and temperatures; the 
incubation time with the peroxidase reaction developer (peroxidase substrate kit) was 
reduced to the minimum developing time. The same methodology was repeated again 
after obtaining new batches of vinculin and a-actinin antibodies.
Unfortunately, all these technical alterations were not successful in reducing vinculin, a- 
actinin and APC background staining. However, after 10 experiments, the best results 
of APC staining in formalin-fixed, paraffin-embedded BCC were obtained with no pre­
treatment, using the standard Extra-avidin method, antibody concentration at 1.0 |ig/ml 
and incubation O/N at 4°C. Although few cases were examined, cryostat sections of 
BCC fixed in fresh acetone for 1 hour at - 20°C and extracted with 0.5% (v/v) Triton x- 
100 in DPBS for 5-10 min using gentle agitation have shown similar APC staining 
results.
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In all cases, the staining pattern of APC in normal epidermis adjacent to the tumour, was 
heterogeneous. All cases have shown weakly positive and diffuse cytoplasmic staining 
of APC throughout epidermal layers. Stratum comeum was negative.
Ten of 32 of the cases showed patchy but strongly positive APC staining which was 
often enriched at cell-cell junctions particularly in spinous and granular cells towards 
the specimen margins (Fig 134A). Immunofluorescent staining gave similar results 
(Fig. 135).
Similar findings have recently been reported by Midgley and colleagues (1997). In 
20/32 of the examples, same pattern of APC staining was observed but in reduced 
intensity. Very weak cytoplasmic APC staining was noted in the basal cell layer. In 
addition, the staining of APC in the outer cells of sweat and sebaceous glands was 
largely cytoplasmic whereas outer root sheath cells showed heterogeneous staining as 
described above in normal epidermis. No APC nuclear staining in normal epidermal 
and adnexal cells was seen. The staining in the tumour cells was cytoplasmic (Fig. 
134B) in almost half of the cases whereas it was negative in 17/32 of the cases.
The inconsistency and the different outcome of the immunohistochemical staining 
results of vinculin, a-actinin and APC in normal epidermis and BCC cast a doubt about 
how genuine is the staining in each experiment. Therefore it is inappropriate to draw 
any conclusions based on these results.
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Figure 134. APC staining in normal epidermis and nodular BCC. (A) strong APC staining in 
normal epidermis adjacent to tumour with enrichment at cell-cell junctions particularly in spinous 
and granular cells. (B) Weak cytoplasmic staining o f  APC in tumour cells. x500.
1
Figure 135. Immunofluorescence staining o f  
APC in normal epidermis adjacent to tumour. 
Weak staining with enrichment at cell-cell 
junctions. Scale bar H OO^m .
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Appendix E
Presentations arising from this thesis 
• Poster presentations
1. BSID meeting (April, 1998- Liverpool)
IMMUNOSTAINING OF p-CATENIN AND E-CADHERIN IN PARAFFIN 
EMBEDDED AND FROZEN BASAL CELL CARCINOMA. A.Al-Mvouf. M.B. 
Hodgins, R.M.MacKie, Dept, of Dermatology, University of Glasgow.
The Sonic hedgehog (SHH)/Patched (PTC) signalling pathway is dysregulated in Basal 
cell carcinoma (BCC). During development there is interaction between SHH/PTC and 
Wingless (Wnt) pathways. p-Catenin which associates with E-cadherin in cell-cell 
junctions, is a key component of the Wnt pathway. Activation by Wnt redistributes p- 
catenin to the nucleus to form a complex with T cell factor (Tcf) and lymphoid enhancer 
factor (Lef) transcription factors. The aim of this study was to investigate the cellular 
distribution of p-catenin and E-cadherin in BCC and whether the Wingless pathway is 
activated.
We demonstrated by immunohistochemistry, using monoclonal antibodies and 
microwave antigen retrieval, the distribution of P-catenin and E-cadherin in paired 
paraffin-embedded and frozen specimens of 12 BCC and in a further 20 paraffin- 
embedded BCC. The results have shown uniform membrane staining of p-catenin and 
E-cadherin in normal epidermis in all cases. E-Cadherin staining was reduced in tumour 
cell membranes in 30/32 paraffin-embedded cases (93.8%) and in all the frozen 
samples. Tumour cell membrane staining of p-catenin was reduced in 29/32 paraffin- 
embedded cases (96.6%) and in all the frozen samples. There was good agreement 
between staining of membranes in paraffin-embedded and frozen samples. We 
observed uneven membrane staining of P-catenin and E-cadherin within the tumour 
lobules compared with the normal epidermis ranging from reduced staining intensity to
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complete absence. We also observed variable degrees of diffuse cytoplasmic 
distribution of both antibodies in normal and tumour cells.
Our data has shown that reduction in tumour cell membrane P-catenin and E-cadherin in 
comparison with the normal epidermis is a characteristic in BCC, although it is not yet 
clear whether the decrease in membrane p-catenin is accompanied by a redistribution to 
the cell nucleus.
2. BSID meeting ( April, 2000-Edinburgh) (submitted)
NUCLEAR P-CATENIN IS CHARACTERISTIC OF PILOMATRIXOMA. A.Al- 
Mvouf, M.B. Hodgins and R.M.MacKie, Department of Dermatology, University of 
Glasgow.
Wnt and Sonic hedgehog (Shh) signalling are important in development of epidermis 
and appendages. Dysregulation of Shh has been shown to underlie basal cell 
carcinoma (BCC) but the role of Wnt signalling in epidermal tumourigenesis remains 
unclear. Recently, mutations in p-catenin were found in the hair follicle tumours 
pilomatrixoma (PMX) and trichofolliculoma. In addition to its function in intercellular 
adhesion, p-catenin is a key component of the Wnt pathway. Activation by Wnt 
redistributes P-catenin to the nucleus to form a complex with T cell factor (Tcf) and 
lymphoid enhancer factor (Lef) transcription factors. In an earlier study we found 
evidence for redistribution of p-catenin to the nucleus in only a small proportion of 
BCC.
The aim of this study was to compare the cellular distribution of p-catenin in paraffin- 
embedded BCC and PMX by immunohistochemistry with monoclonal antibodies to 
the N and C terminal domains. There was uniform membrane staining of the N and C 
termini of p-catenin in normal epidermis immediately above the tumour mass in all 
cases. BCC showed reduced membrane p-catenin compared with the normal epidermis 
in most cases (30/32 N- and 29/32 C- termini) and variable, weak nuclear staining in a 
minority (8/32 N-terminus, 13/32 C-terminus). Tumour cell membrane staining of N
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and C termini of P-catenin was evenly reduced in 4/7 PMX but there was strong 
nuclear staining with both the N and C terminal antibodies in all 7 tumours. There was 
also a variable degree of diffuse cytoplasmic distribution of both termini in normal and 
tumour cells.
Our data has shown that nuclear localisation of P-catenin in tumour cells in comparison 
with the normal epidermis is characteristic of PMX. The accompanying decrease in 
membrane p-catenin, in some cases, may indicate a redistribution from cell membrane 
to the nucleus. These results provide evidence that Wnt signalling may be activated in 
some BCC but that this pathway is of particular importance in PMX.
• Oral presentation
Presented at the Skin Biology Club, Falkirk, May (1999) A. Al-Myouf, M.B. Hodgins 
and R.M. MacKie. Localisation of p-catenin in normal skin and basal cell carcinoma.
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